1 | | GO:0009987 | cellular process | 920 | 106 | 12581 | 12673 | 1.84e-158 | 0.90 | 0.50 | 1.8 |
2 | | GO:0008152 | metabolic process | 768 | 258 | 8925 | 16329 | 1.17e-140 | 0.75 | 0.35 | 2.1 |
3 | | GO:0044237 | cellular metabolic process | 721 | 305 | 8197 | 17057 | 1.16e-129 | 0.70 | 0.32 | 2.2 |
4 | | GO:0032502 | developmental process | 462 | 564 | 3683 | 21571 | 4.01e-114 | 0.45 | 0.15 | 3.1 |
5 | | GO:0044238 | primary metabolic process | 691 | 335 | 8164 | 17090 | 1.74e-111 | 0.67 | 0.32 | 2.1 |
6 | | GO:0065007 | biological regulation | 557 | 469 | 5705 | 19549 | 5.03e-102 | 0.54 | 0.23 | 2.4 |
7 | | GO:0050896 | response to stimulus | 432 | 594 | 3524 | 21730 | 1.49e-101 | 0.42 | 0.14 | 3.0 |
8 | | GO:0007154 | cell communication | 484 | 542 | 4781 | 20473 | 1.08e-88 | 0.47 | 0.19 | 2.5 |
9 | | GO:0032501 | multicellular organismal process | 462 | 564 | 4429 | 20825 | 1.83e-87 | 0.45 | 0.18 | 2.6 |
10 | | GO:0006950 | response to stress | 268 | 758 | 1572 | 23682 | 6.81e-85 | 0.26 | 0.06 | 4.2 |
11 | | GO:0048518 | positive regulation of biological process | 255 | 771 | 1429 | 23825 | 4.31e-84 | 0.25 | 0.06 | 4.4 |
12 | | GO:0048856 | anatomical structure development | 335 | 691 | 2500 | 22754 | 1.56e-83 | 0.33 | 0.10 | 3.3 |
13 | | GO:0048869 | cellular developmental process | 311 | 715 | 2205 | 23049 | 1.49e-81 | 0.30 | 0.09 | 3.5 |
14 | | GO:0030154 | cell differentiation | 311 | 715 | 2205 | 23049 | 1.49e-81 | 0.30 | 0.09 | 3.5 |
15 | | GO:0065008 | regulation of biological quality | 251 | 775 | 1457 | 23797 | 8.34e-80 | 0.24 | 0.06 | 4.2 |
16 | | GO:0048522 | positive regulation of cellular process | 237 | 789 | 1298 | 23956 | 2.26e-79 | 0.23 | 0.05 | 4.5 |
17 | | GO:0050789 | regulation of biological process | 481 | 545 | 5055 | 20199 | 3.74e-79 | 0.47 | 0.20 | 2.3 |
18 | | GO:0048731 | system development | 302 | 724 | 2206 | 23048 | 4.72e-76 | 0.29 | 0.09 | 3.4 |
19 | | GO:0048468 | cell development | 249 | 777 | 1519 | 23735 | 3.63e-75 | 0.24 | 0.06 | 4.0 |
20 | | GO:0007165 | signal transduction | 436 | 590 | 4400 | 20854 | 2.60e-74 | 0.42 | 0.17 | 2.4 |
21 | | GO:0048513 | organ development | 258 | 768 | 1653 | 23601 | 3.66e-74 | 0.25 | 0.07 | 3.8 |
22 | | GO:0007275 | multicellular organismal development | 340 | 686 | 2827 | 22427 | 9.99e-74 | 0.33 | 0.11 | 3.0 |
23 | | GO:0008219 | cell death | 193 | 833 | 985 | 24269 | 4.69e-68 | 0.19 | 0.04 | 4.8 |
24 | | GO:0016265 | death | 193 | 833 | 985 | 24269 | 4.69e-68 | 0.19 | 0.04 | 4.8 |
25 | | GO:0012501 | programmed cell death | 188 | 838 | 934 | 24320 | 7.93e-68 | 0.18 | 0.04 | 5.0 |
26 | | GO:0050793 | regulation of developmental process | 193 | 833 | 995 | 24259 | 1.99e-67 | 0.19 | 0.04 | 4.8 |
27 | | GO:0006915 | apoptosis | 186 | 840 | 925 | 24329 | 5.24e-67 | 0.18 | 0.04 | 4.9 |
28 | | GO:0050794 | regulation of cellular process | 439 | 587 | 4741 | 20513 | 1.44e-66 | 0.43 | 0.19 | 2.3 |
29 | | GO:0048519 | negative regulation of biological process | 228 | 798 | 1466 | 23788 | 1.62e-64 | 0.22 | 0.06 | 3.8 |
30 | | GO:0042221 | response to chemical stimulus | 172 | 854 | 827 | 24427 | 1.32e-63 | 0.17 | 0.03 | 5.1 |
31 | | GO:0008283 | cell proliferation | 185 | 841 | 987 | 24267 | 1.87e-62 | 0.18 | 0.04 | 4.6 |
32 | | GO:0006082 | organic acid metabolic process | 143 | 883 | 632 | 24622 | 1.89e-56 | 0.14 | 0.03 | 5.6 |
33 | | GO:0019752 | carboxylic acid metabolic process | 142 | 884 | 629 | 24625 | 6.10e-56 | 0.14 | 0.02 | 5.6 |
34 | | GO:0009605 | response to external stimulus | 172 | 854 | 962 | 24292 | 2.75e-55 | 0.17 | 0.04 | 4.4 |
35 | | GO:0043067 | regulation of programmed cell death | 143 | 883 | 654 | 24600 | 7.26e-55 | 0.14 | 0.03 | 5.4 |
36 | | GO:0042981 | regulation of apoptosis | 142 | 884 | 645 | 24609 | 8.71e-55 | 0.14 | 0.03 | 5.4 |
37 | | GO:0048523 | negative regulation of cellular process | 202 | 824 | 1352 | 23902 | 3.83e-54 | 0.20 | 0.05 | 3.7 |
38 | | GO:0043170 | macromolecule metabolic process | 534 | 492 | 7238 | 18016 | 4.69e-53 | 0.52 | 0.29 | 1.8 |
39 | | GO:0051179 | localization | 357 | 669 | 3860 | 21394 | 5.86e-51 | 0.35 | 0.15 | 2.3 |
40 | | GO:0019538 | protein metabolic process | 355 | 671 | 3837 | 21417 | 1.32e-50 | 0.35 | 0.15 | 2.3 |
41 | | GO:0007242 | intracellular signaling cascade | 226 | 800 | 1789 | 23465 | 1.23e-49 | 0.22 | 0.07 | 3.1 |
42 | | GO:0042127 | regulation of cell proliferation | 134 | 892 | 644 | 24610 | 3.31e-49 | 0.13 | 0.03 | 5.1 |
43 | | GO:0042592 | homeostatic process | 146 | 880 | 807 | 24447 | 3.27e-47 | 0.14 | 0.03 | 4.5 |
44 | | GO:0044260 | cellular macromolecule metabolic process | 339 | 687 | 3710 | 21544 | 8.61e-47 | 0.33 | 0.15 | 2.2 |
45 | | GO:0009056 | catabolic process | 150 | 876 | 878 | 24376 | 7.60e-46 | 0.15 | 0.03 | 4.2 |
46 | | GO:0051093 | negative regulation of developmental process | 107 | 919 | 437 | 24817 | 7.79e-45 | 0.10 | 0.02 | 6.0 |
47 | | GO:0006796 | phosphate metabolic process | 175 | 851 | 1222 | 24032 | 2.76e-44 | 0.17 | 0.05 | 3.5 |
48 | | GO:0006793 | phosphorus metabolic process | 175 | 851 | 1222 | 24032 | 2.76e-44 | 0.17 | 0.05 | 3.5 |
49 | | GO:0009653 | anatomical structure morphogenesis | 177 | 849 | 1260 | 23994 | 8.60e-44 | 0.17 | 0.05 | 3.5 |
50 | | GO:0002376 | immune system process | 166 | 860 | 1117 | 24137 | 9.01e-44 | 0.16 | 0.04 | 3.7 |
51 | | GO:0044267 | cellular protein metabolic process | 325 | 701 | 3588 | 21666 | 1.11e-43 | 0.32 | 0.14 | 2.2 |
52 | | GO:0009611 | response to wounding | 125 | 901 | 639 | 24615 | 2.14e-43 | 0.12 | 0.03 | 4.8 |
53 | | GO:0044248 | cellular catabolic process | 131 | 895 | 720 | 24534 | 1.66e-42 | 0.13 | 0.03 | 4.5 |
54 | | GO:0016310 | phosphorylation | 153 | 873 | 1016 | 24238 | 7.57e-41 | 0.15 | 0.04 | 3.7 |
55 | | GO:0007267 | cell\-cell signaling | 136 | 890 | 813 | 24441 | 1.37e-40 | 0.13 | 0.03 | 4.1 |
56 | | GO:0006468 | protein amino acid phosphorylation | 133 | 893 | 854 | 24400 | 9.18e-37 | 0.13 | 0.03 | 3.8 |
57 | | GO:0007243 | protein kinase cascade | 99 | 927 | 475 | 24779 | 2.29e-36 | 0.10 | 0.02 | 5.1 |
58 | | GO:0032787 | monocarboxylic acid metabolic process | 81 | 945 | 303 | 24951 | 2.38e-36 | 0.08 | 0.01 | 6.6 |
59 | | GO:0006629 | lipid metabolic process | 133 | 893 | 868 | 24386 | 4.16e-36 | 0.13 | 0.03 | 3.8 |
60 | | GO:0043066 | negative regulation of apoptosis | 80 | 946 | 297 | 24957 | 4.17e-36 | 0.08 | 0.01 | 6.6 |
61 | | GO:0043069 | negative regulation of programmed cell death | 80 | 946 | 300 | 24954 | 7.60e-36 | 0.08 | 0.01 | 6.6 |
62 | | GO:0006066 | alcohol metabolic process | 94 | 932 | 436 | 24818 | 1.44e-35 | 0.09 | 0.02 | 5.3 |
63 | | GO:0065009 | regulation of molecular function | 117 | 909 | 687 | 24567 | 1.60e-35 | 0.11 | 0.03 | 4.2 |
64 | | GO:0043687 | post\-translational protein modification | 194 | 832 | 1736 | 23518 | 2.31e-35 | 0.19 | 0.07 | 2.8 |
65 | | GO:0043412 | biopolymer modification | 217 | 809 | 2096 | 23158 | 3.26e-35 | 0.21 | 0.08 | 2.5 |
66 | | GO:0009893 | positive regulation of metabolic process | 105 | 921 | 560 | 24694 | 4.86e-35 | 0.10 | 0.02 | 4.6 |
67 | | GO:0031325 | positive regulation of cellular metabolic process | 103 | 923 | 545 | 24709 | 1.24e-34 | 0.10 | 0.02 | 4.7 |
68 | | GO:0009058 | biosynthetic process | 345 | 681 | 4386 | 20868 | 1.72e-34 | 0.34 | 0.17 | 1.9 |
69 | | GO:0006464 | protein modification process | 211 | 815 | 2032 | 23222 | 3.13e-34 | 0.21 | 0.08 | 2.6 |
70 | | GO:0044255 | cellular lipid metabolic process | 117 | 909 | 717 | 24537 | 5.52e-34 | 0.11 | 0.03 | 4.0 |
71 | | GO:0008284 | positive regulation of cell proliferation | 80 | 946 | 330 | 24924 | 2.23e-33 | 0.08 | 0.01 | 6.0 |
72 | | GO:0009887 | organ morphogenesis | 101 | 925 | 546 | 24708 | 2.74e-33 | 0.10 | 0.02 | 4.6 |
73 | | GO:0043283 | biopolymer metabolic process | 405 | 621 | 5650 | 19604 | 3.11e-33 | 0.39 | 0.22 | 1.8 |
74 | | GO:0006091 | generation of precursor metabolites and energy | 77 | 949 | 308 | 24946 | 6.40e-33 | 0.08 | 0.01 | 6.2 |
75 | | GO:0007166 | cell surface receptor linked signal transduction | 225 | 801 | 2314 | 22940 | 6.57e-33 | 0.22 | 0.09 | 2.4 |
76 | | GO:0007167 | enzyme linked receptor protein signaling pathway | 82 | 944 | 360 | 24894 | 1.51e-32 | 0.08 | 0.01 | 5.6 |
77 | | GO:0006928 | cell motility | 101 | 925 | 572 | 24682 | 7.98e-32 | 0.10 | 0.02 | 4.3 |
78 | | GO:0051674 | localization of cell | 101 | 925 | 572 | 24682 | 7.98e-32 | 0.10 | 0.02 | 4.3 |
79 | | GO:0016043 | cellular component organization and biogenesis | 260 | 766 | 2963 | 22291 | 1.58e-31 | 0.25 | 0.12 | 2.2 |
80 | | GO:0051234 | establishment of localization | 284 | 742 | 3397 | 21857 | 1.89e-31 | 0.28 | 0.13 | 2.1 |
81 | | GO:0006006 | glucose metabolic process | 56 | 970 | 151 | 25103 | 2.14e-31 | 0.05 | 0.01 | 9.1 |
82 | | GO:0044249 | cellular biosynthetic process | 153 | 873 | 1261 | 23993 | 3.87e-31 | 0.15 | 0.05 | 3.0 |
83 | | GO:0006954 | inflammatory response | 86 | 940 | 432 | 24822 | 2.06e-30 | 0.08 | 0.02 | 4.9 |
84 | | GO:0051094 | positive regulation of developmental process | 87 | 939 | 443 | 24811 | 2.20e-30 | 0.08 | 0.02 | 4.8 |
85 | | GO:0048878 | chemical homeostasis | 84 | 942 | 415 | 24839 | 3.66e-30 | 0.08 | 0.02 | 5.0 |
86 | | GO:0019725 | cellular homeostasis | 84 | 942 | 421 | 24833 | 8.81e-30 | 0.08 | 0.02 | 4.9 |
87 | | GO:0019318 | hexose metabolic process | 60 | 966 | 197 | 25057 | 1.03e-29 | 0.06 | 0.01 | 7.5 |
88 | | GO:0035295 | tube development | 63 | 963 | 225 | 25029 | 2.01e-29 | 0.06 | 0.01 | 6.9 |
89 | | GO:0005996 | monosaccharide metabolic process | 60 | 966 | 205 | 25049 | 6.16e-29 | 0.06 | 0.01 | 7.2 |
90 | | GO:0006807 | nitrogen compound metabolic process | 89 | 937 | 490 | 24764 | 6.86e-29 | 0.09 | 0.02 | 4.5 |
91 | | GO:0008015 | blood circulation | 64 | 962 | 240 | 25014 | 7.35e-29 | 0.06 | 0.01 | 6.6 |
92 | | GO:0003013 | circulatory system process | 64 | 962 | 240 | 25014 | 7.35e-29 | 0.06 | 0.01 | 6.6 |
93 | | GO:0001775 | cell activation | 69 | 957 | 286 | 24968 | 8.39e-29 | 0.07 | 0.01 | 5.9 |
94 | | GO:0051239 | regulation of multicellular organismal process | 73 | 953 | 326 | 24928 | 1.14e-28 | 0.07 | 0.01 | 5.5 |
95 | | GO:0044262 | cellular carbohydrate metabolic process | 79 | 947 | 391 | 24863 | 2.27e-28 | 0.08 | 0.02 | 5.0 |
96 | | GO:0005975 | carbohydrate metabolic process | 96 | 930 | 582 | 24672 | 2.93e-28 | 0.09 | 0.02 | 4.1 |
97 | | GO:0006952 | defense response | 114 | 912 | 805 | 24449 | 2.97e-28 | 0.11 | 0.03 | 3.5 |
98 | | GO:0003008 | system process | 175 | 851 | 1689 | 23565 | 4.08e-28 | 0.17 | 0.07 | 2.6 |
99 | | GO:0006631 | fatty acid metabolic process | 61 | 965 | 227 | 25027 | 1.04e-27 | 0.06 | 0.01 | 6.6 |
100 | | GO:0050790 | regulation of catalytic activity | 96 | 930 | 604 | 24650 | 3.55e-27 | 0.09 | 0.02 | 3.9 |
101 | | GO:0043085 | positive regulation of catalytic activity | 69 | 957 | 311 | 24943 | 5.99e-27 | 0.07 | 0.01 | 5.5 |
102 | | GO:0001568 | blood vessel development | 61 | 965 | 240 | 25014 | 1.30e-26 | 0.06 | 0.01 | 6.3 |
103 | | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 61 | 965 | 242 | 25012 | 1.90e-26 | 0.06 | 0.01 | 6.2 |
104 | | GO:0006810 | transport | 263 | 763 | 3274 | 21980 | 2.06e-26 | 0.26 | 0.13 | 2.0 |
105 | | GO:0001944 | vasculature development | 61 | 965 | 244 | 25010 | 2.76e-26 | 0.06 | 0.01 | 6.2 |
106 | | GO:0006955 | immune response | 114 | 912 | 855 | 24399 | 3.02e-26 | 0.11 | 0.03 | 3.3 |
107 | | GO:0045321 | leukocyte activation | 61 | 965 | 251 | 25003 | 9.92e-26 | 0.06 | 0.01 | 6.0 |
108 | | GO:0048646 | anatomical structure formation | 57 | 969 | 219 | 25035 | 2.23e-25 | 0.06 | 0.01 | 6.4 |
109 | | GO:0055082 | cellular chemical homeostasis | 68 | 958 | 329 | 24925 | 4.84e-25 | 0.07 | 0.01 | 5.1 |
110 | | GO:0019222 | regulation of metabolic process | 259 | 767 | 3284 | 21970 | 8.21e-25 | 0.25 | 0.13 | 1.9 |
111 | | GO:0006916 | anti\-apoptosis | 54 | 972 | 203 | 25051 | 1.74e-24 | 0.05 | 0.01 | 6.5 |
112 | | GO:0051186 | cofactor metabolic process | 56 | 970 | 223 | 25031 | 2.63e-24 | 0.05 | 0.01 | 6.2 |
113 | | GO:0001525 | angiogenesis | 50 | 976 | 171 | 25083 | 2.70e-24 | 0.05 | 0.01 | 7.2 |
114 | | GO:0007155 | cell adhesion | 121 | 905 | 1016 | 24238 | 5.83e-24 | 0.12 | 0.04 | 2.9 |
115 | | GO:0022610 | biological adhesion | 121 | 905 | 1016 | 24238 | 5.83e-24 | 0.12 | 0.04 | 2.9 |
116 | | GO:0043065 | positive regulation of apoptosis | 64 | 962 | 307 | 24947 | 8.33e-24 | 0.06 | 0.01 | 5.1 |
117 | | GO:0001666 | response to hypoxia | 36 | 990 | 74 | 25180 | 8.79e-24 | 0.04 | 0.00 | 12.0 |
118 | | GO:0031323 | regulation of cellular metabolic process | 252 | 774 | 3210 | 22044 | 9.39e-24 | 0.25 | 0.13 | 1.9 |
119 | | GO:0035239 | tube morphogenesis | 48 | 978 | 162 | 25092 | 1.40e-23 | 0.05 | 0.01 | 7.3 |
120 | | GO:0006732 | coenzyme metabolic process | 46 | 980 | 146 | 25108 | 1.44e-23 | 0.04 | 0.01 | 7.8 |
121 | | GO:0043068 | positive regulation of programmed cell death | 64 | 962 | 311 | 24943 | 1.52e-23 | 0.06 | 0.01 | 5.1 |
122 | | GO:0006873 | cellular ion homeostasis | 65 | 961 | 324 | 24930 | 2.26e-23 | 0.06 | 0.01 | 4.9 |
123 | | GO:0008371 | obsolete biological process | 72 | 954 | 406 | 24848 | 5.27e-23 | 0.07 | 0.02 | 4.4 |
124 | | GO:0006118 | electron transport | 70 | 956 | 386 | 24868 | 7.05e-23 | 0.07 | 0.02 | 4.5 |
125 | | GO:0009967 | positive regulation of signal transduction | 53 | 973 | 215 | 25039 | 9.40e-23 | 0.05 | 0.01 | 6.1 |
126 | | GO:0016477 | cell migration | 68 | 958 | 369 | 24885 | 1.36e-22 | 0.07 | 0.01 | 4.5 |
127 | | GO:0048514 | blood vessel morphogenesis | 52 | 974 | 210 | 25044 | 2.01e-22 | 0.05 | 0.01 | 6.1 |
128 | | GO:0043549 | regulation of kinase activity | 61 | 965 | 300 | 24954 | 2.91e-22 | 0.06 | 0.01 | 5.0 |
129 | | GO:0050801 | ion homeostasis | 66 | 960 | 354 | 24900 | 3.36e-22 | 0.06 | 0.01 | 4.6 |
130 | | GO:0046649 | lymphocyte activation | 53 | 973 | 223 | 25031 | 3.94e-22 | 0.05 | 0.01 | 5.8 |
131 | | GO:0009308 | amine metabolic process | 74 | 952 | 448 | 24806 | 5.28e-22 | 0.07 | 0.02 | 4.1 |
132 | | GO:0051338 | regulation of transferase activity | 61 | 965 | 306 | 24948 | 6.99e-22 | 0.06 | 0.01 | 4.9 |
133 | | GO:0006979 | response to oxidative stress | 41 | 985 | 124 | 25130 | 8.59e-22 | 0.04 | 0.00 | 8.1 |
134 | | GO:0006917 | induction of apoptosis | 55 | 971 | 252 | 25002 | 2.01e-21 | 0.05 | 0.01 | 5.4 |
135 | | GO:0006519 | amino acid and derivative metabolic process | 68 | 958 | 392 | 24862 | 2.53e-21 | 0.07 | 0.02 | 4.3 |
136 | | GO:0012502 | induction of programmed cell death | 55 | 971 | 254 | 25000 | 2.76e-21 | 0.05 | 0.01 | 5.3 |
137 | | GO:0006996 | organelle organization and biogenesis | 143 | 883 | 1453 | 23801 | 5.71e-21 | 0.14 | 0.06 | 2.4 |
138 | | GO:0045859 | regulation of protein kinase activity | 58 | 968 | 291 | 24963 | 7.34e-21 | 0.06 | 0.01 | 4.9 |
139 | | GO:0009966 | regulation of signal transduction | 89 | 937 | 662 | 24592 | 7.74e-21 | 0.09 | 0.03 | 3.3 |
140 | | GO:0009719 | response to endogenous stimulus | 41 | 985 | 134 | 25120 | 9.26e-21 | 0.04 | 0.01 | 7.5 |
141 | | GO:0008285 | negative regulation of cell proliferation | 59 | 967 | 304 | 24950 | 1.04e-20 | 0.06 | 0.01 | 4.8 |
142 | | GO:0042110 | T cell activation | 42 | 984 | 143 | 25111 | 1.12e-20 | 0.04 | 0.01 | 7.2 |
143 | | GO:0002520 | immune system development | 56 | 970 | 274 | 24980 | 1.26e-20 | 0.05 | 0.01 | 5.0 |
144 | | GO:0045935 | positive regulation of nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 68 | 958 | 410 | 24844 | 2.17e-20 | 0.07 | 0.02 | 4.1 |
145 | | GO:0048534 | hemopoietic or lymphoid organ development | 54 | 972 | 258 | 24996 | 2.44e-20 | 0.05 | 0.01 | 5.2 |
146 | | GO:0030097 | hemopoiesis | 52 | 974 | 241 | 25013 | 3.92e-20 | 0.05 | 0.01 | 5.3 |
147 | | GO:0007610 | behavior | 74 | 952 | 497 | 24757 | 1.07e-19 | 0.07 | 0.02 | 3.7 |
148 | | GO:0007399 | nervous system development | 108 | 918 | 966 | 24288 | 1.45e-19 | 0.11 | 0.04 | 2.8 |
149 | | GO:0006366 | transcription from RNA polymerase II promoter | 96 | 930 | 794 | 24460 | 1.58e-19 | 0.09 | 0.03 | 3.0 |
150 | | GO:0006357 | regulation of transcription from RNA polymerase II promoter | 80 | 946 | 579 | 24675 | 1.86e-19 | 0.08 | 0.02 | 3.4 |
151 | | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 49 | 977 | 222 | 25032 | 2.13e-19 | 0.05 | 0.01 | 5.4 |
152 | | GO:0019226 | transmission of nerve impulse | 68 | 958 | 435 | 24819 | 3.57e-19 | 0.07 | 0.02 | 3.8 |
153 | | GO:0030003 | cellular cation homeostasis | 49 | 977 | 227 | 25027 | 4.73e-19 | 0.05 | 0.01 | 5.3 |
154 | | GO:0032879 | regulation of localization | 50 | 976 | 237 | 25017 | 4.73e-19 | 0.05 | 0.01 | 5.2 |
155 | | GO:0045941 | positive regulation of transcription | 64 | 962 | 392 | 24862 | 5.95e-19 | 0.06 | 0.02 | 4.0 |
156 | | GO:0045893 | positive regulation of transcription\, DNA\-dependent | 58 | 968 | 325 | 24929 | 7.28e-19 | 0.06 | 0.01 | 4.4 |
157 | | GO:0051254 | positive regulation of RNA metabolic process | 58 | 968 | 327 | 24927 | 9.37e-19 | 0.06 | 0.01 | 4.4 |
158 | | GO:0007005 | mitochondrion organization and biogenesis | 37 | 989 | 125 | 25129 | 1.81e-18 | 0.04 | 0.00 | 7.3 |
159 | | GO:0006520 | amino acid metabolic process | 56 | 970 | 312 | 24942 | 2.35e-18 | 0.05 | 0.01 | 4.4 |
160 | | GO:0006800 | oxygen and reactive oxygen species metabolic process | 26 | 1000 | 49 | 25205 | 2.86e-18 | 0.03 | 0.00 | 13.1 |
161 | | GO:0009725 | response to hormone stimulus | 36 | 990 | 120 | 25134 | 3.66e-18 | 0.04 | 0.00 | 7.4 |
162 | | GO:0030005 | cellular di\-\, tri\-valent inorganic cation homeostasis | 45 | 981 | 201 | 25053 | 3.99e-18 | 0.04 | 0.01 | 5.5 |
163 | | GO:0055066 | di\-\, tri\-valent inorganic cation homeostasis | 45 | 981 | 202 | 25052 | 4.70e-18 | 0.04 | 0.01 | 5.5 |
164 | | GO:0033674 | positive regulation of kinase activity | 43 | 983 | 183 | 25071 | 4.83e-18 | 0.04 | 0.01 | 5.8 |
165 | | GO:0015980 | energy derivation by oxidation of organic compounds | 38 | 988 | 138 | 25116 | 4.84e-18 | 0.04 | 0.01 | 6.8 |
166 | | GO:0009892 | negative regulation of metabolic process | 75 | 951 | 551 | 24703 | 5.59e-18 | 0.07 | 0.02 | 3.4 |
167 | | GO:0055080 | cation homeostasis | 50 | 976 | 254 | 25000 | 5.83e-18 | 0.05 | 0.01 | 4.8 |
168 | | GO:0040007 | growth | 60 | 966 | 366 | 24888 | 6.47e-18 | 0.06 | 0.01 | 4.0 |
169 | | GO:0046903 | secretion | 59 | 967 | 356 | 24898 | 7.84e-18 | 0.06 | 0.01 | 4.1 |
170 | | GO:0051347 | positive regulation of transferase activity | 43 | 983 | 186 | 25068 | 8.08e-18 | 0.04 | 0.01 | 5.7 |
171 | | GO:0008632 | apoptotic program | 33 | 993 | 100 | 25154 | 8.75e-18 | 0.03 | 0.00 | 8.1 |
172 | | GO:0007517 | muscle development | 49 | 977 | 254 | 25000 | 2.56e-17 | 0.05 | 0.01 | 4.7 |
173 | | GO:0009891 | positive regulation of biosynthetic process | 33 | 993 | 106 | 25148 | 3.68e-17 | 0.03 | 0.00 | 7.7 |
174 | | GO:0001816 | cytokine production | 39 | 987 | 160 | 25094 | 6.00e-17 | 0.04 | 0.01 | 6.0 |
175 | | GO:0031324 | negative regulation of cellular metabolic process | 72 | 954 | 541 | 24713 | 7.74e-17 | 0.07 | 0.02 | 3.3 |
176 | | GO:0046651 | lymphocyte proliferation | 29 | 997 | 79 | 25175 | 8.48e-17 | 0.03 | 0.00 | 9.0 |
177 | | GO:0032943 | mononuclear cell proliferation | 29 | 997 | 79 | 25175 | 8.48e-17 | 0.03 | 0.00 | 9.0 |
178 | | GO:0009889 | regulation of biosynthetic process | 49 | 977 | 264 | 24990 | 9.95e-17 | 0.05 | 0.01 | 4.6 |
179 | | GO:0006139 | nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 275 | 751 | 4119 | 21135 | 9.98e-17 | 0.27 | 0.16 | 1.6 |
180 | | GO:0051704 | multi\-organism process | 63 | 963 | 431 | 24823 | 1.36e-16 | 0.06 | 0.02 | 3.6 |
181 | | GO:0007049 | cell cycle | 95 | 931 | 879 | 24375 | 1.98e-16 | 0.09 | 0.03 | 2.7 |
182 | | GO:0045860 | positive regulation of protein kinase activity | 40 | 986 | 177 | 25077 | 2.22e-16 | 0.04 | 0.01 | 5.6 |
183 | | GO:0018108 | peptidyl\-tyrosine phosphorylation | 27 | 999 | 69 | 25185 | 2.71e-16 | 0.03 | 0.00 | 9.6 |
184 | | GO:0007268 | synaptic transmission | 59 | 967 | 390 | 24864 | 3.24e-16 | 0.06 | 0.02 | 3.7 |
185 | | GO:0018212 | peptidyl\-tyrosine modification | 27 | 999 | 71 | 25183 | 4.82e-16 | 0.03 | 0.00 | 9.4 |
186 | | GO:0006461 | protein complex assembly | 60 | 966 | 409 | 24845 | 6.35e-16 | 0.06 | 0.02 | 3.6 |
187 | | GO:0007249 | I\-kappaB kinase/NF\-kappaB cascade | 37 | 989 | 159 | 25095 | 1.34e-15 | 0.04 | 0.01 | 5.7 |
188 | | GO:0010033 | response to organic substance | 31 | 995 | 106 | 25148 | 1.41e-15 | 0.03 | 0.00 | 7.2 |
189 | | GO:0018193 | peptidyl\-amino acid modification | 36 | 990 | 150 | 25104 | 1.43e-15 | 0.04 | 0.01 | 5.9 |
190 | | GO:0051174 | regulation of phosphorus metabolic process | 31 | 995 | 108 | 25146 | 2.18e-15 | 0.03 | 0.00 | 7.1 |
191 | | GO:0019220 | regulation of phosphate metabolic process | 31 | 995 | 108 | 25146 | 2.18e-15 | 0.03 | 0.00 | 7.1 |
192 | | GO:0000003 | reproduction | 79 | 947 | 680 | 24574 | 2.27e-15 | 0.08 | 0.03 | 2.9 |
193 | | GO:0051246 | regulation of protein metabolic process | 57 | 969 | 387 | 24867 | 2.95e-15 | 0.06 | 0.02 | 3.6 |
194 | | GO:0051241 | negative regulation of multicellular organismal process | 29 | 997 | 94 | 25160 | 3.65e-15 | 0.03 | 0.00 | 7.6 |
195 | | GO:0042325 | regulation of phosphorylation | 30 | 996 | 103 | 25151 | 4.44e-15 | 0.03 | 0.00 | 7.2 |
196 | | GO:0022414 | reproductive process | 56 | 970 | 380 | 24874 | 5.08e-15 | 0.05 | 0.02 | 3.6 |
197 | | GO:0048583 | regulation of response to stimulus | 40 | 986 | 199 | 25055 | 6.75e-15 | 0.04 | 0.01 | 4.9 |
198 | | GO:0007507 | heart development | 38 | 988 | 179 | 25075 | 7.11e-15 | 0.04 | 0.01 | 5.2 |
199 | | GO:0031399 | regulation of protein modification process | 29 | 997 | 97 | 25157 | 7.21e-15 | 0.03 | 0.00 | 7.4 |
200 | | GO:0051049 | regulation of transport | 40 | 986 | 200 | 25054 | 7.80e-15 | 0.04 | 0.01 | 4.9 |
201 | | GO:0042098 | T cell proliferation | 24 | 1002 | 60 | 25194 | 8.30e-15 | 0.02 | 0.00 | 9.8 |
202 | | GO:0032268 | regulation of cellular protein metabolic process | 51 | 975 | 325 | 24929 | 9.56e-15 | 0.05 | 0.01 | 3.9 |
203 | | GO:0002521 | leukocyte differentiation | 34 | 992 | 143 | 25111 | 1.11e-14 | 0.03 | 0.01 | 5.9 |
204 | | GO:0001501 | skeletal development | 48 | 978 | 291 | 24963 | 1.12e-14 | 0.05 | 0.01 | 4.1 |
205 | | GO:0000302 | response to reactive oxygen species | 20 | 1006 | 36 | 25218 | 1.17e-14 | 0.02 | 0.00 | 13.7 |
206 | | GO:0003018 | vascular process in circulatory system | 26 | 1000 | 76 | 25178 | 1.31e-14 | 0.03 | 0.00 | 8.4 |
207 | | GO:0051187 | cofactor catabolic process | 20 | 1006 | 38 | 25216 | 2.55e-14 | 0.02 | 0.00 | 13.0 |
208 | | GO:0009888 | tissue development | 60 | 966 | 452 | 24802 | 3.48e-14 | 0.06 | 0.02 | 3.3 |
209 | | GO:0050880 | regulation of blood vessel size | 25 | 1001 | 74 | 25180 | 5.32e-14 | 0.02 | 0.00 | 8.3 |
210 | | GO:0035150 | regulation of tube size | 25 | 1001 | 74 | 25180 | 5.32e-14 | 0.02 | 0.00 | 8.3 |
211 | | GO:0030099 | myeloid cell differentiation | 29 | 997 | 107 | 25147 | 6.00e-14 | 0.03 | 0.00 | 6.7 |
212 | | GO:0048771 | tissue remodeling | 36 | 990 | 175 | 25079 | 8.31e-14 | 0.04 | 0.01 | 5.1 |
213 | | GO:0001932 | regulation of protein amino acid phosphorylation | 25 | 1001 | 76 | 25178 | 8.74e-14 | 0.02 | 0.00 | 8.1 |
214 | | GO:0048872 | homeostasis of number of cells | 24 | 1002 | 69 | 25185 | 1.01e-13 | 0.02 | 0.00 | 8.6 |
215 | | GO:0019395 | fatty acid oxidation | 20 | 1006 | 42 | 25212 | 1.10e-13 | 0.02 | 0.00 | 11.7 |
216 | | GO:0007626 | locomotory behavior | 49 | 977 | 324 | 24930 | 1.11e-13 | 0.05 | 0.01 | 3.7 |
217 | | GO:0014706 | striated muscle development | 34 | 992 | 158 | 25096 | 1.34e-13 | 0.03 | 0.01 | 5.3 |
218 | | GO:0009991 | response to extracellular stimulus | 28 | 998 | 103 | 25151 | 1.53e-13 | 0.03 | 0.00 | 6.7 |
219 | | GO:0006084 | acetyl\-CoA metabolic process | 19 | 1007 | 37 | 25217 | 1.59e-13 | 0.02 | 0.00 | 12.6 |
220 | | GO:0050865 | regulation of cell activation | 29 | 997 | 114 | 25140 | 2.35e-13 | 0.03 | 0.00 | 6.3 |
221 | | GO:0045333 | cellular respiration | 21 | 1005 | 51 | 25203 | 2.51e-13 | 0.02 | 0.00 | 10.1 |
222 | | GO:0040008 | regulation of growth | 42 | 984 | 249 | 25005 | 2.70e-13 | 0.04 | 0.01 | 4.2 |
223 | | GO:0051641 | cellular localization | 107 | 919 | 1198 | 24056 | 3.84e-13 | 0.10 | 0.05 | 2.2 |
224 | | GO:0046164 | alcohol catabolic process | 28 | 998 | 108 | 25146 | 4.09e-13 | 0.03 | 0.00 | 6.4 |
225 | | GO:0009310 | amine catabolic process | 26 | 1000 | 91 | 25163 | 4.30e-13 | 0.03 | 0.00 | 7.0 |
226 | | GO:0006875 | cellular metal ion homeostasis | 34 | 992 | 166 | 25088 | 4.53e-13 | 0.03 | 0.01 | 5.0 |
227 | | GO:0055065 | metal ion homeostasis | 34 | 992 | 166 | 25088 | 4.53e-13 | 0.03 | 0.01 | 5.0 |
228 | | GO:0032270 | positive regulation of cellular protein metabolic process | 27 | 999 | 100 | 25154 | 4.75e-13 | 0.03 | 0.00 | 6.6 |
229 | | GO:0009790 | embryonic development | 54 | 972 | 403 | 24851 | 4.88e-13 | 0.05 | 0.02 | 3.3 |
230 | | GO:0044270 | nitrogen compound catabolic process | 26 | 1000 | 93 | 25161 | 6.54e-13 | 0.03 | 0.00 | 6.9 |
231 | | GO:0051098 | regulation of binding | 27 | 999 | 102 | 25152 | 7.07e-13 | 0.03 | 0.00 | 6.5 |
232 | | GO:0043122 | regulation of I\-kappaB kinase/NF\-kappaB cascade | 29 | 997 | 121 | 25133 | 8.42e-13 | 0.03 | 0.00 | 5.9 |
233 | | GO:0031667 | response to nutrient levels | 26 | 1000 | 95 | 25159 | 9.87e-13 | 0.03 | 0.00 | 6.7 |
234 | | GO:0002694 | regulation of leukocyte activation | 28 | 998 | 113 | 25141 | 1.04e-12 | 0.03 | 0.00 | 6.1 |
235 | | GO:0006633 | fatty acid biosynthetic process | 25 | 1001 | 87 | 25167 | 1.09e-12 | 0.02 | 0.00 | 7.1 |
236 | | GO:0051247 | positive regulation of protein metabolic process | 27 | 999 | 105 | 25149 | 1.26e-12 | 0.03 | 0.00 | 6.3 |
237 | | GO:0006007 | glucose catabolic process | 25 | 1001 | 88 | 25166 | 1.35e-12 | 0.02 | 0.00 | 7.0 |
238 | | GO:0009057 | macromolecule catabolic process | 60 | 966 | 498 | 24756 | 1.48e-12 | 0.06 | 0.02 | 3.0 |
239 | | GO:0006801 | superoxide metabolic process | 15 | 1011 | 21 | 25233 | 1.74e-12 | 0.01 | 0.00 | 17.6 |
240 | | GO:0006935 | chemotaxis | 40 | 986 | 242 | 25012 | 1.76e-12 | 0.04 | 0.01 | 4.1 |
241 | | GO:0042330 | taxis | 40 | 986 | 242 | 25012 | 1.76e-12 | 0.04 | 0.01 | 4.1 |
242 | | GO:0009628 | response to abiotic stimulus | 56 | 970 | 445 | 24809 | 1.77e-12 | 0.05 | 0.02 | 3.1 |
243 | | GO:0006874 | cellular calcium ion homeostasis | 32 | 994 | 155 | 25099 | 1.83e-12 | 0.03 | 0.01 | 5.1 |
244 | | GO:0055074 | calcium ion homeostasis | 32 | 994 | 155 | 25099 | 1.83e-12 | 0.03 | 0.01 | 5.1 |
245 | | GO:0051649 | establishment of cellular localization | 103 | 923 | 1168 | 24086 | 1.97e-12 | 0.10 | 0.05 | 2.2 |
246 | | GO:0006508 | proteolysis | 84 | 942 | 862 | 24392 | 2.25e-12 | 0.08 | 0.03 | 2.4 |
247 | | GO:0006094 | gluconeogenesis | 16 | 1010 | 27 | 25227 | 2.55e-12 | 0.02 | 0.00 | 14.6 |
248 | | GO:0051046 | regulation of secretion | 26 | 1000 | 100 | 25154 | 2.66e-12 | 0.03 | 0.00 | 6.4 |
249 | | GO:0046849 | bone remodeling | 32 | 994 | 158 | 25096 | 2.86e-12 | 0.03 | 0.01 | 5.0 |
250 | | GO:0019320 | hexose catabolic process | 26 | 1000 | 101 | 25153 | 3.22e-12 | 0.03 | 0.00 | 6.3 |
251 | | GO:0045595 | regulation of cell differentiation | 38 | 988 | 225 | 25029 | 3.57e-12 | 0.04 | 0.01 | 4.2 |
252 | | GO:0006096 | glycolysis | 23 | 1003 | 76 | 25178 | 3.58e-12 | 0.02 | 0.00 | 7.4 |
253 | | GO:0002682 | regulation of immune system process | 36 | 990 | 203 | 25051 | 3.83e-12 | 0.04 | 0.01 | 4.4 |
254 | | GO:0030029 | actin filament\-based process | 43 | 983 | 285 | 24969 | 3.87e-12 | 0.04 | 0.01 | 3.7 |
255 | | GO:0042542 | response to hydrogen peroxide | 16 | 1010 | 28 | 25226 | 3.87e-12 | 0.02 | 0.00 | 14.1 |
256 | | GO:0006099 | tricarboxylic acid cycle | 16 | 1010 | 28 | 25226 | 3.87e-12 | 0.02 | 0.00 | 14.1 |
257 | | GO:0046356 | acetyl\-CoA catabolic process | 16 | 1010 | 28 | 25226 | 3.87e-12 | 0.02 | 0.00 | 14.1 |
258 | | GO:0046365 | monosaccharide catabolic process | 26 | 1000 | 102 | 25152 | 3.89e-12 | 0.03 | 0.00 | 6.3 |
259 | | GO:0043123 | positive regulation of I\-kappaB kinase/NF\-kappaB cascade | 27 | 999 | 112 | 25142 | 4.58e-12 | 0.03 | 0.00 | 5.9 |
260 | | GO:0043406 | positive regulation of MAP kinase activity | 25 | 1001 | 94 | 25160 | 4.58e-12 | 0.02 | 0.00 | 6.5 |
261 | | GO:0046394 | carboxylic acid biosynthetic process | 26 | 1000 | 103 | 25151 | 4.70e-12 | 0.03 | 0.00 | 6.2 |
262 | | GO:0016053 | organic acid biosynthetic process | 26 | 1000 | 103 | 25151 | 4.70e-12 | 0.03 | 0.00 | 6.2 |
263 | | GO:0050878 | regulation of body fluid levels | 35 | 991 | 195 | 25059 | 5.65e-12 | 0.03 | 0.01 | 4.4 |
264 | | GO:0051249 | regulation of lymphocyte activation | 26 | 1000 | 104 | 25150 | 5.66e-12 | 0.03 | 0.00 | 6.2 |
265 | | GO:0015758 | glucose transport | 19 | 1007 | 48 | 25206 | 6.02e-12 | 0.02 | 0.00 | 9.7 |
266 | | GO:0009063 | amino acid catabolic process | 23 | 1003 | 79 | 25175 | 6.96e-12 | 0.02 | 0.00 | 7.2 |
267 | | GO:0044275 | cellular carbohydrate catabolic process | 29 | 997 | 134 | 25120 | 7.38e-12 | 0.03 | 0.01 | 5.3 |
268 | | GO:0007010 | cytoskeleton organization and biogenesis | 67 | 959 | 625 | 24629 | 9.68e-12 | 0.07 | 0.02 | 2.6 |
269 | | GO:0043405 | regulation of MAP kinase activity | 28 | 998 | 126 | 25128 | 9.85e-12 | 0.03 | 0.00 | 5.5 |
270 | | GO:0008286 | insulin receptor signaling pathway | 18 | 1008 | 43 | 25211 | 1.03e-11 | 0.02 | 0.00 | 10.3 |
271 | | GO:0051726 | regulation of cell cycle | 46 | 980 | 333 | 24921 | 1.05e-11 | 0.04 | 0.01 | 3.4 |
272 | | GO:0008645 | hexose transport | 19 | 1007 | 50 | 25204 | 1.07e-11 | 0.02 | 0.00 | 9.4 |
273 | | GO:0015749 | monosaccharide transport | 19 | 1007 | 50 | 25204 | 1.07e-11 | 0.02 | 0.00 | 9.4 |
274 | | GO:0000165 | MAPKKK cascade | 35 | 991 | 201 | 25053 | 1.20e-11 | 0.03 | 0.01 | 4.3 |
275 | | GO:0019319 | hexose biosynthetic process | 16 | 1010 | 31 | 25223 | 1.25e-11 | 0.02 | 0.00 | 12.7 |
276 | | GO:0009109 | coenzyme catabolic process | 16 | 1010 | 31 | 25223 | 1.25e-11 | 0.02 | 0.00 | 12.7 |
277 | | GO:0019219 | regulation of nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 192 | 834 | 2853 | 22401 | 1.28e-11 | 0.19 | 0.11 | 1.7 |
278 | | GO:0055086 | nucleobase\, nucleoside and nucleotide metabolic process | 43 | 983 | 297 | 24957 | 1.29e-11 | 0.04 | 0.01 | 3.6 |
279 | | GO:0050877 | neurological system process | 112 | 914 | 1360 | 23894 | 1.43e-11 | 0.11 | 0.05 | 2.0 |
280 | | GO:0006809 | nitric oxide biosynthetic process | 16 | 1010 | 32 | 25222 | 1.81e-11 | 0.02 | 0.00 | 12.3 |
281 | | GO:0046209 | nitric oxide metabolic process | 16 | 1010 | 32 | 25222 | 1.81e-11 | 0.02 | 0.00 | 12.3 |
282 | | GO:0006090 | pyruvate metabolic process | 16 | 1010 | 32 | 25222 | 1.81e-11 | 0.02 | 0.00 | 12.3 |
283 | | GO:0044242 | cellular lipid catabolic process | 24 | 1002 | 93 | 25161 | 2.09e-11 | 0.02 | 0.00 | 6.4 |
284 | | GO:0016052 | carbohydrate catabolic process | 29 | 997 | 141 | 25113 | 2.16e-11 | 0.03 | 0.01 | 5.1 |
285 | | GO:0050863 | regulation of T cell activation | 23 | 1003 | 85 | 25169 | 2.43e-11 | 0.02 | 0.00 | 6.7 |
286 | | GO:0008624 | induction of apoptosis by extracellular signals | 18 | 1008 | 46 | 25208 | 2.53e-11 | 0.02 | 0.00 | 9.6 |
287 | | GO:0046364 | monosaccharide biosynthetic process | 16 | 1010 | 33 | 25221 | 2.59e-11 | 0.02 | 0.00 | 11.9 |
288 | | GO:0009060 | aerobic respiration | 17 | 1009 | 40 | 25214 | 3.19e-11 | 0.02 | 0.00 | 10.5 |
289 | | GO:0031328 | positive regulation of cellular biosynthetic process | 18 | 1008 | 47 | 25207 | 3.37e-11 | 0.02 | 0.00 | 9.4 |
290 | | GO:0046395 | carboxylic acid catabolic process | 18 | 1008 | 47 | 25207 | 3.37e-11 | 0.02 | 0.00 | 9.4 |
291 | | GO:0016054 | organic acid catabolic process | 18 | 1008 | 47 | 25207 | 3.37e-11 | 0.02 | 0.00 | 9.4 |
292 | | GO:0051251 | positive regulation of lymphocyte activation | 21 | 1005 | 70 | 25184 | 3.55e-11 | 0.02 | 0.00 | 7.4 |
293 | | GO:0009607 | response to biotic stimulus | 46 | 980 | 347 | 24907 | 3.67e-11 | 0.04 | 0.01 | 3.3 |
294 | | GO:0042060 | wound healing | 35 | 991 | 212 | 25042 | 4.42e-11 | 0.03 | 0.01 | 4.1 |
295 | | GO:0046165 | alcohol biosynthetic process | 16 | 1010 | 35 | 25219 | 5.15e-11 | 0.02 | 0.00 | 11.3 |
296 | | GO:0006839 | mitochondrial transport | 21 | 1005 | 72 | 25182 | 5.52e-11 | 0.02 | 0.00 | 7.2 |
297 | | GO:0032101 | regulation of response to external stimulus | 20 | 1006 | 64 | 25190 | 5.65e-11 | 0.02 | 0.00 | 7.7 |
298 | | GO:0019932 | second\-messenger\-mediated signaling | 43 | 983 | 313 | 24941 | 5.81e-11 | 0.04 | 0.01 | 3.4 |
299 | | GO:0009062 | fatty acid catabolic process | 17 | 1009 | 42 | 25212 | 5.90e-11 | 0.02 | 0.00 | 10.0 |
300 | | GO:0034404 | nucleobase\, nucleoside and nucleotide biosynthetic process | 41 | 985 | 288 | 24966 | 6.14e-11 | 0.04 | 0.01 | 3.5 |
301 | | GO:0016042 | lipid catabolic process | 33 | 993 | 192 | 25062 | 6.24e-11 | 0.03 | 0.01 | 4.2 |
302 | | GO:0008217 | regulation of blood pressure | 23 | 1003 | 90 | 25164 | 6.46e-11 | 0.02 | 0.00 | 6.3 |
303 | | GO:0042113 | B cell activation | 23 | 1003 | 90 | 25164 | 6.46e-11 | 0.02 | 0.00 | 6.3 |
304 | | GO:0006259 | DNA metabolic process | 64 | 962 | 611 | 24643 | 6.57e-11 | 0.06 | 0.02 | 2.6 |
305 | | GO:0048545 | response to steroid hormone stimulus | 20 | 1006 | 65 | 25189 | 7.12e-11 | 0.02 | 0.00 | 7.6 |
306 | | GO:0030036 | actin cytoskeleton organization and biogenesis | 39 | 987 | 267 | 24987 | 9.15e-11 | 0.04 | 0.01 | 3.6 |
307 | | GO:0009117 | nucleotide metabolic process | 40 | 986 | 280 | 24974 | 9.56e-11 | 0.04 | 0.01 | 3.5 |
308 | | GO:0006753 | nucleoside phosphate metabolic process | 40 | 986 | 280 | 24974 | 9.56e-11 | 0.04 | 0.01 | 3.5 |
309 | | GO:0022008 | neurogenesis | 51 | 975 | 427 | 24827 | 9.59e-11 | 0.05 | 0.02 | 2.9 |
310 | | GO:0045937 | positive regulation of phosphate metabolic process | 18 | 1008 | 51 | 25203 | 1.01e-10 | 0.02 | 0.00 | 8.7 |
311 | | GO:0010562 | positive regulation of phosphorus metabolic process | 18 | 1008 | 51 | 25203 | 1.01e-10 | 0.02 | 0.00 | 8.7 |
312 | | GO:0002696 | positive regulation of leukocyte activation | 21 | 1005 | 75 | 25179 | 1.05e-10 | 0.02 | 0.00 | 6.9 |
313 | | GO:0050867 | positive regulation of cell activation | 21 | 1005 | 75 | 25179 | 1.05e-10 | 0.02 | 0.00 | 6.9 |
314 | | GO:0001776 | leukocyte homeostasis | 14 | 1012 | 25 | 25229 | 1.06e-10 | 0.01 | 0.00 | 13.8 |
315 | | GO:0008610 | lipid biosynthetic process | 44 | 982 | 333 | 24921 | 1.08e-10 | 0.04 | 0.01 | 3.3 |
316 | | GO:0019221 | cytokine and chemokine mediated signaling pathway | 19 | 1007 | 59 | 25195 | 1.11e-10 | 0.02 | 0.00 | 7.9 |
317 | | GO:0006936 | muscle contraction | 35 | 991 | 221 | 25033 | 1.21e-10 | 0.03 | 0.01 | 3.9 |
318 | | GO:0003012 | muscle system process | 35 | 991 | 221 | 25033 | 1.21e-10 | 0.03 | 0.01 | 3.9 |
319 | | GO:0030098 | lymphocyte differentiation | 24 | 1002 | 103 | 25151 | 1.28e-10 | 0.02 | 0.00 | 5.7 |
320 | | GO:0051270 | regulation of cell motility | 23 | 1003 | 94 | 25160 | 1.35e-10 | 0.02 | 0.00 | 6.0 |
321 | | GO:0009059 | macromolecule biosynthetic process | 226 | 800 | 3637 | 21617 | 1.39e-10 | 0.22 | 0.14 | 1.5 |
322 | | GO:0010468 | regulation of gene expression | 191 | 835 | 2926 | 22328 | 1.59e-10 | 0.19 | 0.12 | 1.6 |
323 | | GO:0030323 | respiratory tube development | 21 | 1005 | 78 | 25176 | 1.93e-10 | 0.02 | 0.00 | 6.6 |
324 | | GO:0051345 | positive regulation of hydrolase activity | 23 | 1003 | 96 | 25158 | 1.93e-10 | 0.02 | 0.00 | 5.9 |
325 | | GO:0044271 | nitrogen compound biosynthetic process | 26 | 1000 | 127 | 25127 | 2.55e-10 | 0.03 | 0.01 | 5.0 |
326 | | GO:0007599 | hemostasis | 30 | 996 | 171 | 25083 | 2.98e-10 | 0.03 | 0.01 | 4.3 |
327 | | GO:0050900 | leukocyte migration | 17 | 1009 | 48 | 25206 | 3.18e-10 | 0.02 | 0.00 | 8.7 |
328 | | GO:0050730 | regulation of peptidyl\-tyrosine phosphorylation | 17 | 1009 | 48 | 25206 | 3.18e-10 | 0.02 | 0.00 | 8.7 |
329 | | GO:0008202 | steroid metabolic process | 34 | 992 | 218 | 25036 | 3.19e-10 | 0.03 | 0.01 | 3.8 |
330 | | GO:0042743 | hydrogen peroxide metabolic process | 12 | 1014 | 17 | 25237 | 3.30e-10 | 0.01 | 0.00 | 17.4 |
331 | | GO:0032844 | regulation of homeostatic process | 14 | 1012 | 28 | 25226 | 3.33e-10 | 0.01 | 0.00 | 12.3 |
332 | | GO:0022402 | cell cycle process | 56 | 970 | 510 | 24744 | 3.37e-10 | 0.05 | 0.02 | 2.7 |
333 | | GO:0001763 | morphogenesis of a branching structure | 18 | 1008 | 56 | 25198 | 3.52e-10 | 0.02 | 0.00 | 7.9 |
334 | | GO:0045934 | negative regulation of nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 48 | 978 | 403 | 24851 | 3.73e-10 | 0.05 | 0.02 | 2.9 |
335 | | GO:0042327 | positive regulation of phosphorylation | 17 | 1009 | 49 | 25205 | 4.13e-10 | 0.02 | 0.00 | 8.5 |
336 | | GO:0043086 | negative regulation of catalytic activity | 25 | 1001 | 121 | 25133 | 4.75e-10 | 0.02 | 0.00 | 5.1 |
337 | | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 28 | 998 | 153 | 25101 | 5.01e-10 | 0.03 | 0.01 | 4.5 |
338 | | GO:0002250 | adaptive immune response | 28 | 998 | 153 | 25101 | 5.01e-10 | 0.03 | 0.01 | 4.5 |
339 | | GO:0002252 | immune effector process | 32 | 994 | 199 | 25055 | 5.37e-10 | 0.03 | 0.01 | 4.0 |
340 | | GO:0050870 | positive regulation of T cell activation | 18 | 1008 | 58 | 25196 | 5.65e-10 | 0.02 | 0.00 | 7.6 |
341 | | GO:0007596 | blood coagulation | 29 | 997 | 165 | 25089 | 5.66e-10 | 0.03 | 0.01 | 4.3 |
342 | | GO:0019216 | regulation of lipid metabolic process | 16 | 1010 | 43 | 25211 | 5.87e-10 | 0.02 | 0.00 | 9.2 |
343 | | GO:0006635 | fatty acid beta\-oxidation | 14 | 1012 | 30 | 25224 | 6.74e-10 | 0.01 | 0.00 | 11.5 |
344 | | GO:0006749 | glutathione metabolic process | 13 | 1013 | 24 | 25230 | 6.76e-10 | 0.01 | 0.00 | 13.3 |
345 | | GO:0048754 | branching morphogenesis of a tube | 17 | 1009 | 51 | 25203 | 6.86e-10 | 0.02 | 0.00 | 8.2 |
346 | | GO:0050817 | coagulation | 30 | 996 | 178 | 25076 | 6.94e-10 | 0.03 | 0.01 | 4.1 |
347 | | GO:0001503 | ossification | 27 | 999 | 145 | 25109 | 7.29e-10 | 0.03 | 0.01 | 4.6 |
348 | | GO:0031214 | biomineral formation | 27 | 999 | 145 | 25109 | 7.29e-10 | 0.03 | 0.01 | 4.6 |
349 | | GO:0051101 | regulation of DNA binding | 20 | 1006 | 76 | 25178 | 7.30e-10 | 0.02 | 0.00 | 6.5 |
350 | | GO:0030324 | lung development | 20 | 1006 | 76 | 25178 | 7.30e-10 | 0.02 | 0.00 | 6.5 |
351 | | GO:0051707 | response to other organism | 36 | 990 | 251 | 25003 | 7.50e-10 | 0.04 | 0.01 | 3.5 |
352 | | GO:0001817 | regulation of cytokine production | 17 | 1009 | 52 | 25202 | 8.77e-10 | 0.02 | 0.00 | 8.0 |
353 | | GO:0042129 | regulation of T cell proliferation | 16 | 1010 | 45 | 25209 | 1.01e-09 | 0.02 | 0.00 | 8.8 |
354 | | GO:0042089 | cytokine biosynthetic process | 22 | 1004 | 97 | 25157 | 1.16e-09 | 0.02 | 0.00 | 5.6 |
355 | | GO:0000060 | protein import into nucleus\, translocation | 14 | 1012 | 32 | 25222 | 1.31e-09 | 0.01 | 0.00 | 10.8 |
356 | | GO:0042107 | cytokine metabolic process | 22 | 1004 | 98 | 25156 | 1.37e-09 | 0.02 | 0.00 | 5.5 |
357 | | GO:0050670 | regulation of lymphocyte proliferation | 17 | 1009 | 54 | 25200 | 1.42e-09 | 0.02 | 0.00 | 7.7 |
358 | | GO:0032944 | regulation of mononuclear cell proliferation | 17 | 1009 | 54 | 25200 | 1.42e-09 | 0.02 | 0.00 | 7.7 |
359 | | GO:0016481 | negative regulation of transcription | 44 | 982 | 366 | 24888 | 1.56e-09 | 0.04 | 0.01 | 3.0 |
360 | | GO:0003001 | generation of a signal involved in cell\-cell signaling | 23 | 1003 | 109 | 25145 | 1.64e-09 | 0.02 | 0.00 | 5.2 |
361 | | GO:0006919 | caspase activation | 16 | 1010 | 47 | 25207 | 1.69e-09 | 0.02 | 0.00 | 8.4 |
362 | | GO:0031401 | positive regulation of protein modification process | 17 | 1009 | 55 | 25199 | 1.79e-09 | 0.02 | 0.00 | 7.6 |
363 | | GO:0042391 | regulation of membrane potential | 22 | 1004 | 100 | 25154 | 1.90e-09 | 0.02 | 0.00 | 5.4 |
364 | | GO:0006725 | aromatic compound metabolic process | 31 | 995 | 199 | 25055 | 1.97e-09 | 0.03 | 0.01 | 3.8 |
365 | | GO:0031960 | response to corticosteroid stimulus | 13 | 1013 | 27 | 25227 | 2.05e-09 | 0.01 | 0.00 | 11.9 |
366 | | GO:0043281 | regulation of caspase activity | 18 | 1008 | 64 | 25190 | 2.11e-09 | 0.02 | 0.00 | 6.9 |
367 | | GO:0042744 | hydrogen peroxide catabolic process | 11 | 1015 | 16 | 25238 | 2.24e-09 | 0.01 | 0.00 | 16.9 |
368 | | GO:0010035 | response to inorganic substance | 17 | 1009 | 56 | 25198 | 2.24e-09 | 0.02 | 0.00 | 7.5 |
369 | | GO:0043284 | biopolymer biosynthetic process | 187 | 839 | 2949 | 22305 | 2.27e-09 | 0.18 | 0.12 | 1.6 |
370 | | GO:0045786 | negative regulation of cell cycle | 28 | 998 | 166 | 25088 | 2.51e-09 | 0.03 | 0.01 | 4.2 |
371 | | GO:0052548 | regulation of endopeptidase activity | 18 | 1008 | 65 | 25189 | 2.60e-09 | 0.02 | 0.00 | 6.8 |
372 | | GO:0052547 | regulation of peptidase activity | 18 | 1008 | 65 | 25189 | 2.60e-09 | 0.02 | 0.00 | 6.8 |
373 | | GO:0016044 | membrane organization and biogenesis | 43 | 983 | 359 | 24895 | 2.65e-09 | 0.04 | 0.01 | 2.9 |
374 | | GO:0008637 | apoptotic mitochondrial changes | 13 | 1013 | 28 | 25226 | 2.89e-09 | 0.01 | 0.00 | 11.4 |
375 | | GO:0021700 | developmental maturation | 22 | 1004 | 103 | 25151 | 3.05e-09 | 0.02 | 0.00 | 5.3 |
376 | | GO:0006605 | protein targeting | 34 | 992 | 241 | 25013 | 3.23e-09 | 0.03 | 0.01 | 3.5 |
377 | | GO:0045765 | regulation of angiogenesis | 16 | 1010 | 50 | 25204 | 3.54e-09 | 0.02 | 0.00 | 7.9 |
378 | | GO:0050798 | activated T cell proliferation | 11 | 1015 | 17 | 25237 | 3.55e-09 | 0.01 | 0.00 | 15.9 |
379 | | GO:0042035 | regulation of cytokine biosynthetic process | 20 | 1006 | 85 | 25169 | 3.82e-09 | 0.02 | 0.00 | 5.8 |
380 | | GO:0032940 | secretion by cell | 33 | 993 | 231 | 25023 | 4.16e-09 | 0.03 | 0.01 | 3.5 |
381 | | GO:0001934 | positive regulation of protein amino acid phosphorylation | 15 | 1011 | 43 | 25211 | 4.16e-09 | 0.01 | 0.00 | 8.6 |
382 | | GO:0050727 | regulation of inflammatory response | 15 | 1011 | 43 | 25211 | 4.16e-09 | 0.01 | 0.00 | 8.6 |
383 | | GO:0002684 | positive regulation of immune system process | 27 | 999 | 159 | 25095 | 4.25e-09 | 0.03 | 0.01 | 4.2 |
384 | | GO:0009890 | negative regulation of biosynthetic process | 18 | 1008 | 68 | 25186 | 4.76e-09 | 0.02 | 0.00 | 6.5 |
385 | | GO:0010557 | positive regulation of macromolecule biosynthetic process | 19 | 1007 | 77 | 25177 | 4.79e-09 | 0.02 | 0.00 | 6.1 |
386 | | GO:0008203 | cholesterol metabolic process | 21 | 1005 | 96 | 25158 | 4.81e-09 | 0.02 | 0.00 | 5.4 |
387 | | GO:0006350 | transcription | 182 | 844 | 2872 | 22382 | 4.96e-09 | 0.18 | 0.11 | 1.6 |
388 | | GO:0046879 | hormone secretion | 17 | 1009 | 60 | 25194 | 5.38e-09 | 0.02 | 0.00 | 7.0 |
389 | | GO:0045449 | regulation of transcription | 177 | 849 | 2775 | 22479 | 5.38e-09 | 0.17 | 0.11 | 1.6 |
390 | | GO:0043280 | positive regulation of caspase activity | 16 | 1010 | 52 | 25202 | 5.65e-09 | 0.02 | 0.00 | 7.6 |
391 | | GO:0031589 | cell\-substrate adhesion | 24 | 1002 | 129 | 25125 | 6.45e-09 | 0.02 | 0.01 | 4.6 |
392 | | GO:0043062 | extracellular structure organization and biogenesis | 25 | 1001 | 140 | 25114 | 6.51e-09 | 0.02 | 0.01 | 4.4 |
393 | | GO:0007050 | cell cycle arrest | 21 | 1005 | 98 | 25156 | 6.60e-09 | 0.02 | 0.00 | 5.3 |
394 | | GO:0035264 | multicellular organism growth | 15 | 1011 | 45 | 25209 | 6.91e-09 | 0.01 | 0.00 | 8.2 |
395 | | GO:0007565 | female pregnancy | 20 | 1006 | 89 | 25165 | 7.51e-09 | 0.02 | 0.00 | 5.5 |
396 | | GO:0016337 | cell\-cell adhesion | 43 | 983 | 374 | 24880 | 7.95e-09 | 0.04 | 0.01 | 2.8 |
397 | | GO:0065003 | macromolecular complex assembly | 70 | 956 | 786 | 24468 | 8.04e-09 | 0.07 | 0.03 | 2.2 |
398 | | GO:0016051 | carbohydrate biosynthetic process | 26 | 1000 | 153 | 25101 | 8.08e-09 | 0.03 | 0.01 | 4.2 |
399 | | GO:0007519 | skeletal muscle development | 23 | 1003 | 121 | 25133 | 9.33e-09 | 0.02 | 0.00 | 4.7 |
400 | | GO:0006606 | protein import into nucleus | 22 | 1004 | 111 | 25143 | 1.01e-08 | 0.02 | 0.00 | 4.9 |
401 | | GO:0001505 | regulation of neurotransmitter levels | 22 | 1004 | 111 | 25143 | 1.01e-08 | 0.02 | 0.00 | 4.9 |
402 | | GO:0031347 | regulation of defense response | 18 | 1008 | 72 | 25182 | 1.02e-08 | 0.02 | 0.00 | 6.2 |
403 | | GO:0010038 | response to metal ion | 15 | 1011 | 47 | 25207 | 1.12e-08 | 0.01 | 0.00 | 7.9 |
404 | | GO:0002573 | myeloid leukocyte differentiation | 15 | 1011 | 47 | 25207 | 1.12e-08 | 0.01 | 0.00 | 7.9 |
405 | | GO:0030334 | regulation of cell migration | 19 | 1007 | 82 | 25172 | 1.16e-08 | 0.02 | 0.00 | 5.7 |
406 | | GO:0051090 | regulation of transcription factor activity | 17 | 1009 | 64 | 25190 | 1.21e-08 | 0.02 | 0.00 | 6.5 |
407 | | GO:0051240 | positive regulation of multicellular organismal process | 20 | 1006 | 92 | 25162 | 1.22e-08 | 0.02 | 0.00 | 5.4 |
408 | | GO:0046883 | regulation of hormone secretion | 14 | 1012 | 40 | 25214 | 1.32e-08 | 0.01 | 0.00 | 8.6 |
409 | | GO:0051170 | nuclear import | 22 | 1004 | 113 | 25141 | 1.34e-08 | 0.02 | 0.00 | 4.8 |
410 | | GO:0031326 | regulation of cellular biosynthetic process | 27 | 999 | 169 | 25085 | 1.34e-08 | 0.03 | 0.01 | 3.9 |
411 | | GO:0033002 | muscle cell proliferation | 13 | 1013 | 33 | 25221 | 1.39e-08 | 0.01 | 0.00 | 9.7 |
412 | | GO:0019217 | regulation of fatty acid metabolic process | 10 | 1016 | 15 | 25239 | 1.51e-08 | 0.01 | 0.00 | 16.4 |
413 | | GO:0048584 | positive regulation of response to stimulus | 24 | 1002 | 136 | 25118 | 1.59e-08 | 0.02 | 0.01 | 4.3 |
414 | | GO:0016125 | sterol metabolic process | 21 | 1005 | 105 | 25149 | 1.89e-08 | 0.02 | 0.00 | 4.9 |
415 | | GO:0008643 | carbohydrate transport | 19 | 1007 | 85 | 25169 | 1.91e-08 | 0.02 | 0.00 | 5.5 |
416 | | GO:0048699 | generation of neurons | 44 | 982 | 403 | 24851 | 2.15e-08 | 0.04 | 0.02 | 2.7 |
417 | | GO:0000278 | mitotic cell cycle | 43 | 983 | 390 | 24864 | 2.40e-08 | 0.04 | 0.02 | 2.7 |
418 | | GO:0050864 | regulation of B cell activation | 13 | 1013 | 35 | 25219 | 2.46e-08 | 0.01 | 0.00 | 9.1 |
419 | | GO:0030072 | peptide hormone secretion | 13 | 1013 | 35 | 25219 | 2.46e-08 | 0.01 | 0.00 | 9.1 |
420 | | GO:0060047 | heart contraction | 19 | 1007 | 87 | 25167 | 2.64e-08 | 0.02 | 0.00 | 5.4 |
421 | | GO:0003015 | heart process | 19 | 1007 | 87 | 25167 | 2.64e-08 | 0.02 | 0.00 | 5.4 |
422 | | GO:0010556 | regulation of macromolecule biosynthetic process | 30 | 996 | 213 | 25041 | 2.78e-08 | 0.03 | 0.01 | 3.5 |
423 | | GO:0015833 | peptide transport | 15 | 1011 | 51 | 25203 | 2.80e-08 | 0.01 | 0.00 | 7.2 |
424 | | GO:0002790 | peptide secretion | 13 | 1013 | 36 | 25218 | 3.23e-08 | 0.01 | 0.00 | 8.9 |
425 | | GO:0051235 | maintenance of localization | 15 | 1011 | 52 | 25202 | 3.48e-08 | 0.01 | 0.00 | 7.1 |
426 | | GO:0050673 | epithelial cell proliferation | 15 | 1011 | 52 | 25202 | 3.48e-08 | 0.01 | 0.00 | 7.1 |
427 | | GO:0006790 | sulfur metabolic process | 20 | 1006 | 100 | 25154 | 4.10e-08 | 0.02 | 0.00 | 4.9 |
428 | | GO:0051716 | cellular response to stimulus | 13 | 1013 | 37 | 25217 | 4.21e-08 | 0.01 | 0.00 | 8.6 |
429 | | GO:0009072 | aromatic amino acid family metabolic process | 13 | 1013 | 37 | 25217 | 4.21e-08 | 0.01 | 0.00 | 8.6 |
430 | | GO:0051252 | regulation of RNA metabolic process | 165 | 861 | 2625 | 22629 | 4.83e-08 | 0.16 | 0.10 | 1.5 |
431 | | GO:0030198 | extracellular matrix organization and biogenesis | 17 | 1009 | 72 | 25182 | 5.35e-08 | 0.02 | 0.00 | 5.8 |
432 | | GO:0050671 | positive regulation of lymphocyte proliferation | 13 | 1013 | 38 | 25216 | 5.44e-08 | 0.01 | 0.00 | 8.4 |
433 | | GO:0032946 | positive regulation of mononuclear cell proliferation | 13 | 1013 | 38 | 25216 | 5.44e-08 | 0.01 | 0.00 | 8.4 |
434 | | GO:0007259 | JAK\-STAT cascade | 14 | 1012 | 46 | 25208 | 5.68e-08 | 0.01 | 0.00 | 7.5 |
435 | | GO:0007160 | cell\-matrix adhesion | 22 | 1004 | 124 | 25130 | 5.75e-08 | 0.02 | 0.00 | 4.4 |
436 | | GO:0032774 | RNA biosynthetic process | 167 | 859 | 2673 | 22581 | 6.12e-08 | 0.16 | 0.11 | 1.5 |
437 | | GO:0040014 | regulation of multicellular organism growth | 13 | 1013 | 39 | 25215 | 7.00e-08 | 0.01 | 0.00 | 8.2 |
438 | | GO:0017038 | protein import | 23 | 1003 | 137 | 25117 | 7.07e-08 | 0.02 | 0.01 | 4.1 |
439 | | GO:0045165 | cell fate commitment | 21 | 1005 | 115 | 25139 | 7.44e-08 | 0.02 | 0.00 | 4.5 |
440 | | GO:0042100 | B cell proliferation | 11 | 1015 | 25 | 25229 | 7.46e-08 | 0.01 | 0.00 | 10.8 |
441 | | GO:0042102 | positive regulation of T cell proliferation | 12 | 1014 | 32 | 25222 | 7.81e-08 | 0.01 | 0.00 | 9.2 |
442 | | GO:0006351 | transcription\, DNA\-dependent | 166 | 860 | 2666 | 22588 | 7.93e-08 | 0.16 | 0.11 | 1.5 |
443 | | GO:0030593 | neutrophil chemotaxis | 10 | 1016 | 19 | 25235 | 8.02e-08 | 0.01 | 0.00 | 13.0 |
444 | | GO:0002260 | lymphocyte homeostasis | 10 | 1016 | 19 | 25235 | 8.02e-08 | 0.01 | 0.00 | 13.0 |
445 | | GO:0030217 | T cell differentiation | 16 | 1010 | 65 | 25189 | 8.03e-08 | 0.02 | 0.00 | 6.1 |
446 | | GO:0007586 | digestion | 22 | 1004 | 127 | 25127 | 8.34e-08 | 0.02 | 0.01 | 4.3 |
447 | | GO:0045892 | negative regulation of transcription\, DNA\-dependent | 33 | 993 | 267 | 24987 | 9.55e-08 | 0.03 | 0.01 | 3.0 |
448 | | GO:0002443 | leukocyte mediated immunity | 24 | 1002 | 152 | 25102 | 1.03e-07 | 0.02 | 0.01 | 3.9 |
449 | | GO:0045637 | regulation of myeloid cell differentiation | 14 | 1012 | 49 | 25205 | 1.10e-07 | 0.01 | 0.00 | 7.0 |
450 | | GO:0051253 | negative regulation of RNA metabolic process | 33 | 993 | 269 | 24985 | 1.12e-07 | 0.03 | 0.01 | 3.0 |
451 | | GO:0048585 | negative regulation of response to stimulus | 13 | 1013 | 41 | 25213 | 1.14e-07 | 0.01 | 0.00 | 7.8 |
452 | | GO:0007605 | sensory perception of sound | 25 | 1001 | 165 | 25089 | 1.14e-07 | 0.02 | 0.01 | 3.7 |
453 | | GO:0001655 | urogenital system development | 16 | 1010 | 67 | 25187 | 1.15e-07 | 0.02 | 0.00 | 5.9 |
454 | | GO:0050954 | sensory perception of mechanical stimulus | 25 | 1001 | 167 | 25087 | 1.40e-07 | 0.02 | 0.01 | 3.7 |
455 | | GO:0006355 | regulation of transcription\, DNA\-dependent | 162 | 864 | 2608 | 22646 | 1.40e-07 | 0.16 | 0.10 | 1.5 |
456 | | GO:0001822 | kidney development | 15 | 1011 | 59 | 25195 | 1.42e-07 | 0.01 | 0.00 | 6.3 |
457 | | GO:0032602 | chemokine production | 9 | 1017 | 15 | 25239 | 1.57e-07 | 0.01 | 0.00 | 14.8 |
458 | | GO:0043009 | chordate embryonic development | 26 | 1000 | 181 | 25073 | 1.64e-07 | 0.03 | 0.01 | 3.5 |
459 | | GO:0003006 | reproductive developmental process | 21 | 1005 | 122 | 25132 | 1.79e-07 | 0.02 | 0.00 | 4.2 |
460 | | GO:0051325 | interphase | 21 | 1005 | 122 | 25132 | 1.79e-07 | 0.02 | 0.00 | 4.2 |
461 | | GO:0009792 | embryonic development ending in birth or egg hatching | 26 | 1000 | 182 | 25072 | 1.80e-07 | 0.03 | 0.01 | 3.5 |
462 | | GO:0009306 | protein secretion | 17 | 1009 | 80 | 25174 | 1.99e-07 | 0.02 | 0.00 | 5.2 |
463 | | GO:0000187 | activation of MAPK activity | 17 | 1009 | 80 | 25174 | 1.99e-07 | 0.02 | 0.00 | 5.2 |
464 | | GO:0009064 | glutamine family amino acid metabolic process | 15 | 1011 | 61 | 25193 | 2.06e-07 | 0.01 | 0.00 | 6.1 |
465 | | GO:0009165 | nucleotide biosynthetic process | 27 | 999 | 197 | 25057 | 2.22e-07 | 0.03 | 0.01 | 3.4 |
466 | | GO:0045597 | positive regulation of cell differentiation | 18 | 1008 | 91 | 25163 | 2.23e-07 | 0.02 | 0.00 | 4.9 |
467 | | GO:0045927 | positive regulation of growth | 12 | 1014 | 36 | 25218 | 2.23e-07 | 0.01 | 0.00 | 8.2 |
468 | | GO:0051047 | positive regulation of secretion | 13 | 1013 | 44 | 25210 | 2.25e-07 | 0.01 | 0.00 | 7.3 |
469 | | GO:0042692 | muscle cell differentiation | 17 | 1009 | 81 | 25173 | 2.32e-07 | 0.02 | 0.00 | 5.2 |
470 | | GO:0040018 | positive regulation of multicellular organism growth | 10 | 1016 | 22 | 25232 | 2.32e-07 | 0.01 | 0.00 | 11.2 |
471 | | GO:0048659 | smooth muscle cell proliferation | 10 | 1016 | 22 | 25232 | 2.32e-07 | 0.01 | 0.00 | 11.2 |
472 | | GO:0043491 | protein kinase B signaling cascade | 8 | 1018 | 11 | 25243 | 2.70e-07 | 0.01 | 0.00 | 17.9 |
473 | | GO:0051216 | cartilage development | 14 | 1012 | 54 | 25200 | 3.01e-07 | 0.01 | 0.00 | 6.4 |
474 | | GO:0008361 | regulation of cell size | 29 | 997 | 227 | 25027 | 3.04e-07 | 0.03 | 0.01 | 3.1 |
475 | | GO:0046907 | intracellular transport | 75 | 951 | 964 | 24290 | 3.05e-07 | 0.07 | 0.04 | 1.9 |
476 | | GO:0010467 | gene expression | 217 | 809 | 3792 | 21462 | 3.19e-07 | 0.21 | 0.15 | 1.4 |
477 | | GO:0051384 | response to glucocorticoid stimulus | 10 | 1016 | 23 | 25231 | 3.21e-07 | 0.01 | 0.00 | 10.7 |
478 | | GO:0050871 | positive regulation of B cell activation | 10 | 1016 | 23 | 25231 | 3.21e-07 | 0.01 | 0.00 | 10.7 |
479 | | GO:0002274 | myeloid leukocyte activation | 11 | 1015 | 30 | 25224 | 3.28e-07 | 0.01 | 0.00 | 9.0 |
480 | | GO:0002009 | morphogenesis of an epithelium | 20 | 1006 | 116 | 25138 | 3.42e-07 | 0.02 | 0.00 | 4.2 |
481 | | GO:0002440 | production of molecular mediator of immune response | 13 | 1013 | 46 | 25208 | 3.46e-07 | 0.01 | 0.00 | 7.0 |
482 | | GO:0050678 | regulation of epithelial cell proliferation | 13 | 1013 | 46 | 25208 | 3.46e-07 | 0.01 | 0.00 | 7.0 |
483 | | GO:0051329 | interphase of mitotic cell cycle | 20 | 1006 | 117 | 25137 | 3.86e-07 | 0.02 | 0.00 | 4.2 |
484 | | GO:0009314 | response to radiation | 23 | 1003 | 153 | 25101 | 4.10e-07 | 0.02 | 0.01 | 3.7 |
485 | | GO:0006690 | icosanoid metabolic process | 13 | 1013 | 47 | 25207 | 4.26e-07 | 0.01 | 0.00 | 6.8 |
486 | | GO:0042593 | glucose homeostasis | 11 | 1015 | 31 | 25223 | 4.29e-07 | 0.01 | 0.00 | 8.7 |
487 | | GO:0033500 | carbohydrate homeostasis | 11 | 1015 | 31 | 25223 | 4.29e-07 | 0.01 | 0.00 | 8.7 |
488 | | GO:0006953 | acute\-phase response | 12 | 1014 | 39 | 25215 | 4.57e-07 | 0.01 | 0.00 | 7.6 |
489 | | GO:0034103 | regulation of tissue remodeling | 12 | 1014 | 39 | 25215 | 4.57e-07 | 0.01 | 0.00 | 7.6 |
490 | | GO:0046850 | regulation of bone remodeling | 12 | 1014 | 39 | 25215 | 4.57e-07 | 0.01 | 0.00 | 7.6 |
491 | | GO:0051336 | regulation of hydrolase activity | 30 | 996 | 246 | 25008 | 4.67e-07 | 0.03 | 0.01 | 3.0 |
492 | | GO:0016049 | cell growth | 28 | 998 | 219 | 25035 | 4.77e-07 | 0.03 | 0.01 | 3.1 |
493 | | GO:0048741 | skeletal muscle fiber development | 17 | 1009 | 86 | 25168 | 4.85e-07 | 0.02 | 0.00 | 4.9 |
494 | | GO:0048747 | muscle fiber development | 17 | 1009 | 86 | 25168 | 4.85e-07 | 0.02 | 0.00 | 4.9 |
495 | | GO:0048469 | cell maturation | 17 | 1009 | 86 | 25168 | 4.85e-07 | 0.02 | 0.00 | 4.9 |
496 | | GO:0001836 | release of cytochrome c from mitochondria | 9 | 1017 | 18 | 25236 | 5.05e-07 | 0.01 | 0.00 | 12.3 |
497 | | GO:0030155 | regulation of cell adhesion | 18 | 1008 | 97 | 25157 | 5.10e-07 | 0.02 | 0.00 | 4.6 |
498 | | GO:0042108 | positive regulation of cytokine biosynthetic process | 14 | 1012 | 57 | 25197 | 5.28e-07 | 0.01 | 0.00 | 6.0 |
499 | | GO:0006879 | cellular iron ion homeostasis | 11 | 1015 | 32 | 25222 | 5.56e-07 | 0.01 | 0.00 | 8.5 |
500 | | GO:0055072 | iron ion homeostasis | 11 | 1015 | 32 | 25222 | 5.56e-07 | 0.01 | 0.00 | 8.5 |
501 | | GO:0030595 | leukocyte chemotaxis | 11 | 1015 | 32 | 25222 | 5.56e-07 | 0.01 | 0.00 | 8.5 |
502 | | GO:0009411 | response to UV | 13 | 1013 | 49 | 25205 | 6.38e-07 | 0.01 | 0.00 | 6.5 |
503 | | GO:0008635 | caspase activation via cytochrome c | 7 | 1019 | 8 | 25246 | 6.62e-07 | 0.01 | 0.00 | 21.5 |
504 | | GO:0051881 | regulation of mitochondrial membrane potential | 8 | 1018 | 13 | 25241 | 6.79e-07 | 0.01 | 0.00 | 15.1 |
505 | | GO:0051271 | negative regulation of cell motility | 11 | 1015 | 33 | 25221 | 7.15e-07 | 0.01 | 0.00 | 8.2 |
506 | | GO:0006693 | prostaglandin metabolic process | 9 | 1017 | 19 | 25235 | 7.19e-07 | 0.01 | 0.00 | 11.7 |
507 | | GO:0006692 | prostanoid metabolic process | 9 | 1017 | 19 | 25235 | 7.19e-07 | 0.01 | 0.00 | 11.7 |
508 | | GO:0006974 | response to DNA damage stimulus | 39 | 987 | 383 | 24871 | 7.25e-07 | 0.04 | 0.02 | 2.5 |
509 | | GO:0009187 | cyclic nucleotide metabolic process | 14 | 1012 | 59 | 25195 | 7.54e-07 | 0.01 | 0.00 | 5.8 |
510 | | GO:0043524 | negative regulation of neuron apoptosis | 10 | 1016 | 26 | 25228 | 7.93e-07 | 0.01 | 0.00 | 9.5 |
511 | | GO:0051262 | protein tetramerization | 10 | 1016 | 26 | 25228 | 7.93e-07 | 0.01 | 0.00 | 9.5 |
512 | | GO:0007606 | sensory perception of chemical stimulus | 2 | 1024 | 493 | 24761 | 9.19e-07 | 0.00 | 0.02 | 0.1 |
513 | | GO:0051051 | negative regulation of transport | 13 | 1013 | 51 | 25203 | 9.38e-07 | 0.01 | 0.00 | 6.3 |
514 | | GO:0007417 | central nervous system development | 36 | 990 | 336 | 24918 | 9.43e-07 | 0.04 | 0.01 | 2.6 |
515 | | GO:0048660 | regulation of smooth muscle cell proliferation | 9 | 1017 | 20 | 25234 | 1.01e-06 | 0.01 | 0.00 | 11.1 |
516 | | GO:0042033 | chemokine biosynthetic process | 8 | 1018 | 14 | 25240 | 1.03e-06 | 0.01 | 0.00 | 14.1 |
517 | | GO:0050755 | chemokine metabolic process | 8 | 1018 | 14 | 25240 | 1.03e-06 | 0.01 | 0.00 | 14.1 |
518 | | GO:0022403 | cell cycle phase | 41 | 985 | 418 | 24836 | 1.06e-06 | 0.04 | 0.02 | 2.4 |
519 | | GO:0051402 | neuron apoptosis | 13 | 1013 | 52 | 25202 | 1.13e-06 | 0.01 | 0.00 | 6.2 |
520 | | GO:0045923 | positive regulation of fatty acid metabolic process | 7 | 1019 | 9 | 25245 | 1.14e-06 | 0.01 | 0.00 | 19.1 |
521 | | GO:0002377 | immunoglobulin production | 11 | 1015 | 35 | 25219 | 1.16e-06 | 0.01 | 0.00 | 7.7 |
522 | | GO:0002526 | acute inflammatory response | 21 | 1005 | 139 | 25115 | 1.20e-06 | 0.02 | 0.01 | 3.7 |
523 | | GO:0042493 | response to drug | 18 | 1008 | 104 | 25150 | 1.24e-06 | 0.02 | 0.00 | 4.3 |
524 | | GO:0051259 | protein oligomerization | 19 | 1007 | 116 | 25138 | 1.32e-06 | 0.02 | 0.00 | 4.0 |
525 | | GO:0043523 | regulation of neuron apoptosis | 12 | 1014 | 44 | 25210 | 1.34e-06 | 0.01 | 0.00 | 6.7 |
526 | | GO:0042133 | neurotransmitter metabolic process | 12 | 1014 | 44 | 25210 | 1.34e-06 | 0.01 | 0.00 | 6.7 |
527 | | GO:0051091 | positive regulation of transcription factor activity | 11 | 1015 | 36 | 25218 | 1.46e-06 | 0.01 | 0.00 | 7.5 |
528 | | GO:0045834 | positive regulation of lipid metabolic process | 8 | 1018 | 15 | 25239 | 1.53e-06 | 0.01 | 0.00 | 13.1 |
529 | | GO:0050796 | regulation of insulin secretion | 8 | 1018 | 15 | 25239 | 1.53e-06 | 0.01 | 0.00 | 13.1 |
530 | | GO:0021915 | neural tube development | 12 | 1014 | 45 | 25209 | 1.64e-06 | 0.01 | 0.00 | 6.6 |
531 | | GO:0006984 | ER\-nuclear signaling pathway | 10 | 1016 | 29 | 25225 | 1.78e-06 | 0.01 | 0.00 | 8.5 |
532 | | GO:0030073 | insulin secretion | 10 | 1016 | 29 | 25225 | 1.78e-06 | 0.01 | 0.00 | 8.5 |
533 | | GO:0046146 | tetrahydrobiopterin metabolic process | 7 | 1019 | 10 | 25244 | 1.87e-06 | 0.01 | 0.00 | 17.2 |
534 | | GO:0002449 | lymphocyte mediated immunity | 21 | 1005 | 144 | 25110 | 1.99e-06 | 0.02 | 0.01 | 3.6 |
535 | | GO:0002791 | regulation of peptide secretion | 8 | 1018 | 16 | 25238 | 2.21e-06 | 0.01 | 0.00 | 12.3 |
536 | | GO:0006662 | glycerol ether metabolic process | 11 | 1015 | 38 | 25216 | 2.27e-06 | 0.01 | 0.00 | 7.1 |
537 | | GO:0032103 | positive regulation of response to external stimulus | 10 | 1016 | 30 | 25224 | 2.30e-06 | 0.01 | 0.00 | 8.2 |
538 | | GO:0001657 | ureteric bud development | 10 | 1016 | 30 | 25224 | 2.30e-06 | 0.01 | 0.00 | 8.2 |
539 | | GO:0044243 | multicellular organismal catabolic process | 10 | 1016 | 30 | 25224 | 2.30e-06 | 0.01 | 0.00 | 8.2 |
540 | | GO:0006811 | ion transport | 80 | 946 | 1107 | 24147 | 2.32e-06 | 0.08 | 0.04 | 1.8 |
541 | | GO:0043542 | endothelial cell migration | 9 | 1017 | 23 | 25231 | 2.54e-06 | 0.01 | 0.00 | 9.6 |
542 | | GO:0007260 | tyrosine phosphorylation of STAT protein | 9 | 1017 | 23 | 25231 | 2.54e-06 | 0.01 | 0.00 | 9.6 |
543 | | GO:0019439 | aromatic compound catabolic process | 9 | 1017 | 23 | 25231 | 2.54e-06 | 0.01 | 0.00 | 9.6 |
544 | | GO:0007631 | feeding behavior | 13 | 1013 | 57 | 25197 | 2.73e-06 | 0.01 | 0.00 | 5.6 |
545 | | GO:0007204 | elevation of cytosolic calcium ion concentration | 16 | 1010 | 88 | 25166 | 2.74e-06 | 0.02 | 0.00 | 4.5 |
546 | | GO:0051050 | positive regulation of transport | 14 | 1012 | 67 | 25187 | 2.78e-06 | 0.01 | 0.00 | 5.1 |
547 | | GO:0009617 | response to bacterium | 20 | 1006 | 135 | 25119 | 2.80e-06 | 0.02 | 0.01 | 3.6 |
548 | | GO:0001656 | metanephros development | 11 | 1015 | 39 | 25215 | 2.81e-06 | 0.01 | 0.00 | 6.9 |
549 | | GO:0043388 | positive regulation of DNA binding | 11 | 1015 | 39 | 25215 | 2.81e-06 | 0.01 | 0.00 | 6.9 |
550 | | GO:0042632 | cholesterol homeostasis | 10 | 1016 | 31 | 25223 | 2.93e-06 | 0.01 | 0.00 | 7.9 |
551 | | GO:0055092 | sterol homeostasis | 10 | 1016 | 31 | 25223 | 2.93e-06 | 0.01 | 0.00 | 7.9 |
552 | | GO:0055088 | lipid homeostasis | 10 | 1016 | 31 | 25223 | 2.93e-06 | 0.01 | 0.00 | 7.9 |
553 | | GO:0051480 | cytosolic calcium ion homeostasis | 16 | 1010 | 89 | 25165 | 3.11e-06 | 0.02 | 0.00 | 4.4 |
554 | | GO:0002237 | response to molecule of bacterial origin | 8 | 1018 | 17 | 25237 | 3.14e-06 | 0.01 | 0.00 | 11.6 |
555 | | GO:0043648 | dicarboxylic acid metabolic process | 8 | 1018 | 17 | 25237 | 3.14e-06 | 0.01 | 0.00 | 11.6 |
556 | | GO:0050776 | regulation of immune response | 19 | 1007 | 124 | 25130 | 3.18e-06 | 0.02 | 0.00 | 3.8 |
557 | | GO:0006469 | negative regulation of protein kinase activity | 14 | 1012 | 68 | 25186 | 3.24e-06 | 0.01 | 0.00 | 5.1 |
558 | | GO:0033673 | negative regulation of kinase activity | 14 | 1012 | 68 | 25186 | 3.24e-06 | 0.01 | 0.00 | 5.1 |
559 | | GO:0033157 | regulation of intracellular protein transport | 11 | 1015 | 40 | 25214 | 3.46e-06 | 0.01 | 0.00 | 6.8 |
560 | | GO:0014031 | mesenchymal cell development | 11 | 1015 | 40 | 25214 | 3.46e-06 | 0.01 | 0.00 | 6.8 |
561 | | GO:0048762 | mesenchymal cell differentiation | 11 | 1015 | 40 | 25214 | 3.46e-06 | 0.01 | 0.00 | 6.8 |
562 | | GO:0002683 | negative regulation of immune system process | 12 | 1014 | 49 | 25205 | 3.50e-06 | 0.01 | 0.00 | 6.0 |
563 | | GO:0045445 | myoblast differentiation | 12 | 1014 | 49 | 25205 | 3.50e-06 | 0.01 | 0.00 | 6.0 |
564 | | GO:0048598 | embryonic morphogenesis | 23 | 1003 | 176 | 25078 | 3.54e-06 | 0.02 | 0.01 | 3.2 |
565 | | GO:0042311 | vasodilation | 10 | 1016 | 32 | 25222 | 3.71e-06 | 0.01 | 0.00 | 7.7 |
566 | | GO:0007548 | sex differentiation | 18 | 1008 | 114 | 25140 | 3.95e-06 | 0.02 | 0.00 | 3.9 |
567 | | GO:0007254 | JNK cascade | 15 | 1011 | 80 | 25174 | 4.00e-06 | 0.01 | 0.00 | 4.6 |
568 | | GO:0006112 | energy reserve metabolic process | 15 | 1011 | 80 | 25174 | 4.00e-06 | 0.01 | 0.00 | 4.6 |
569 | | GO:0008629 | induction of apoptosis by intracellular signals | 12 | 1014 | 50 | 25204 | 4.19e-06 | 0.01 | 0.00 | 5.9 |
570 | | GO:0050708 | regulation of protein secretion | 11 | 1015 | 41 | 25213 | 4.23e-06 | 0.01 | 0.00 | 6.6 |
571 | | GO:0042445 | hormone metabolic process | 17 | 1009 | 103 | 25151 | 4.30e-06 | 0.02 | 0.00 | 4.1 |
572 | | GO:0031329 | regulation of cellular catabolic process | 8 | 1018 | 18 | 25236 | 4.38e-06 | 0.01 | 0.00 | 10.9 |
573 | | GO:0051171 | regulation of nitrogen compound metabolic process | 9 | 1017 | 25 | 25229 | 4.42e-06 | 0.01 | 0.00 | 8.9 |
574 | | GO:0043029 | T cell homeostasis | 7 | 1019 | 12 | 25242 | 4.52e-06 | 0.01 | 0.00 | 14.4 |
575 | | GO:0046006 | regulation of activated T cell proliferation | 7 | 1019 | 12 | 25242 | 4.52e-06 | 0.01 | 0.00 | 14.4 |
576 | | GO:0042310 | vasoconstriction | 10 | 1016 | 33 | 25221 | 4.67e-06 | 0.01 | 0.00 | 7.5 |
577 | | GO:0043112 | receptor metabolic process | 10 | 1016 | 33 | 25221 | 4.67e-06 | 0.01 | 0.00 | 7.5 |
578 | | GO:0048666 | neuron development | 29 | 997 | 264 | 24990 | 4.78e-06 | 0.03 | 0.01 | 2.7 |
579 | | GO:0051188 | cofactor biosynthetic process | 19 | 1007 | 128 | 25126 | 4.81e-06 | 0.02 | 0.01 | 3.7 |
580 | | GO:0046483 | heterocycle metabolic process | 17 | 1009 | 104 | 25150 | 4.83e-06 | 0.02 | 0.00 | 4.0 |
581 | | GO:0009416 | response to light stimulus | 18 | 1008 | 116 | 25138 | 4.90e-06 | 0.02 | 0.00 | 3.8 |
582 | | GO:0051348 | negative regulation of transferase activity | 14 | 1012 | 71 | 25183 | 5.02e-06 | 0.01 | 0.00 | 4.9 |
583 | | GO:0007423 | sensory organ development | 20 | 1006 | 141 | 25113 | 5.05e-06 | 0.02 | 0.01 | 3.5 |
584 | | GO:0006260 | DNA replication | 29 | 997 | 265 | 24989 | 5.11e-06 | 0.03 | 0.01 | 2.7 |
585 | | GO:0051099 | positive regulation of binding | 11 | 1015 | 42 | 25212 | 5.15e-06 | 0.01 | 0.00 | 6.4 |
586 | | GO:0030183 | B cell differentiation | 11 | 1015 | 42 | 25212 | 5.15e-06 | 0.01 | 0.00 | 6.4 |
587 | | GO:0007608 | sensory perception of smell | 2 | 1024 | 445 | 24809 | 5.82e-06 | 0.00 | 0.02 | 0.1 |
588 | | GO:0001894 | tissue homeostasis | 10 | 1016 | 34 | 25220 | 5.83e-06 | 0.01 | 0.00 | 7.2 |
589 | | GO:0048871 | multicellular organismal homeostasis | 10 | 1016 | 34 | 25220 | 5.83e-06 | 0.01 | 0.00 | 7.2 |
590 | | GO:0044236 | multicellular organismal metabolic process | 10 | 1016 | 34 | 25220 | 5.83e-06 | 0.01 | 0.00 | 7.2 |
591 | | GO:0009069 | serine family amino acid metabolic process | 10 | 1016 | 34 | 25220 | 5.83e-06 | 0.01 | 0.00 | 7.2 |
592 | | GO:0043408 | regulation of MAPKKK cascade | 12 | 1014 | 52 | 25202 | 5.93e-06 | 0.01 | 0.00 | 5.7 |
593 | | GO:0032386 | regulation of intracellular transport | 12 | 1014 | 52 | 25202 | 5.93e-06 | 0.01 | 0.00 | 5.7 |
594 | | GO:0031098 | stress\-activated protein kinase signaling pathway | 15 | 1011 | 83 | 25171 | 5.94e-06 | 0.01 | 0.00 | 4.4 |
595 | | GO:0030316 | osteoclast differentiation | 8 | 1018 | 19 | 25235 | 6.01e-06 | 0.01 | 0.00 | 10.4 |
596 | | GO:0000079 | regulation of cyclin\-dependent protein kinase activity | 13 | 1013 | 62 | 25192 | 6.08e-06 | 0.01 | 0.00 | 5.2 |
597 | | GO:0009968 | negative regulation of signal transduction | 20 | 1006 | 144 | 25110 | 6.70e-06 | 0.02 | 0.01 | 3.4 |
598 | | GO:0051173 | positive regulation of nitrogen compound metabolic process | 7 | 1019 | 13 | 25241 | 6.72e-06 | 0.01 | 0.00 | 13.3 |
599 | | GO:0008625 | induction of apoptosis via death domain receptors | 7 | 1019 | 13 | 25241 | 6.72e-06 | 0.01 | 0.00 | 13.3 |
600 | | GO:0045073 | regulation of chemokine biosynthetic process | 7 | 1019 | 13 | 25241 | 6.72e-06 | 0.01 | 0.00 | 13.3 |
601 | | GO:0032615 | interleukin\-12 production | 7 | 1019 | 13 | 25241 | 6.72e-06 | 0.01 | 0.00 | 13.3 |
602 | | GO:0006639 | acylglycerol metabolic process | 10 | 1016 | 35 | 25219 | 7.23e-06 | 0.01 | 0.00 | 7.0 |
603 | | GO:0006638 | neutral lipid metabolic process | 10 | 1016 | 35 | 25219 | 7.23e-06 | 0.01 | 0.00 | 7.0 |
604 | | GO:0046456 | icosanoid biosynthetic process | 10 | 1016 | 35 | 25219 | 7.23e-06 | 0.01 | 0.00 | 7.0 |
605 | | GO:0030574 | collagen catabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
606 | | GO:0044254 | multicellular organismal protein catabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
607 | | GO:0044266 | multicellular organismal macromolecule catabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
608 | | GO:0044268 | multicellular organismal protein metabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
609 | | GO:0044259 | multicellular organismal macromolecule metabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
610 | | GO:0044256 | protein digestion | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
611 | | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 23 | 1003 | 185 | 25069 | 7.44e-06 | 0.02 | 0.01 | 3.1 |
612 | | GO:0009190 | cyclic nucleotide biosynthetic process | 11 | 1015 | 44 | 25210 | 7.53e-06 | 0.01 | 0.00 | 6.2 |
613 | | GO:0042554 | superoxide release | 6 | 1020 | 8 | 25246 | 8.00e-06 | 0.01 | 0.00 | 18.5 |
614 | | GO:0045884 | regulation of survival gene product expression | 8 | 1018 | 20 | 25234 | 8.13e-06 | 0.01 | 0.00 | 9.8 |
615 | | GO:0042558 | pteridine and derivative metabolic process | 8 | 1018 | 20 | 25234 | 8.13e-06 | 0.01 | 0.00 | 9.8 |
616 | | GO:0016070 | RNA metabolic process | 183 | 843 | 3241 | 22013 | 8.16e-06 | 0.18 | 0.13 | 1.4 |
617 | | GO:0045454 | cell redox homeostasis | 12 | 1014 | 54 | 25200 | 8.27e-06 | 0.01 | 0.00 | 5.5 |
618 | | GO:0008016 | regulation of heart contraction | 14 | 1012 | 75 | 25179 | 8.72e-06 | 0.01 | 0.00 | 4.6 |
619 | | GO:0045787 | positive regulation of cell cycle | 10 | 1016 | 36 | 25218 | 8.92e-06 | 0.01 | 0.00 | 6.8 |
620 | | GO:0042306 | regulation of protein import into nucleus | 10 | 1016 | 36 | 25218 | 8.92e-06 | 0.01 | 0.00 | 6.8 |
621 | | GO:0050818 | regulation of coagulation | 10 | 1016 | 36 | 25218 | 8.92e-06 | 0.01 | 0.00 | 6.8 |
622 | | GO:0046822 | regulation of nucleocytoplasmic transport | 11 | 1015 | 45 | 25209 | 9.04e-06 | 0.01 | 0.00 | 6.0 |
623 | | GO:0048661 | positive regulation of smooth muscle cell proliferation | 7 | 1019 | 14 | 25240 | 9.74e-06 | 0.01 | 0.00 | 12.3 |
624 | | GO:0051223 | regulation of protein transport | 11 | 1015 | 46 | 25208 | 1.08e-05 | 0.01 | 0.00 | 5.9 |
625 | | GO:0001558 | regulation of cell growth | 22 | 1004 | 176 | 25078 | 1.08e-05 | 0.02 | 0.01 | 3.1 |
626 | | GO:0033554 | cellular response to stress | 8 | 1018 | 21 | 25233 | 1.08e-05 | 0.01 | 0.00 | 9.4 |
627 | | GO:0030193 | regulation of blood coagulation | 8 | 1018 | 21 | 25233 | 1.08e-05 | 0.01 | 0.00 | 9.4 |
628 | | GO:0016525 | negative regulation of angiogenesis | 8 | 1018 | 21 | 25233 | 1.08e-05 | 0.01 | 0.00 | 9.4 |
629 | | GO:0043434 | response to peptide hormone stimulus | 10 | 1016 | 37 | 25217 | 1.09e-05 | 0.01 | 0.00 | 6.7 |
630 | | GO:0046486 | glycerolipid metabolic process | 10 | 1016 | 37 | 25217 | 1.09e-05 | 0.01 | 0.00 | 6.7 |
631 | | GO:0048609 | reproductive process in a multicellular organism | 15 | 1011 | 88 | 25166 | 1.11e-05 | 0.01 | 0.00 | 4.2 |
632 | | GO:0032504 | multicellular organism reproduction | 15 | 1011 | 88 | 25166 | 1.11e-05 | 0.01 | 0.00 | 4.2 |
633 | | GO:0031644 | regulation of neurological system process | 14 | 1012 | 77 | 25177 | 1.14e-05 | 0.01 | 0.00 | 4.5 |
634 | | GO:0050731 | positive regulation of peptidyl\-tyrosine phosphorylation | 9 | 1017 | 29 | 25225 | 1.19e-05 | 0.01 | 0.00 | 7.6 |
635 | | GO:0046058 | cAMP metabolic process | 9 | 1017 | 29 | 25225 | 1.19e-05 | 0.01 | 0.00 | 7.6 |
636 | | GO:0032102 | negative regulation of response to external stimulus | 9 | 1017 | 29 | 25225 | 1.19e-05 | 0.01 | 0.00 | 7.6 |
637 | | GO:0032963 | collagen metabolic process | 9 | 1017 | 29 | 25225 | 1.19e-05 | 0.01 | 0.00 | 7.6 |
638 | | GO:0032496 | response to lipopolysaccharide | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
639 | | GO:0008354 | germ cell migration | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
640 | | GO:0006729 | tetrahydrobiopterin biosynthetic process | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
641 | | GO:0042104 | positive regulation of activated T cell proliferation | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
642 | | GO:0007200 | G\-protein signaling\, coupled to IP3 second messenger (phospholipase C activating) | 16 | 1010 | 101 | 25153 | 1.29e-05 | 0.02 | 0.00 | 3.9 |
643 | | GO:0044265 | cellular macromolecule catabolic process | 37 | 989 | 397 | 24857 | 1.33e-05 | 0.04 | 0.02 | 2.3 |
644 | | GO:0045670 | regulation of osteoclast differentiation | 7 | 1019 | 15 | 25239 | 1.38e-05 | 0.01 | 0.00 | 11.5 |
645 | | GO:0042036 | negative regulation of cytokine biosynthetic process | 8 | 1018 | 22 | 25232 | 1.43e-05 | 0.01 | 0.00 | 9.0 |
646 | | GO:0050728 | negative regulation of inflammatory response | 8 | 1018 | 22 | 25232 | 1.43e-05 | 0.01 | 0.00 | 9.0 |
647 | | GO:0007172 | signal complex assembly | 8 | 1018 | 22 | 25232 | 1.43e-05 | 0.01 | 0.00 | 9.0 |
648 | | GO:0006575 | amino acid derivative metabolic process | 16 | 1010 | 102 | 25152 | 1.44e-05 | 0.02 | 0.00 | 3.9 |
649 | | GO:0006641 | triacylglycerol metabolic process | 9 | 1017 | 30 | 25224 | 1.50e-05 | 0.01 | 0.00 | 7.4 |
650 | | GO:0045596 | negative regulation of cell differentiation | 15 | 1011 | 91 | 25163 | 1.58e-05 | 0.01 | 0.00 | 4.1 |
651 | | GO:0007584 | response to nutrient | 13 | 1013 | 69 | 25185 | 1.66e-05 | 0.01 | 0.00 | 4.6 |
652 | | GO:0007389 | pattern specification process | 24 | 1002 | 211 | 25043 | 1.83e-05 | 0.02 | 0.01 | 2.8 |
653 | | GO:0042326 | negative regulation of phosphorylation | 8 | 1018 | 23 | 25231 | 1.86e-05 | 0.01 | 0.00 | 8.6 |
654 | | GO:0031348 | negative regulation of defense response | 8 | 1018 | 23 | 25231 | 1.86e-05 | 0.01 | 0.00 | 8.6 |
655 | | GO:0050663 | cytokine secretion | 9 | 1017 | 31 | 25223 | 1.87e-05 | 0.01 | 0.00 | 7.1 |
656 | | GO:0001819 | positive regulation of cytokine production | 9 | 1017 | 31 | 25223 | 1.87e-05 | 0.01 | 0.00 | 7.1 |
657 | | GO:0051048 | negative regulation of secretion | 9 | 1017 | 31 | 25223 | 1.87e-05 | 0.01 | 0.00 | 7.1 |
658 | | GO:0045428 | regulation of nitric oxide biosynthetic process | 7 | 1019 | 16 | 25238 | 1.92e-05 | 0.01 | 0.00 | 10.8 |
659 | | GO:0001658 | ureteric bud branching | 7 | 1019 | 16 | 25238 | 1.92e-05 | 0.01 | 0.00 | 10.8 |
660 | | GO:0030182 | neuron differentiation | 33 | 993 | 344 | 24910 | 1.94e-05 | 0.03 | 0.01 | 2.4 |
661 | | GO:0009894 | regulation of catabolic process | 10 | 1016 | 40 | 25214 | 1.95e-05 | 0.01 | 0.00 | 6.2 |
662 | | GO:0001838 | embryonic epithelial tube formation | 10 | 1016 | 40 | 25214 | 1.95e-05 | 0.01 | 0.00 | 6.2 |
663 | | GO:0045926 | negative regulation of growth | 14 | 1012 | 82 | 25172 | 2.12e-05 | 0.01 | 0.00 | 4.2 |
664 | | GO:0006913 | nucleocytoplasmic transport | 29 | 997 | 286 | 24968 | 2.24e-05 | 0.03 | 0.01 | 2.5 |
665 | | GO:0030278 | regulation of ossification | 9 | 1017 | 32 | 25222 | 2.31e-05 | 0.01 | 0.00 | 6.9 |
666 | | GO:0051146 | striated muscle cell differentiation | 9 | 1017 | 32 | 25222 | 2.31e-05 | 0.01 | 0.00 | 6.9 |
667 | | GO:0016311 | dephosphorylation | 22 | 1004 | 186 | 25068 | 2.35e-05 | 0.02 | 0.01 | 2.9 |
668 | | GO:0045936 | negative regulation of phosphate metabolic process | 8 | 1018 | 24 | 25230 | 2.40e-05 | 0.01 | 0.00 | 8.2 |
669 | | GO:0010563 | negative regulation of phosphorus metabolic process | 8 | 1018 | 24 | 25230 | 2.40e-05 | 0.01 | 0.00 | 8.2 |
670 | | GO:0006767 | water\-soluble vitamin metabolic process | 11 | 1015 | 51 | 25203 | 2.49e-05 | 0.01 | 0.00 | 5.3 |
671 | | GO:0051169 | nuclear transport | 29 | 997 | 289 | 24965 | 2.57e-05 | 0.03 | 0.01 | 2.5 |
672 | | GO:0051341 | regulation of oxidoreductase activity | 7 | 1019 | 17 | 25237 | 2.62e-05 | 0.01 | 0.00 | 10.1 |
673 | | GO:0055008 | cardiac muscle morphogensis | 7 | 1019 | 17 | 25237 | 2.62e-05 | 0.01 | 0.00 | 10.1 |
674 | | GO:0048644 | muscle morphogenesis | 7 | 1019 | 17 | 25237 | 2.62e-05 | 0.01 | 0.00 | 10.1 |
675 | | GO:0008104 | protein localization | 71 | 955 | 1019 | 24235 | 2.81e-05 | 0.07 | 0.04 | 1.7 |
676 | | GO:0051128 | regulation of cellular component organization and biogenesis | 32 | 994 | 336 | 24918 | 2.91e-05 | 0.03 | 0.01 | 2.3 |
677 | | GO:0016331 | morphogenesis of embryonic epithelium | 11 | 1015 | 52 | 25202 | 2.91e-05 | 0.01 | 0.00 | 5.2 |
678 | | GO:0051238 | sequestering of metal ion | 6 | 1020 | 11 | 25243 | 2.98e-05 | 0.01 | 0.00 | 13.4 |
679 | | GO:0051592 | response to calcium ion | 6 | 1020 | 11 | 25243 | 2.98e-05 | 0.01 | 0.00 | 13.4 |
680 | | GO:0007595 | lactation | 8 | 1018 | 25 | 25229 | 3.05e-05 | 0.01 | 0.00 | 7.9 |
681 | | GO:0006171 | cAMP biosynthetic process | 8 | 1018 | 25 | 25229 | 3.05e-05 | 0.01 | 0.00 | 7.9 |
682 | | GO:0006968 | cellular defense response | 15 | 1011 | 97 | 25157 | 3.07e-05 | 0.01 | 0.00 | 3.8 |
683 | | GO:0001654 | eye development | 13 | 1013 | 74 | 25180 | 3.19e-05 | 0.01 | 0.00 | 4.3 |
684 | | GO:0051209 | release of sequestered calcium ion into cytosol | 5 | 1021 | 6 | 25248 | 3.41e-05 | 0.00 | 0.00 | 20.5 |
685 | | GO:0051283 | negative regulation of sequestering of calcium ion | 5 | 1021 | 6 | 25248 | 3.41e-05 | 0.00 | 0.00 | 20.5 |
686 | | GO:0051282 | regulation of sequestering of calcium ion | 5 | 1021 | 6 | 25248 | 3.41e-05 | 0.00 | 0.00 | 20.5 |
687 | | GO:0007281 | germ cell development | 9 | 1017 | 34 | 25220 | 3.47e-05 | 0.01 | 0.00 | 6.5 |
688 | | GO:0051591 | response to cAMP | 7 | 1019 | 18 | 25236 | 3.51e-05 | 0.01 | 0.00 | 9.6 |
689 | | GO:0007229 | integrin\-mediated signaling pathway | 13 | 1013 | 75 | 25179 | 3.61e-05 | 0.01 | 0.00 | 4.3 |
690 | | GO:0030308 | negative regulation of cell growth | 12 | 1014 | 64 | 25190 | 3.64e-05 | 0.01 | 0.00 | 4.6 |
691 | | GO:0019722 | calcium\-mediated signaling | 10 | 1016 | 44 | 25210 | 3.95e-05 | 0.01 | 0.00 | 5.6 |
692 | | GO:0030218 | erythrocyte differentiation | 10 | 1016 | 44 | 25210 | 3.95e-05 | 0.01 | 0.00 | 5.6 |
693 | | GO:0034101 | erythrocyte homeostasis | 10 | 1016 | 44 | 25210 | 3.95e-05 | 0.01 | 0.00 | 5.6 |
694 | | GO:0045792 | negative regulation of cell size | 12 | 1014 | 65 | 25189 | 4.16e-05 | 0.01 | 0.00 | 4.5 |
695 | | GO:0007568 | aging | 9 | 1017 | 35 | 25219 | 4.21e-05 | 0.01 | 0.00 | 6.3 |
696 | | GO:0042475 | odontogenesis of dentine\-containing teeth | 9 | 1017 | 35 | 25219 | 4.21e-05 | 0.01 | 0.00 | 6.3 |
697 | | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 15 | 1011 | 100 | 25154 | 4.21e-05 | 0.01 | 0.00 | 3.7 |
698 | | GO:0051130 | positive regulation of cellular component organization and biogenesis | 14 | 1012 | 88 | 25166 | 4.25e-05 | 0.01 | 0.00 | 3.9 |
699 | | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 6 | 1020 | 12 | 25242 | 4.33e-05 | 0.01 | 0.00 | 12.3 |
700 | | GO:0046887 | positive regulation of hormone secretion | 6 | 1020 | 12 | 25242 | 4.33e-05 | 0.01 | 0.00 | 12.3 |
701 | | GO:0006766 | vitamin metabolic process | 13 | 1013 | 77 | 25177 | 4.60e-05 | 0.01 | 0.00 | 4.2 |
702 | | GO:0031668 | cellular response to extracellular stimulus | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
703 | | GO:0019229 | regulation of vasoconstriction | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
704 | | GO:0006109 | regulation of carbohydrate metabolic process | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
705 | | GO:0048145 | regulation of fibroblast proliferation | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
706 | | GO:0048144 | fibroblast proliferation | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
707 | | GO:0009074 | aromatic amino acid family catabolic process | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
708 | | GO:0019438 | aromatic compound biosynthetic process | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
709 | | GO:0042476 | odontogenesis | 10 | 1016 | 45 | 25209 | 4.66e-05 | 0.01 | 0.00 | 5.5 |
710 | | GO:0015992 | proton transport | 15 | 1011 | 101 | 25153 | 4.66e-05 | 0.01 | 0.00 | 3.7 |
711 | | GO:0045137 | development of primary sexual characteristics | 14 | 1012 | 89 | 25165 | 4.74e-05 | 0.01 | 0.00 | 3.9 |
712 | | GO:0009108 | coenzyme biosynthetic process | 12 | 1014 | 66 | 25188 | 4.75e-05 | 0.01 | 0.00 | 4.5 |
713 | | GO:0014032 | neural crest cell development | 8 | 1018 | 27 | 25227 | 4.83e-05 | 0.01 | 0.00 | 7.3 |
714 | | GO:0014033 | neural crest cell differentiation | 8 | 1018 | 27 | 25227 | 4.83e-05 | 0.01 | 0.00 | 7.3 |
715 | | GO:0030301 | cholesterol transport | 8 | 1018 | 27 | 25227 | 4.83e-05 | 0.01 | 0.00 | 7.3 |
716 | | GO:0015918 | sterol transport | 8 | 1018 | 27 | 25227 | 4.83e-05 | 0.01 | 0.00 | 7.3 |
717 | | GO:0030336 | negative regulation of cell migration | 8 | 1018 | 27 | 25227 | 4.83e-05 | 0.01 | 0.00 | 7.3 |
718 | | GO:0006284 | base\-excision repair | 9 | 1017 | 36 | 25218 | 5.08e-05 | 0.01 | 0.00 | 6.2 |
719 | | GO:0006733 | oxidoreduction coenzyme metabolic process | 9 | 1017 | 36 | 25218 | 5.08e-05 | 0.01 | 0.00 | 6.2 |
720 | | GO:0032147 | activation of protein kinase activity | 13 | 1013 | 78 | 25176 | 5.18e-05 | 0.01 | 0.00 | 4.1 |
721 | | GO:0003081 | regulation of systemic arterial blood pressure by renin\-angiotensin | 5 | 1021 | 7 | 25247 | 5.66e-05 | 0.00 | 0.00 | 17.6 |
722 | | GO:0006818 | hydrogen transport | 15 | 1011 | 103 | 25151 | 5.70e-05 | 0.01 | 0.00 | 3.6 |
723 | | GO:0019953 | sexual reproduction | 36 | 990 | 412 | 24842 | 5.83e-05 | 0.04 | 0.02 | 2.2 |
724 | | GO:0016485 | protein processing | 16 | 1010 | 116 | 25138 | 5.86e-05 | 0.02 | 0.00 | 3.4 |
725 | | GO:0033036 | macromolecule localization | 72 | 954 | 1067 | 24187 | 5.98e-05 | 0.07 | 0.04 | 1.7 |
726 | | GO:0051092 | activation of NF\-kappaB transcription factor | 8 | 1018 | 28 | 25226 | 6.00e-05 | 0.01 | 0.00 | 7.0 |
727 | | GO:0007585 | respiratory gaseous exchange | 9 | 1017 | 37 | 25217 | 6.10e-05 | 0.01 | 0.00 | 6.0 |
728 | | GO:0048015 | phosphoinositide\-mediated signaling | 18 | 1008 | 143 | 25111 | 6.13e-05 | 0.02 | 0.01 | 3.1 |
729 | | GO:0000902 | cell morphogenesis | 36 | 990 | 415 | 24839 | 6.23e-05 | 0.04 | 0.02 | 2.1 |
730 | | GO:0032989 | cellular structure morphogenesis | 36 | 990 | 415 | 24839 | 6.23e-05 | 0.04 | 0.02 | 2.1 |
731 | | GO:0043623 | cellular protein complex assembly | 14 | 1012 | 92 | 25162 | 6.54e-05 | 0.01 | 0.00 | 3.7 |
732 | | GO:0001841 | neural tube formation | 9 | 1017 | 38 | 25216 | 7.28e-05 | 0.01 | 0.00 | 5.8 |
733 | | GO:0001839 | neural plate morphogenesis | 9 | 1017 | 38 | 25216 | 7.28e-05 | 0.01 | 0.00 | 5.8 |
734 | | GO:0050679 | positive regulation of epithelial cell proliferation | 8 | 1018 | 29 | 25225 | 7.39e-05 | 0.01 | 0.00 | 6.8 |
735 | | GO:0001569 | patterning of blood vessels | 7 | 1019 | 21 | 25233 | 7.80e-05 | 0.01 | 0.00 | 8.2 |
736 | | GO:0009065 | glutamine family amino acid catabolic process | 7 | 1019 | 21 | 25233 | 7.80e-05 | 0.01 | 0.00 | 8.2 |
737 | | GO:0010564 | regulation of cell cycle process | 12 | 1014 | 70 | 25184 | 7.85e-05 | 0.01 | 0.00 | 4.2 |
738 | | GO:0001508 | regulation of action potential | 11 | 1015 | 59 | 25195 | 7.98e-05 | 0.01 | 0.00 | 4.6 |
739 | | GO:0007588 | excretion | 11 | 1015 | 59 | 25195 | 7.98e-05 | 0.01 | 0.00 | 4.6 |
740 | | GO:0007420 | brain development | 23 | 1003 | 219 | 25035 | 8.31e-05 | 0.02 | 0.01 | 2.6 |
741 | | GO:0001818 | negative regulation of cytokine production | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
742 | | GO:0045736 | negative regulation of cyclin\-dependent protein kinase activity | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
743 | | GO:0006739 | NADP metabolic process | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
744 | | GO:0006559 | L\-phenylalanine catabolic process | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
745 | | GO:0006558 | L\-phenylalanine metabolic process | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
746 | | GO:0006536 | glutamate metabolic process | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
747 | | GO:0055010 | ventricular cardiac muscle morphogenesis | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
748 | | GO:0030030 | cell projection organization and biogenesis | 30 | 996 | 327 | 24927 | 8.56e-05 | 0.03 | 0.01 | 2.3 |
749 | | GO:0048858 | cell projection morphogenesis | 30 | 996 | 327 | 24927 | 8.56e-05 | 0.03 | 0.01 | 2.3 |
750 | | GO:0032990 | cell part morphogenesis | 30 | 996 | 327 | 24927 | 8.56e-05 | 0.03 | 0.01 | 2.3 |
751 | | GO:0001840 | neural plate development | 9 | 1017 | 39 | 25215 | 8.65e-05 | 0.01 | 0.00 | 5.7 |
752 | | GO:0051208 | sequestering of calcium ion | 5 | 1021 | 8 | 25246 | 8.90e-05 | 0.00 | 0.00 | 15.4 |
753 | | GO:0048008 | platelet\-derived growth factor receptor signaling pathway | 5 | 1021 | 8 | 25246 | 8.90e-05 | 0.00 | 0.00 | 15.4 |
754 | | GO:0043410 | positive regulation of MAPKKK cascade | 8 | 1018 | 30 | 25224 | 9.04e-05 | 0.01 | 0.00 | 6.6 |
755 | | GO:0034330 | cell junction assembly and maintenance | 8 | 1018 | 30 | 25224 | 9.04e-05 | 0.01 | 0.00 | 6.6 |
756 | | GO:0016064 | immunoglobulin mediated immune response | 16 | 1010 | 121 | 25133 | 9.19e-05 | 0.02 | 0.00 | 3.3 |
757 | | GO:0045184 | establishment of protein localization | 65 | 961 | 951 | 24303 | 9.45e-05 | 0.06 | 0.04 | 1.7 |
758 | | GO:0045840 | positive regulation of mitosis | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
759 | | GO:0009743 | response to carbohydrate stimulus | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
760 | | GO:0007006 | mitochondrial membrane organization and biogenesis | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
761 | | GO:0034329 | cell junction assembly | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
762 | | GO:0019724 | B cell mediated immunity | 16 | 1010 | 122 | 25132 | 1.00e-04 | 0.02 | 0.00 | 3.2 |
763 | | GO:0010558 | negative regulation of macromolecule biosynthetic process | 10 | 1016 | 50 | 25204 | 1.01e-04 | 0.01 | 0.00 | 4.9 |
764 | | GO:0042446 | hormone biosynthetic process | 10 | 1016 | 50 | 25204 | 1.01e-04 | 0.01 | 0.00 | 4.9 |
765 | | GO:0006812 | cation transport | 55 | 971 | 765 | 24489 | 1.04e-04 | 0.05 | 0.03 | 1.8 |
766 | | GO:0009636 | response to toxin | 8 | 1018 | 31 | 25223 | 1.10e-04 | 0.01 | 0.00 | 6.4 |
767 | | GO:0050819 | negative regulation of coagulation | 8 | 1018 | 31 | 25223 | 1.10e-04 | 0.01 | 0.00 | 6.4 |
768 | | GO:0000096 | sulfur amino acid metabolic process | 8 | 1018 | 31 | 25223 | 1.10e-04 | 0.01 | 0.00 | 6.4 |
769 | | GO:0019218 | regulation of steroid metabolic process | 6 | 1020 | 15 | 25239 | 1.14e-04 | 0.01 | 0.00 | 9.8 |
770 | | GO:0048009 | insulin\-like growth factor receptor signaling pathway | 6 | 1020 | 15 | 25239 | 1.14e-04 | 0.01 | 0.00 | 9.8 |
771 | | GO:0042088 | T\-helper 1 type immune response | 6 | 1020 | 15 | 25239 | 1.14e-04 | 0.01 | 0.00 | 9.8 |
772 | | GO:0009755 | hormone\-mediated signaling | 6 | 1020 | 15 | 25239 | 1.14e-04 | 0.01 | 0.00 | 9.8 |
773 | | GO:0019228 | regulation of action potential in neuron | 10 | 1016 | 51 | 25203 | 1.16e-04 | 0.01 | 0.00 | 4.8 |
774 | | GO:0019751 | polyol metabolic process | 10 | 1016 | 51 | 25203 | 1.16e-04 | 0.01 | 0.00 | 4.8 |
775 | | GO:0050804 | regulation of synaptic transmission | 11 | 1015 | 62 | 25192 | 1.18e-04 | 0.01 | 0.00 | 4.4 |
776 | | GO:0019935 | cyclic\-nucleotide\-mediated signaling | 18 | 1008 | 152 | 25102 | 1.24e-04 | 0.02 | 0.01 | 2.9 |
777 | | GO:0006769 | nicotinamide metabolic process | 7 | 1019 | 23 | 25231 | 1.25e-04 | 0.01 | 0.00 | 7.5 |
778 | | GO:0006470 | protein amino acid dephosphorylation | 19 | 1007 | 167 | 25087 | 1.31e-04 | 0.02 | 0.01 | 2.8 |
779 | | GO:0043691 | reverse cholesterol transport | 5 | 1021 | 9 | 25245 | 1.34e-04 | 0.00 | 0.00 | 13.7 |
780 | | GO:0030503 | regulation of cell redox homeostasis | 5 | 1021 | 9 | 25245 | 1.34e-04 | 0.00 | 0.00 | 13.7 |
781 | | GO:0008366 | axon ensheathment | 9 | 1017 | 42 | 25212 | 1.41e-04 | 0.01 | 0.00 | 5.3 |
782 | | GO:0007272 | ensheathment of neurons | 9 | 1017 | 42 | 25212 | 1.41e-04 | 0.01 | 0.00 | 5.3 |
783 | | GO:0043473 | pigmentation | 9 | 1017 | 42 | 25212 | 1.41e-04 | 0.01 | 0.00 | 5.3 |
784 | | GO:0032800 | receptor biosynthetic process | 4 | 1022 | 4 | 25250 | 1.42e-04 | 0.00 | 0.00 | 24.6 |
785 | | GO:0007262 | STAT protein nuclear translocation | 4 | 1022 | 4 | 25250 | 1.42e-04 | 0.00 | 0.00 | 24.6 |
786 | | GO:0006897 | endocytosis | 24 | 1002 | 241 | 25013 | 1.50e-04 | 0.02 | 0.01 | 2.5 |
787 | | GO:0010324 | membrane invagination | 24 | 1002 | 241 | 25013 | 1.50e-04 | 0.02 | 0.01 | 2.5 |
788 | | GO:0050920 | regulation of chemotaxis | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
789 | | GO:0042594 | response to starvation | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
790 | | GO:0007159 | leukocyte adhesion | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
791 | | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
792 | | GO:0030888 | regulation of B cell proliferation | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
793 | | GO:0051899 | membrane depolarization | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
794 | | GO:0030239 | myofibril assembly | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
795 | | GO:0055002 | striated muscle cell development | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
796 | | GO:0042440 | pigment metabolic process | 10 | 1016 | 53 | 25201 | 1.53e-04 | 0.01 | 0.00 | 4.6 |
797 | | GO:0009620 | response to fungus | 7 | 1019 | 24 | 25230 | 1.57e-04 | 0.01 | 0.00 | 7.2 |
798 | | GO:0007040 | lysosome organization and biogenesis | 7 | 1019 | 24 | 25230 | 1.57e-04 | 0.01 | 0.00 | 7.2 |
799 | | GO:0007346 | regulation of mitotic cell cycle | 12 | 1014 | 76 | 25178 | 1.57e-04 | 0.01 | 0.00 | 3.9 |
800 | | GO:0042990 | regulation of transcription factor import into nucleus | 8 | 1018 | 33 | 25221 | 1.59e-04 | 0.01 | 0.00 | 6.0 |
801 | | GO:0042991 | transcription factor import into nucleus | 8 | 1018 | 33 | 25221 | 1.59e-04 | 0.01 | 0.00 | 6.0 |
802 | | GO:0051272 | positive regulation of cell motility | 8 | 1018 | 33 | 25221 | 1.59e-04 | 0.01 | 0.00 | 6.0 |
803 | | GO:0043285 | biopolymer catabolic process | 33 | 993 | 383 | 24871 | 1.60e-04 | 0.03 | 0.02 | 2.1 |
804 | | GO:0051969 | regulation of transmission of nerve impulse | 11 | 1015 | 65 | 25189 | 1.71e-04 | 0.01 | 0.00 | 4.2 |
805 | | GO:0046777 | protein amino acid autophosphorylation | 11 | 1015 | 65 | 25189 | 1.71e-04 | 0.01 | 0.00 | 4.2 |
806 | | GO:0019748 | secondary metabolic process | 11 | 1015 | 65 | 25189 | 1.71e-04 | 0.01 | 0.00 | 4.2 |
807 | | GO:0006939 | smooth muscle contraction | 10 | 1016 | 54 | 25200 | 1.76e-04 | 0.01 | 0.00 | 4.6 |
808 | | GO:0016569 | covalent chromatin modification | 10 | 1016 | 54 | 25200 | 1.76e-04 | 0.01 | 0.00 | 4.6 |
809 | | GO:0042552 | myelination | 8 | 1018 | 34 | 25220 | 1.90e-04 | 0.01 | 0.00 | 5.8 |
810 | | GO:0030041 | actin filament polymerization | 8 | 1018 | 34 | 25220 | 1.90e-04 | 0.01 | 0.00 | 5.8 |
811 | | GO:0048568 | embryonic organ development | 8 | 1018 | 34 | 25220 | 1.90e-04 | 0.01 | 0.00 | 5.8 |
812 | | GO:0007498 | mesoderm development | 11 | 1015 | 66 | 25188 | 1.92e-04 | 0.01 | 0.00 | 4.1 |
813 | | GO:0050714 | positive regulation of protein secretion | 7 | 1019 | 25 | 25229 | 1.94e-04 | 0.01 | 0.00 | 6.9 |
814 | | GO:0002761 | regulation of myeloid leukocyte differentiation | 7 | 1019 | 25 | 25229 | 1.94e-04 | 0.01 | 0.00 | 6.9 |
815 | | GO:0032635 | interleukin\-6 production | 7 | 1019 | 25 | 25229 | 1.94e-04 | 0.01 | 0.00 | 6.9 |
816 | | GO:0000086 | G2/M transition of mitotic cell cycle | 7 | 1019 | 25 | 25229 | 1.94e-04 | 0.01 | 0.00 | 6.9 |
817 | | GO:0032768 | regulation of monooxygenase activity | 5 | 1021 | 10 | 25244 | 1.94e-04 | 0.00 | 0.00 | 12.3 |
818 | | GO:0050999 | regulation of nitric\-oxide synthase activity | 5 | 1021 | 10 | 25244 | 1.94e-04 | 0.00 | 0.00 | 12.3 |
819 | | GO:0045075 | regulation of interleukin\-12 biosynthetic process | 5 | 1021 | 10 | 25244 | 1.94e-04 | 0.00 | 0.00 | 12.3 |
820 | | GO:0042090 | interleukin\-12 biosynthetic process | 5 | 1021 | 10 | 25244 | 1.94e-04 | 0.00 | 0.00 | 12.3 |
821 | | GO:0050848 | regulation of calcium\-mediated signaling | 5 | 1021 | 10 | 25244 | 1.94e-04 | 0.00 | 0.00 | 12.3 |
822 | | GO:0046890 | regulation of lipid biosynthetic process | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
823 | | GO:0003014 | renal system process | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
824 | | GO:0030195 | negative regulation of blood coagulation | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
825 | | GO:0030799 | regulation of cyclic nucleotide metabolic process | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
826 | | GO:0055001 | muscle cell development | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
827 | | GO:0042559 | pteridine and derivative biosynthetic process | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
828 | | GO:0001952 | regulation of cell\-matrix adhesion | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
829 | | GO:0000082 | G1/S transition of mitotic cell cycle | 10 | 1016 | 55 | 25199 | 2.00e-04 | 0.01 | 0.00 | 4.5 |
830 | | GO:0006281 | DNA repair | 28 | 998 | 313 | 24941 | 2.09e-04 | 0.03 | 0.01 | 2.2 |
831 | | GO:0008406 | gonad development | 12 | 1014 | 79 | 25175 | 2.17e-04 | 0.01 | 0.00 | 3.7 |
832 | | GO:0030282 | bone mineralization | 8 | 1018 | 35 | 25219 | 2.26e-04 | 0.01 | 0.00 | 5.6 |
833 | | GO:0006937 | regulation of muscle contraction | 10 | 1016 | 56 | 25198 | 2.28e-04 | 0.01 | 0.00 | 4.4 |
834 | | GO:0050778 | positive regulation of immune response | 14 | 1012 | 105 | 25149 | 2.29e-04 | 0.01 | 0.00 | 3.3 |
835 | | GO:0007033 | vacuole organization and biogenesis | 7 | 1019 | 26 | 25228 | 2.37e-04 | 0.01 | 0.00 | 6.6 |
836 | | GO:0009266 | response to temperature stimulus | 23 | 1003 | 234 | 25020 | 2.38e-04 | 0.02 | 0.01 | 2.4 |
837 | | GO:0016540 | protein autoprocessing | 11 | 1015 | 68 | 25186 | 2.42e-04 | 0.01 | 0.00 | 4.0 |
838 | | GO:0000303 | response to superoxide | 4 | 1022 | 5 | 25249 | 2.49e-04 | 0.00 | 0.00 | 19.7 |
839 | | GO:0046320 | regulation of fatty acid oxidation | 4 | 1022 | 5 | 25249 | 2.49e-04 | 0.00 | 0.00 | 19.7 |
840 | | GO:0006111 | regulation of gluconeogenesis | 4 | 1022 | 5 | 25249 | 2.49e-04 | 0.00 | 0.00 | 19.7 |
841 | | GO:0046851 | negative regulation of bone remodeling | 6 | 1020 | 18 | 25236 | 2.57e-04 | 0.01 | 0.00 | 8.2 |
842 | | GO:0034104 | negative regulation of tissue remodeling | 6 | 1020 | 18 | 25236 | 2.57e-04 | 0.01 | 0.00 | 8.2 |
843 | | GO:0030968 | unfolded protein response | 6 | 1020 | 18 | 25236 | 2.57e-04 | 0.01 | 0.00 | 8.2 |
844 | | GO:0001755 | neural crest cell migration | 6 | 1020 | 18 | 25236 | 2.57e-04 | 0.01 | 0.00 | 8.2 |
845 | | GO:0006570 | tyrosine metabolic process | 6 | 1020 | 18 | 25236 | 2.57e-04 | 0.01 | 0.00 | 8.2 |
846 | | GO:0040029 | regulation of gene expression\, epigenetic | 10 | 1016 | 57 | 25197 | 2.59e-04 | 0.01 | 0.00 | 4.3 |
847 | | GO:0031175 | neurite development | 23 | 1003 | 236 | 25018 | 2.59e-04 | 0.02 | 0.01 | 2.4 |
848 | | GO:0007173 | epidermal growth factor receptor signaling pathway | 8 | 1018 | 36 | 25218 | 2.67e-04 | 0.01 | 0.00 | 5.5 |
849 | | GO:0050866 | negative regulation of cell activation | 8 | 1018 | 36 | 25218 | 2.67e-04 | 0.01 | 0.00 | 5.5 |
850 | | GO:0032271 | regulation of protein polymerization | 8 | 1018 | 36 | 25218 | 2.67e-04 | 0.01 | 0.00 | 5.5 |
851 | | GO:0048608 | reproductive structure development | 12 | 1014 | 81 | 25173 | 2.67e-04 | 0.01 | 0.00 | 3.6 |
852 | | GO:0007179 | transforming growth factor beta receptor signaling pathway | 11 | 1015 | 69 | 25185 | 2.71e-04 | 0.01 | 0.00 | 3.9 |
853 | | GO:0046716 | muscle maintenance | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
854 | | GO:0045123 | cellular extravasation | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
855 | | GO:0031663 | lipopolysaccharide\-mediated signaling pathway | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
856 | | GO:0001516 | prostaglandin biosynthetic process | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
857 | | GO:0046457 | prostanoid biosynthetic process | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
858 | | GO:0032094 | response to food | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
859 | | GO:0051963 | regulation of synaptogenesis | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
860 | | GO:0006750 | glutathione biosynthetic process | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
861 | | GO:0045885 | positive regulation of survival gene product expression | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
862 | | GO:0050707 | regulation of cytokine secretion | 7 | 1019 | 27 | 25227 | 2.89e-04 | 0.01 | 0.00 | 6.4 |
863 | | GO:0019362 | pyridine nucleotide metabolic process | 7 | 1019 | 27 | 25227 | 2.89e-04 | 0.01 | 0.00 | 6.4 |
864 | | GO:0007369 | gastrulation | 9 | 1017 | 47 | 25207 | 2.96e-04 | 0.01 | 0.00 | 4.7 |
865 | | GO:0005977 | glycogen metabolic process | 11 | 1015 | 70 | 25184 | 3.03e-04 | 0.01 | 0.00 | 3.9 |
866 | | GO:0009615 | response to virus | 15 | 1011 | 122 | 25132 | 3.08e-04 | 0.01 | 0.00 | 3.0 |
867 | | GO:0032388 | positive regulation of intracellular transport | 6 | 1020 | 19 | 25235 | 3.26e-04 | 0.01 | 0.00 | 7.8 |
868 | | GO:0032273 | positive regulation of protein polymerization | 6 | 1020 | 19 | 25235 | 3.26e-04 | 0.01 | 0.00 | 7.8 |
869 | | GO:0042551 | neuron maturation | 6 | 1020 | 19 | 25235 | 3.26e-04 | 0.01 | 0.00 | 7.8 |
870 | | GO:0048565 | gut development | 6 | 1020 | 19 | 25235 | 3.26e-04 | 0.01 | 0.00 | 7.8 |
871 | | GO:0030534 | adult behavior | 10 | 1016 | 59 | 25195 | 3.31e-04 | 0.01 | 0.00 | 4.2 |
872 | | GO:0006073 | glucan metabolic process | 11 | 1015 | 71 | 25183 | 3.38e-04 | 0.01 | 0.00 | 3.8 |
873 | | GO:0007088 | regulation of mitosis | 9 | 1017 | 48 | 25206 | 3.39e-04 | 0.01 | 0.00 | 4.6 |
874 | | GO:0006940 | regulation of smooth muscle contraction | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
875 | | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
876 | | GO:0016444 | somatic cell DNA recombination | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
877 | | GO:0016445 | somatic diversification of immunoglobulins | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
878 | | GO:0030335 | positive regulation of cell migration | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
879 | | GO:0008630 | DNA damage response\, signal transduction resulting in induction of apoptosis | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
880 | | GO:0048066 | pigmentation during development | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
881 | | GO:0042092 | T\-helper 2 type immune response | 5 | 1021 | 12 | 25242 | 3.75e-04 | 0.00 | 0.00 | 10.3 |
882 | | GO:0007263 | nitric oxide mediated signal transduction | 5 | 1021 | 12 | 25242 | 3.75e-04 | 0.00 | 0.00 | 10.3 |
883 | | GO:0050807 | regulation of synapse organization and biogenesis | 5 | 1021 | 12 | 25242 | 3.75e-04 | 0.00 | 0.00 | 10.3 |
884 | | GO:0019915 | sequestering of lipid | 5 | 1021 | 12 | 25242 | 3.75e-04 | 0.00 | 0.00 | 10.3 |
885 | | GO:0050767 | regulation of neurogenesis | 11 | 1015 | 72 | 25182 | 3.76e-04 | 0.01 | 0.00 | 3.8 |
886 | | GO:0006163 | purine nucleotide metabolic process | 15 | 1011 | 125 | 25129 | 3.89e-04 | 0.01 | 0.00 | 3.0 |
887 | | GO:0019882 | antigen processing and presentation | 12 | 1014 | 85 | 25169 | 3.96e-04 | 0.01 | 0.00 | 3.5 |
888 | | GO:0000305 | response to oxygen radical | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
889 | | GO:0032104 | regulation of response to extracellular stimulus | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
890 | | GO:0032107 | regulation of response to nutrient levels | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
891 | | GO:0032095 | regulation of response to food | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
892 | | GO:0032098 | regulation of appetite | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
893 | | GO:0046902 | regulation of mitochondrial membrane permeability | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
894 | | GO:0001773 | myeloid dendritic cell activation | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
895 | | GO:0046666 | retinal cell programmed cell death | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
896 | | GO:0045213 | neurotransmitter receptor metabolic process | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
897 | | GO:0006309 | DNA fragmentation during apoptosis | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
898 | | GO:0042345 | regulation of NF\-kappaB import into nucleus | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
899 | | GO:0042348 | NF\-kappaB import into nucleus | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
900 | | GO:0045190 | isotype switching | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
901 | | GO:0002204 | somatic recombination of immunoglobulin genes during immune response | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
902 | | GO:0002208 | somatic diversification of immunoglobulins during immune response | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
903 | | GO:0002381 | immunoglobulin production during immune response | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
904 | | GO:0006140 | regulation of nucleotide metabolic process | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
905 | | GO:0008154 | actin polymerization and/or depolymerization | 11 | 1015 | 73 | 25181 | 4.18e-04 | 0.01 | 0.00 | 3.7 |
906 | | GO:0043392 | negative regulation of DNA binding | 7 | 1019 | 29 | 25225 | 4.19e-04 | 0.01 | 0.00 | 5.9 |
907 | | GO:0031032 | actomyosin structure organization and biogenesis | 7 | 1019 | 29 | 25225 | 4.19e-04 | 0.01 | 0.00 | 5.9 |
908 | | GO:0051301 | cell division | 25 | 1001 | 276 | 24978 | 4.25e-04 | 0.02 | 0.01 | 2.2 |
909 | | GO:0006308 | DNA catabolic process | 8 | 1018 | 39 | 25215 | 4.26e-04 | 0.01 | 0.00 | 5.0 |
910 | | GO:0032880 | regulation of protein localization | 8 | 1018 | 39 | 25215 | 4.26e-04 | 0.01 | 0.00 | 5.0 |
911 | | GO:0046661 | male sex differentiation | 9 | 1017 | 50 | 25204 | 4.42e-04 | 0.01 | 0.00 | 4.4 |
912 | | GO:0048589 | developmental growth | 10 | 1016 | 62 | 25192 | 4.69e-04 | 0.01 | 0.00 | 4.0 |
913 | | GO:0002757 | immune response\-activating signal transduction | 8 | 1018 | 40 | 25214 | 4.94e-04 | 0.01 | 0.00 | 4.9 |
914 | | GO:0051100 | negative regulation of binding | 7 | 1019 | 30 | 25224 | 5.00e-04 | 0.01 | 0.00 | 5.7 |
915 | | GO:0001843 | neural tube closure | 7 | 1019 | 30 | 25224 | 5.00e-04 | 0.01 | 0.00 | 5.7 |
916 | | GO:0001707 | mesoderm formation | 7 | 1019 | 30 | 25224 | 5.00e-04 | 0.01 | 0.00 | 5.7 |
917 | | GO:0030855 | epithelial cell differentiation | 9 | 1017 | 51 | 25203 | 5.02e-04 | 0.01 | 0.00 | 4.3 |
918 | | GO:0046324 | regulation of glucose import | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
919 | | GO:0001990 | regulation of systemic arterial blood pressure by hormone | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
920 | | GO:0050886 | endocrine process | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
921 | | GO:0045191 | regulation of isotype switching | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
922 | | GO:0030808 | regulation of nucleotide biosynthetic process | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
923 | | GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
924 | | GO:0050803 | regulation of synapse structure and activity | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
925 | | GO:0050795 | regulation of behavior | 6 | 1020 | 21 | 25233 | 5.10e-04 | 0.01 | 0.00 | 7.0 |
926 | | GO:0045638 | negative regulation of myeloid cell differentiation | 6 | 1020 | 21 | 25233 | 5.10e-04 | 0.01 | 0.00 | 7.0 |
927 | | GO:0006694 | steroid biosynthetic process | 13 | 1013 | 101 | 25153 | 5.13e-04 | 0.01 | 0.00 | 3.2 |
928 | | GO:0042063 | gliogenesis | 9 | 1017 | 52 | 25202 | 5.69e-04 | 0.01 | 0.00 | 4.3 |
929 | | GO:0016570 | histone modification | 9 | 1017 | 52 | 25202 | 5.69e-04 | 0.01 | 0.00 | 4.3 |
930 | | GO:0002764 | immune response\-regulating signal transduction | 8 | 1018 | 41 | 25213 | 5.71e-04 | 0.01 | 0.00 | 4.8 |
931 | | GO:0007187 | G\-protein signaling\, coupled to cyclic nucleotide second messenger | 16 | 1010 | 145 | 25109 | 5.87e-04 | 0.02 | 0.01 | 2.7 |
932 | | GO:0051651 | maintenance of cellular localization | 7 | 1019 | 31 | 25223 | 5.92e-04 | 0.01 | 0.00 | 5.6 |
933 | | GO:0002200 | somatic diversification of immune receptors | 7 | 1019 | 31 | 25223 | 5.92e-04 | 0.01 | 0.00 | 5.6 |
934 | | GO:0014020 | primary neural tube formation | 7 | 1019 | 31 | 25223 | 5.92e-04 | 0.01 | 0.00 | 5.6 |
935 | | GO:0048305 | immunoglobulin secretion | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
936 | | GO:0008343 | adult feeding behavior | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
937 | | GO:0043496 | regulation of protein homodimerization activity | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
938 | | GO:0051900 | regulation of mitochondrial depolarization | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
939 | | GO:0006983 | ER overload response | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
940 | | GO:0006787 | porphyrin catabolic process | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
941 | | GO:0033015 | tetrapyrrole catabolic process | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
942 | | GO:0016202 | regulation of striated muscle development | 6 | 1020 | 22 | 25232 | 6.28e-04 | 0.01 | 0.00 | 6.7 |
943 | | GO:0050672 | negative regulation of lymphocyte proliferation | 6 | 1020 | 22 | 25232 | 6.28e-04 | 0.01 | 0.00 | 6.7 |
944 | | GO:0032945 | negative regulation of mononuclear cell proliferation | 6 | 1020 | 22 | 25232 | 6.28e-04 | 0.01 | 0.00 | 6.7 |
945 | | GO:0042168 | heme metabolic process | 6 | 1020 | 22 | 25232 | 6.28e-04 | 0.01 | 0.00 | 6.7 |
946 | | GO:0050852 | T cell receptor signaling pathway | 6 | 1020 | 22 | 25232 | 6.28e-04 | 0.01 | 0.00 | 6.7 |
947 | | GO:0007398 | ectoderm development | 20 | 1006 | 203 | 25051 | 6.34e-04 | 0.02 | 0.01 | 2.4 |
948 | | GO:0006643 | membrane lipid metabolic process | 23 | 1003 | 246 | 25008 | 6.46e-04 | 0.02 | 0.01 | 2.3 |
949 | | GO:0009410 | response to xenobiotic stimulus | 8 | 1018 | 42 | 25212 | 6.57e-04 | 0.01 | 0.00 | 4.7 |
950 | | GO:0046323 | glucose import | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
951 | | GO:0031669 | cellular response to nutrient levels | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
952 | | GO:0045408 | regulation of interleukin\-6 biosynthetic process | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
953 | | GO:0016575 | histone deacetylation | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
954 | | GO:0001502 | cartilage condensation | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
955 | | GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
956 | | GO:0042533 | tumor necrosis factor biosynthetic process | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
957 | | GO:0006833 | water transport | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
958 | | GO:0042044 | fluid transport | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
959 | | GO:0007276 | gamete generation | 29 | 997 | 350 | 24904 | 6.71e-04 | 0.03 | 0.01 | 2.0 |
960 | | GO:0006886 | intracellular protein transport | 44 | 982 | 614 | 24640 | 6.79e-04 | 0.04 | 0.02 | 1.8 |
961 | | GO:0048592 | eye morphogenesis | 7 | 1019 | 32 | 25222 | 6.97e-04 | 0.01 | 0.00 | 5.4 |
962 | | GO:0001704 | formation of primary germ layer | 7 | 1019 | 32 | 25222 | 6.97e-04 | 0.01 | 0.00 | 5.4 |
963 | | GO:0048332 | mesoderm morphogenesis | 7 | 1019 | 32 | 25222 | 6.97e-04 | 0.01 | 0.00 | 5.4 |
964 | | GO:0050851 | antigen receptor\-mediated signaling pathway | 7 | 1019 | 32 | 25222 | 6.97e-04 | 0.01 | 0.00 | 5.4 |
965 | | GO:0051052 | regulation of DNA metabolic process | 11 | 1015 | 79 | 25175 | 7.57e-04 | 0.01 | 0.00 | 3.4 |
966 | | GO:0051258 | protein polymerization | 11 | 1015 | 79 | 25175 | 7.57e-04 | 0.01 | 0.00 | 3.4 |
967 | | GO:0045453 | bone resorption | 6 | 1020 | 23 | 25231 | 7.66e-04 | 0.01 | 0.00 | 6.4 |
968 | | GO:0045216 | cell\-cell junction assembly and maintenance | 6 | 1020 | 23 | 25231 | 7.66e-04 | 0.01 | 0.00 | 6.4 |
969 | | GO:0001659 | temperature homeostasis | 20 | 1006 | 209 | 25045 | 8.06e-04 | 0.02 | 0.01 | 2.4 |
970 | | GO:0008544 | epidermis development | 19 | 1007 | 190 | 25064 | 8.14e-04 | 0.02 | 0.01 | 2.5 |
971 | | GO:0002697 | regulation of immune effector process | 7 | 1019 | 33 | 25221 | 8.17e-04 | 0.01 | 0.00 | 5.2 |
972 | | GO:0050918 | positive chemotaxis | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
973 | | GO:0046330 | positive regulation of JNK cascade | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
974 | | GO:0002367 | cytokine production during immune response | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
975 | | GO:0045646 | regulation of erythrocyte differentiation | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
976 | | GO:0002456 | T cell mediated immunity | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
977 | | GO:0060048 | cardiac muscle contraction | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
978 | | GO:0007043 | cell\-cell junction assembly | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
979 | | GO:0006997 | nuclear organization and biogenesis | 8 | 1018 | 44 | 25210 | 8.59e-04 | 0.01 | 0.00 | 4.5 |
980 | | GO:0051353 | positive regulation of oxidoreductase activity | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
981 | | GO:0002262 | myeloid cell homeostasis | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
982 | | GO:0046620 | regulation of organ growth | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
983 | | GO:0046626 | regulation of insulin receptor signaling pathway | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
984 | | GO:0046889 | positive regulation of lipid biosynthetic process | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
985 | | GO:0045080 | positive regulation of chemokine biosynthetic process | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
986 | | GO:0030817 | regulation of cAMP biosynthetic process | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
987 | | GO:0045084 | positive regulation of interleukin\-12 biosynthetic process | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
988 | | GO:0051882 | mitochondrial depolarization | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
989 | | GO:0050850 | positive regulation of calcium\-mediated signaling | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
990 | | GO:0045214 | sarcomere organization | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
991 | | GO:0051260 | protein homooligomerization | 11 | 1015 | 81 | 25173 | 9.11e-04 | 0.01 | 0.00 | 3.3 |
992 | | GO:0043010 | camera\-type eye development | 9 | 1017 | 56 | 25198 | 9.12e-04 | 0.01 | 0.00 | 4.0 |
993 | | GO:0048634 | regulation of muscle development | 6 | 1020 | 24 | 25230 | 9.27e-04 | 0.01 | 0.00 | 6.2 |
994 | | GO:0000018 | regulation of DNA recombination | 6 | 1020 | 24 | 25230 | 9.27e-04 | 0.01 | 0.00 | 6.2 |
995 | | GO:0016447 | somatic recombination of immunoglobulin gene segments | 6 | 1020 | 24 | 25230 | 9.27e-04 | 0.01 | 0.00 | 6.2 |
996 | | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 6 | 1020 | 24 | 25230 | 9.27e-04 | 0.01 | 0.00 | 6.2 |
997 | | GO:0051495 | positive regulation of cytoskeleton organization and biogenesis | 6 | 1020 | 24 | 25230 | 9.27e-04 | 0.01 | 0.00 | 6.2 |
998 | | GO:0003002 | regionalization | 16 | 1010 | 152 | 25102 | 9.32e-04 | 0.02 | 0.01 | 2.6 |
999 | | GO:0007422 | peripheral nervous system development | 7 | 1019 | 34 | 25220 | 9.53e-04 | 0.01 | 0.00 | 5.1 |
1000 | | GO:0031349 | positive regulation of defense response | 7 | 1019 | 34 | 25220 | 9.53e-04 | 0.01 | 0.00 | 5.1 |
1001 | | GO:0043627 | response to estrogen stimulus | 7 | 1019 | 34 | 25220 | 9.53e-04 | 0.01 | 0.00 | 5.1 |
1002 | | GO:0010001 | glial cell differentiation | 8 | 1018 | 45 | 25209 | 9.78e-04 | 0.01 | 0.00 | 4.4 |
1003 | | GO:0002253 | activation of immune response | 11 | 1015 | 82 | 25172 | 9.97e-04 | 0.01 | 0.00 | 3.3 |
1004 | | GO:0016192 | vesicle\-mediated transport | 45 | 981 | 654 | 24600 | 1.03e-03 | 0.04 | 0.03 | 1.7 |
1005 | | GO:0043487 | regulation of RNA stability | 5 | 1021 | 16 | 25238 | 1.08e-03 | 0.00 | 0.00 | 7.7 |
1006 | | GO:0042226 | interleukin\-6 biosynthetic process | 5 | 1021 | 16 | 25238 | 1.08e-03 | 0.00 | 0.00 | 7.7 |
1007 | | GO:0002034 | regulation of blood vessel size by renin\-angiotensin | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1008 | | GO:0003072 | regulation of systemic arterial blood pressure by renal control of peripheral vascular resistence | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1009 | | GO:0002035 | brain renin\-angiotensin system | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1010 | | GO:0031998 | regulation of fatty acid beta\-oxidation | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1011 | | GO:0001777 | T cell homeostatic proliferation | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1012 | | GO:0032100 | positive regulation of appetite | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1013 | | GO:0032097 | positive regulation of response to food | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1014 | | GO:0032109 | positive regulation of response to nutrient levels | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1015 | | GO:0032106 | positive regulation of response to extracellular stimulus | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
1016 | | GO:0046034 | ATP metabolic process | 10 | 1016 | 70 | 25184 | 1.09e-03 | 0.01 | 0.00 | 3.5 |
1017 | | GO:0030522 | intracellular receptor\-mediated signaling pathway | 10 | 1016 | 70 | 25184 | 1.09e-03 | 0.01 | 0.00 | 3.5 |
1018 | | GO:0002695 | negative regulation of leukocyte activation | 7 | 1019 | 35 | 25219 | 1.11e-03 | 0.01 | 0.00 | 4.9 |
1019 | | GO:0001649 | osteoblast differentiation | 7 | 1019 | 35 | 25219 | 1.11e-03 | 0.01 | 0.00 | 4.9 |
1020 | | GO:0030262 | apoptotic nuclear changes | 6 | 1020 | 25 | 25229 | 1.11e-03 | 0.01 | 0.00 | 5.9 |
1021 | | GO:0006921 | cell structure disassembly during apoptosis | 6 | 1020 | 25 | 25229 | 1.11e-03 | 0.01 | 0.00 | 5.9 |
1022 | | GO:0022411 | cellular component disassembly | 6 | 1020 | 25 | 25229 | 1.11e-03 | 0.01 | 0.00 | 5.9 |
1023 | | GO:0046328 | regulation of JNK cascade | 6 | 1020 | 25 | 25229 | 1.11e-03 | 0.01 | 0.00 | 5.9 |
1024 | | GO:0043433 | negative regulation of transcription factor activity | 6 | 1020 | 25 | 25229 | 1.11e-03 | 0.01 | 0.00 | 5.9 |
1025 | | GO:0000051 | urea cycle intermediate metabolic process | 6 | 1020 | 25 | 25229 | 1.11e-03 | 0.01 | 0.00 | 5.9 |
1026 | | GO:0015674 | di\-\, tri\-valent inorganic cation transport | 20 | 1006 | 218 | 25036 | 1.20e-03 | 0.02 | 0.01 | 2.3 |
1027 | | GO:0006164 | purine nucleotide biosynthetic process | 13 | 1013 | 112 | 25142 | 1.23e-03 | 0.01 | 0.00 | 2.9 |
1028 | | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 4 | 1022 | 9 | 25245 | 1.25e-03 | 0.00 | 0.00 | 10.9 |
1029 | | GO:0045830 | positive regulation of isotype switching | 4 | 1022 | 9 | 25245 | 1.25e-03 | 0.00 | 0.00 | 10.9 |
1030 | | GO:0007205 | activation of protein kinase C activity | 7 | 1019 | 36 | 25218 | 1.28e-03 | 0.01 | 0.00 | 4.8 |
1031 | | GO:0045185 | maintenance of protein localization | 7 | 1019 | 36 | 25218 | 1.28e-03 | 0.01 | 0.00 | 4.8 |
1032 | | GO:0002429 | immune response\-activating cell surface receptor signaling pathway | 7 | 1019 | 36 | 25218 | 1.28e-03 | 0.01 | 0.00 | 4.8 |
1033 | | GO:0042742 | defense response to bacterium | 13 | 1013 | 113 | 25141 | 1.32e-03 | 0.01 | 0.00 | 2.8 |
1034 | | GO:0006261 | DNA\-dependent DNA replication | 13 | 1013 | 113 | 25141 | 1.32e-03 | 0.01 | 0.00 | 2.8 |
1035 | | GO:0030162 | regulation of proteolysis | 6 | 1020 | 26 | 25228 | 1.32e-03 | 0.01 | 0.00 | 5.7 |
1036 | | GO:0048628 | myoblast maturation | 6 | 1020 | 26 | 25228 | 1.32e-03 | 0.01 | 0.00 | 5.7 |
1037 | | GO:0009749 | response to glucose stimulus | 5 | 1021 | 17 | 25237 | 1.36e-03 | 0.00 | 0.00 | 7.2 |
1038 | | GO:0009746 | response to hexose stimulus | 5 | 1021 | 17 | 25237 | 1.36e-03 | 0.00 | 0.00 | 7.2 |
1039 | | GO:0034284 | response to monosaccharide stimulus | 5 | 1021 | 17 | 25237 | 1.36e-03 | 0.00 | 0.00 | 7.2 |
1040 | | GO:0006544 | glycine metabolic process | 5 | 1021 | 17 | 25237 | 1.36e-03 | 0.00 | 0.00 | 7.2 |
1041 | | GO:0044264 | cellular polysaccharide metabolic process | 12 | 1014 | 100 | 25154 | 1.44e-03 | 0.01 | 0.00 | 3.0 |
1042 | | GO:0001709 | cell fate determination | 7 | 1019 | 37 | 25217 | 1.47e-03 | 0.01 | 0.00 | 4.7 |
1043 | | GO:0002768 | immune response\-regulating cell surface receptor signaling pathway | 7 | 1019 | 37 | 25217 | 1.47e-03 | 0.01 | 0.00 | 4.7 |
1044 | | GO:0030900 | forebrain development | 11 | 1015 | 87 | 25167 | 1.54e-03 | 0.01 | 0.00 | 3.1 |
1045 | | GO:0030326 | embryonic limb morphogenesis | 9 | 1017 | 61 | 25193 | 1.56e-03 | 0.01 | 0.00 | 3.6 |
1046 | | GO:0035113 | embryonic appendage morphogenesis | 9 | 1017 | 61 | 25193 | 1.56e-03 | 0.01 | 0.00 | 3.6 |
1047 | | GO:0048627 | myoblast development | 6 | 1020 | 27 | 25227 | 1.56e-03 | 0.01 | 0.00 | 5.5 |
1048 | | GO:0009880 | embryonic pattern specification | 8 | 1018 | 49 | 25205 | 1.59e-03 | 0.01 | 0.00 | 4.0 |
1049 | | GO:0006310 | DNA recombination | 13 | 1013 | 116 | 25138 | 1.64e-03 | 0.01 | 0.00 | 2.8 |
1050 | | GO:0006869 | lipid transport | 13 | 1013 | 116 | 25138 | 1.64e-03 | 0.01 | 0.00 | 2.8 |
1051 | | GO:0007611 | learning and/or memory | 11 | 1015 | 88 | 25166 | 1.67e-03 | 0.01 | 0.00 | 3.1 |
1052 | | GO:0005976 | polysaccharide metabolic process | 12 | 1014 | 102 | 25152 | 1.68e-03 | 0.01 | 0.00 | 2.9 |
1053 | | GO:0016126 | sterol biosynthetic process | 7 | 1019 | 38 | 25216 | 1.68e-03 | 0.01 | 0.00 | 4.5 |
1054 | | GO:0046824 | positive regulation of nucleocytoplasmic transport | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
1055 | | GO:0032583 | regulation of gene\-specific transcription | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
1056 | | GO:0045776 | negative regulation of blood pressure | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
1057 | | GO:0042130 | negative regulation of T cell proliferation | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
1058 | | GO:0030225 | macrophage differentiation | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
1059 | | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
1060 | | GO:0006525 | arginine metabolic process | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
1061 | | GO:0030856 | regulation of epithelial cell differentiation | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1062 | | GO:0001542 | ovulation from ovarian follicle | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1063 | | GO:0032845 | negative regulation of homeostatic process | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1064 | | GO:0045911 | positive regulation of DNA recombination | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1065 | | GO:0001782 | B cell homeostasis | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1066 | | GO:0030814 | regulation of cAMP metabolic process | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1067 | | GO:0033344 | cholesterol efflux | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1068 | | GO:0043255 | regulation of carbohydrate biosynthetic process | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1069 | | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1070 | | GO:0046427 | positive regulation of JAK\-STAT cascade | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1071 | | GO:0001953 | negative regulation of cell\-matrix adhesion | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1072 | | GO:0048333 | mesodermal cell differentiation | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
1073 | | GO:0030518 | steroid hormone receptor signaling pathway | 9 | 1017 | 62 | 25192 | 1.73e-03 | 0.01 | 0.00 | 3.6 |
1074 | | GO:0045761 | regulation of adenylate cyclase activity | 8 | 1018 | 50 | 25204 | 1.78e-03 | 0.01 | 0.00 | 3.9 |
1075 | | GO:0006695 | cholesterol biosynthetic process | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
1076 | | GO:0003073 | regulation of systemic arterial blood pressure | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
1077 | | GO:0045444 | fat cell differentiation | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
1078 | | GO:0031647 | regulation of protein stability | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
1079 | | GO:0006626 | protein targeting to mitochondrion | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
1080 | | GO:0019430 | removal of superoxide radicals | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1081 | | GO:0045540 | regulation of cholesterol biosynthetic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1082 | | GO:0003071 | regulation of systemic arterial blood pressure by renal system process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1083 | | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin\-angiotensin | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1084 | | GO:0045723 | positive regulation of fatty acid biosynthetic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1085 | | GO:0051023 | regulation of immunoglobulin secretion | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1086 | | GO:0002740 | negative regulation of cytokine secretion during immune response | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1087 | | GO:0002739 | regulation of cytokine secretion during immune response | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1088 | | GO:0002374 | cytokine secretion during immune response | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1089 | | GO:0051156 | glucose 6\-phosphate metabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1090 | | GO:0042167 | heme catabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1091 | | GO:0046149 | pigment catabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1092 | | GO:0001955 | blood vessel maturation | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1093 | | GO:0032024 | positive regulation of insulin secretion | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1094 | | GO:0006101 | citrate metabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1095 | | GO:0032909 | regulation of transforming growth factor\-beta2 production | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1096 | | GO:0032906 | transforming growth factor\-beta2 production | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1097 | | GO:0046838 | phosphorylated carbohydrate dephosphorylation | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1098 | | GO:0043011 | myeloid dendritic cell differentiation | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1099 | | GO:0006538 | glutamate catabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1100 | | GO:0045579 | positive regulation of B cell differentiation | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1101 | | GO:0045136 | development of secondary sexual characteristics | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1102 | | GO:0051898 | negative regulation of protein kinase B signaling cascade | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1103 | | GO:0051896 | regulation of protein kinase B signaling cascade | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1104 | | GO:0045415 | negative regulation of interleukin\-8 biosynthetic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1105 | | GO:0046697 | decidualization | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1106 | | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
1107 | | GO:0030258 | lipid modification | 7 | 1019 | 39 | 25215 | 1.92e-03 | 0.01 | 0.00 | 4.4 |
1108 | | GO:0044272 | sulfur compound biosynthetic process | 8 | 1018 | 51 | 25203 | 1.99e-03 | 0.01 | 0.00 | 3.9 |
1109 | | GO:0007186 | G\-protein coupled receptor protein signaling pathway | 86 | 940 | 1499 | 23755 | 2.03e-03 | 0.08 | 0.06 | 1.4 |
1110 | | GO:0042136 | neurotransmitter biosynthetic process | 5 | 1021 | 19 | 25235 | 2.05e-03 | 0.00 | 0.00 | 6.5 |
1111 | | GO:0030500 | regulation of bone mineralization | 5 | 1021 | 19 | 25235 | 2.05e-03 | 0.00 | 0.00 | 6.5 |
1112 | | GO:0043269 | regulation of ion transport | 6 | 1020 | 29 | 25225 | 2.15e-03 | 0.01 | 0.00 | 5.1 |
1113 | | GO:0032507 | maintenance of cellular protein localization | 6 | 1020 | 29 | 25225 | 2.15e-03 | 0.01 | 0.00 | 5.1 |
1114 | | GO:0022602 | ovulation cycle process | 7 | 1019 | 40 | 25214 | 2.18e-03 | 0.01 | 0.00 | 4.3 |
1115 | | GO:0031279 | regulation of cyclase activity | 8 | 1018 | 52 | 25202 | 2.22e-03 | 0.01 | 0.00 | 3.8 |
1116 | | GO:0051339 | regulation of lyase activity | 8 | 1018 | 52 | 25202 | 2.22e-03 | 0.01 | 0.00 | 3.8 |
1117 | | GO:0050930 | induction of positive chemotaxis | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
1118 | | GO:0030728 | ovulation | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
1119 | | GO:0050710 | negative regulation of cytokine secretion | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
1120 | | GO:0030890 | positive regulation of B cell proliferation | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
1121 | | GO:0050884 | neuromuscular process controlling posture | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
1122 | | GO:0045843 | negative regulation of striated muscle development | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
1123 | | GO:0045414 | regulation of interleukin\-8 biosynthetic process | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
1124 | | GO:0035107 | appendage morphogenesis | 9 | 1017 | 65 | 25189 | 2.31e-03 | 0.01 | 0.00 | 3.4 |
1125 | | GO:0035108 | limb morphogenesis | 9 | 1017 | 65 | 25189 | 2.31e-03 | 0.01 | 0.00 | 3.4 |
1126 | | GO:0048736 | appendage development | 9 | 1017 | 65 | 25189 | 2.31e-03 | 0.01 | 0.00 | 3.4 |
1127 | | GO:0060173 | limb development | 9 | 1017 | 65 | 25189 | 2.31e-03 | 0.01 | 0.00 | 3.4 |
1128 | | GO:0006119 | oxidative phosphorylation | 12 | 1014 | 107 | 25147 | 2.42e-03 | 0.01 | 0.00 | 2.8 |
1129 | | GO:0006730 | one\-carbon compound metabolic process | 13 | 1013 | 122 | 25132 | 2.46e-03 | 0.01 | 0.00 | 2.6 |
1130 | | GO:0050715 | positive regulation of cytokine secretion | 5 | 1021 | 20 | 25234 | 2.49e-03 | 0.00 | 0.00 | 6.2 |
1131 | | GO:0051054 | positive regulation of DNA metabolic process | 5 | 1021 | 20 | 25234 | 2.49e-03 | 0.00 | 0.00 | 6.2 |
1132 | | GO:0046425 | regulation of JAK\-STAT cascade | 5 | 1021 | 20 | 25234 | 2.49e-03 | 0.00 | 0.00 | 6.2 |
1133 | | GO:0006081 | aldehyde metabolic process | 5 | 1021 | 20 | 25234 | 2.49e-03 | 0.00 | 0.00 | 6.2 |
1134 | | GO:0006644 | phospholipid metabolic process | 17 | 1009 | 184 | 25070 | 2.72e-03 | 0.02 | 0.01 | 2.3 |
1135 | | GO:0007015 | actin filament organization | 8 | 1018 | 54 | 25200 | 2.74e-03 | 0.01 | 0.00 | 3.6 |
1136 | | GO:0007416 | synaptogenesis | 7 | 1019 | 42 | 25212 | 2.78e-03 | 0.01 | 0.00 | 4.1 |
1137 | | GO:0002016 | regulation of blood volume by renin\-angiotensin | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1138 | | GO:0045079 | negative regulation of chemokine biosynthetic process | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1139 | | GO:0001780 | neutrophil homeostasis | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1140 | | GO:0043535 | regulation of blood vessel endothelial cell migration | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1141 | | GO:0043497 | regulation of protein heterodimerization activity | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1142 | | GO:0048147 | negative regulation of fibroblast proliferation | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1143 | | GO:0042119 | neutrophil activation | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1144 | | GO:0001678 | cellular glucose homeostasis | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1145 | | GO:0002793 | positive regulation of peptide secretion | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1146 | | GO:0046668 | regulation of retinal cell programmed cell death | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1147 | | GO:0001913 | T cell mediated cytotoxicity | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1148 | | GO:0008053 | mitochondrial fusion | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1149 | | GO:0042448 | progesterone metabolic process | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1150 | | GO:0046498 | S\-adenosylhomocysteine metabolic process | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1151 | | GO:0006104 | succinyl\-CoA metabolic process | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
1152 | | GO:0046631 | alpha\-beta T cell activation | 6 | 1020 | 31 | 25223 | 2.88e-03 | 0.01 | 0.00 | 4.8 |
1153 | | GO:0009066 | aspartate family amino acid metabolic process | 6 | 1020 | 31 | 25223 | 2.88e-03 | 0.01 | 0.00 | 4.8 |
1154 | | GO:0035265 | organ growth | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
1155 | | GO:0043331 | response to dsRNA | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
1156 | | GO:0045124 | regulation of bone resorption | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
1157 | | GO:0042730 | fibrinolysis | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
1158 | | GO:0048146 | positive regulation of fibroblast proliferation | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
1159 | | GO:0045913 | positive regulation of carbohydrate metabolic process | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
1160 | | GO:0001504 | neurotransmitter uptake | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
1161 | | GO:0042228 | interleukin\-8 biosynthetic process | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
1162 | | GO:0019933 | cAMP\-mediated signaling | 12 | 1014 | 110 | 25144 | 2.97e-03 | 0.01 | 0.00 | 2.7 |
1163 | | GO:0051222 | positive regulation of protein transport | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
1164 | | GO:0030101 | natural killer cell activation | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
1165 | | GO:0006476 | protein amino acid deacetylation | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
1166 | | GO:0045785 | positive regulation of cell adhesion | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
1167 | | GO:0008543 | fibroblast growth factor receptor signaling pathway | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
1168 | | GO:0032640 | tumor necrosis factor production | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
1169 | | GO:0042219 | amino acid derivative catabolic process | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
1170 | | GO:0006072 | glycerol\-3\-phosphate metabolic process | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
1171 | | GO:0006944 | membrane fusion | 8 | 1018 | 55 | 25199 | 3.03e-03 | 0.01 | 0.00 | 3.6 |
1172 | | GO:0006022 | aminoglycan metabolic process | 8 | 1018 | 55 | 25199 | 3.03e-03 | 0.01 | 0.00 | 3.6 |
1173 | | GO:0008585 | female gonad development | 7 | 1019 | 43 | 25211 | 3.12e-03 | 0.01 | 0.00 | 4.0 |
1174 | | GO:0050905 | neuromuscular process | 7 | 1019 | 43 | 25211 | 3.12e-03 | 0.01 | 0.00 | 4.0 |
1175 | | GO:0009150 | purine ribonucleotide metabolic process | 12 | 1014 | 112 | 25142 | 3.40e-03 | 0.01 | 0.00 | 2.6 |
1176 | | GO:0030163 | protein catabolic process | 22 | 1004 | 272 | 24982 | 3.53e-03 | 0.02 | 0.01 | 2.0 |
1177 | | GO:0051346 | negative regulation of hydrolase activity | 5 | 1021 | 22 | 25232 | 3.54e-03 | 0.00 | 0.00 | 5.6 |
1178 | | GO:0019233 | sensory perception of pain | 5 | 1021 | 22 | 25232 | 3.54e-03 | 0.00 | 0.00 | 5.6 |
1179 | | GO:0030048 | actin filament\-based movement | 5 | 1021 | 22 | 25232 | 3.54e-03 | 0.00 | 0.00 | 5.6 |
1180 | | GO:0050927 | positive regulation of positive chemotaxis | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1181 | | GO:0050926 | regulation of positive chemotaxis | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1182 | | GO:0050709 | negative regulation of protein secretion | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1183 | | GO:0030279 | negative regulation of ossification | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1184 | | GO:0050777 | negative regulation of immune response | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1185 | | GO:0031575 | G1/S transition checkpoint | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1186 | | GO:0030238 | male sex determination | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1187 | | GO:0006970 | response to osmotic stress | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1188 | | GO:0048635 | negative regulation of muscle development | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1189 | | GO:0002062 | chondrocyte differentiation | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
1190 | | GO:0045619 | regulation of lymphocyte differentiation | 6 | 1020 | 33 | 25221 | 3.78e-03 | 0.01 | 0.00 | 4.5 |
1191 | | GO:0051250 | negative regulation of lymphocyte activation | 6 | 1020 | 33 | 25221 | 3.78e-03 | 0.01 | 0.00 | 4.5 |
1192 | | GO:0006778 | porphyrin metabolic process | 6 | 1020 | 33 | 25221 | 3.78e-03 | 0.01 | 0.00 | 4.5 |
1193 | | GO:0033013 | tetrapyrrole metabolic process | 6 | 1020 | 33 | 25221 | 3.78e-03 | 0.01 | 0.00 | 4.5 |
1194 | | GO:0046545 | development of primary female sexual characteristics | 7 | 1019 | 45 | 25209 | 3.91e-03 | 0.01 | 0.00 | 3.8 |
1195 | | GO:0046660 | female sex differentiation | 7 | 1019 | 45 | 25209 | 3.91e-03 | 0.01 | 0.00 | 3.8 |
1196 | | GO:0006909 | phagocytosis | 7 | 1019 | 45 | 25209 | 3.91e-03 | 0.01 | 0.00 | 3.8 |
1197 | | GO:0042770 | DNA damage response\, signal transduction | 8 | 1018 | 58 | 25196 | 4.06e-03 | 0.01 | 0.00 | 3.4 |
1198 | | GO:0031400 | negative regulation of protein modification process | 5 | 1021 | 23 | 25231 | 4.18e-03 | 0.00 | 0.00 | 5.4 |
1199 | | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 5 | 1021 | 23 | 25231 | 4.18e-03 | 0.00 | 0.00 | 5.4 |
1200 | | GO:0042304 | regulation of fatty acid biosynthetic process | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1201 | | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1202 | | GO:0007406 | negative regulation of neuroblast proliferation | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1203 | | GO:0043534 | blood vessel endothelial cell migration | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1204 | | GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1205 | | GO:0030810 | positive regulation of nucleotide biosynthetic process | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1206 | | GO:0045348 | positive regulation of MHC class II biosynthetic process | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1207 | | GO:0048304 | positive regulation of isotype switching to IgG isotypes | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1208 | | GO:0030833 | regulation of actin filament polymerization | 5 | 1021 | 23 | 25231 | 4.18e-03 | 0.00 | 0.00 | 5.4 |
1209 | | GO:0043552 | positive regulation of phosphoinositide 3\-kinase activity | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1210 | | GO:0043551 | regulation of phosphoinositide 3\-kinase activity | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1211 | | GO:0019370 | leukotriene biosynthetic process | 5 | 1021 | 23 | 25231 | 4.18e-03 | 0.00 | 0.00 | 5.4 |
1212 | | GO:0043450 | alkene biosynthetic process | 5 | 1021 | 23 | 25231 | 4.18e-03 | 0.00 | 0.00 | 5.4 |
1213 | | GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1214 | | GO:0046479 | glycosphingolipid catabolic process | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1215 | | GO:0007500 | mesodermal cell fate determination | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1216 | | GO:0048284 | organelle fusion | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1217 | | GO:0007442 | hindgut morphogenesis | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1218 | | GO:0002467 | germinal center formation | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
1219 | | GO:0048732 | gland development | 9 | 1017 | 72 | 25182 | 4.28e-03 | 0.01 | 0.00 | 3.1 |
1220 | | GO:0008652 | amino acid biosynthetic process | 8 | 1018 | 59 | 25195 | 4.46e-03 | 0.01 | 0.00 | 3.3 |
1221 | | GO:0007569 | cell aging | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1222 | | GO:0001933 | negative regulation of protein amino acid phosphorylation | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1223 | | GO:0050729 | positive regulation of inflammatory response | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1224 | | GO:0050921 | positive regulation of chemotaxis | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1225 | | GO:0048520 | positive regulation of behavior | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1226 | | GO:0001976 | regulation of systemic arterial blood pressure by neurological process | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1227 | | GO:0042993 | positive regulation of transcription factor import into nucleus | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1228 | | GO:0050680 | negative regulation of epithelial cell proliferation | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1229 | | GO:0032637 | interleukin\-8 production | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1230 | | GO:0007250 | activation of NF\-kappaB\-inducing kinase activity | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
1231 | | GO:0022607 | cellular component assembly | 21 | 1005 | 261 | 24993 | 4.73e-03 | 0.02 | 0.01 | 2.0 |
1232 | | GO:0042698 | ovulation cycle | 7 | 1019 | 47 | 25207 | 4.84e-03 | 0.01 | 0.00 | 3.7 |
1233 | | GO:0001570 | vasculogenesis | 6 | 1020 | 35 | 25219 | 4.88e-03 | 0.01 | 0.00 | 4.2 |
1234 | | GO:0046632 | alpha\-beta T cell differentiation | 5 | 1021 | 24 | 25230 | 4.89e-03 | 0.00 | 0.00 | 5.1 |
1235 | | GO:0007589 | body fluid secretion | 5 | 1021 | 24 | 25230 | 4.89e-03 | 0.00 | 0.00 | 5.1 |
1236 | | GO:0006898 | receptor\-mediated endocytosis | 8 | 1018 | 60 | 25194 | 4.89e-03 | 0.01 | 0.00 | 3.3 |
1237 | | GO:0007269 | neurotransmitter secretion | 8 | 1018 | 60 | 25194 | 4.89e-03 | 0.01 | 0.00 | 3.3 |
1238 | | GO:0006959 | humoral immune response | 10 | 1016 | 88 | 25166 | 4.95e-03 | 0.01 | 0.00 | 2.8 |
1239 | | GO:0006754 | ATP biosynthetic process | 8 | 1018 | 61 | 25193 | 5.34e-03 | 0.01 | 0.00 | 3.2 |
1240 | | GO:0007162 | negative regulation of cell adhesion | 7 | 1019 | 48 | 25206 | 5.37e-03 | 0.01 | 0.00 | 3.6 |
1241 | | GO:0006817 | phosphate transport | 11 | 1015 | 104 | 25150 | 5.38e-03 | 0.01 | 0.00 | 2.6 |
1242 | | GO:0007009 | plasma membrane organization and biogenesis | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
1243 | | GO:0042307 | positive regulation of protein import into nucleus | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
1244 | | GO:0043488 | regulation of mRNA stability | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
1245 | | GO:0046888 | negative regulation of hormone secretion | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
1246 | | GO:0046470 | phosphatidylcholine metabolic process | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
1247 | | GO:0050868 | negative regulation of T cell activation | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
1248 | | GO:0030168 | platelet activation | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
1249 | | GO:0007257 | activation of JNK activity | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
1250 | | GO:0006904 | vesicle docking during exocytosis | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
1251 | | GO:0032623 | interleukin\-2 production | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
1252 | | GO:0009205 | purine ribonucleoside triphosphate metabolic process | 10 | 1016 | 90 | 25164 | 5.71e-03 | 0.01 | 0.00 | 2.7 |
1253 | | GO:0009309 | amine biosynthetic process | 10 | 1016 | 90 | 25164 | 5.71e-03 | 0.01 | 0.00 | 2.7 |
1254 | | GO:0051055 | negative regulation of lipid biosynthetic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1255 | | GO:0043330 | response to exogenous dsRNA | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1256 | | GO:0048255 | mRNA stabilization | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1257 | | GO:0043489 | RNA stabilization | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1258 | | GO:0045410 | positive regulation of interleukin\-6 biosynthetic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1259 | | GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1260 | | GO:0045981 | positive regulation of nucleotide metabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1261 | | GO:0050994 | regulation of lipid catabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1262 | | GO:0045346 | regulation of MHC class II biosynthetic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1263 | | GO:0045342 | MHC class II biosynthetic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1264 | | GO:0030838 | positive regulation of actin filament polymerization | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1265 | | GO:0006546 | glycine catabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1266 | | GO:0042506 | tyrosine phosphorylation of Stat5 protein | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1267 | | GO:0006110 | regulation of glycolysis | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1268 | | GO:0009068 | aspartate family amino acid catabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
1269 | | GO:0009144 | purine nucleoside triphosphate metabolic process | 10 | 1016 | 91 | 25163 | 6.12e-03 | 0.01 | 0.00 | 2.7 |
1270 | | GO:0022415 | viral reproductive process | 8 | 1018 | 63 | 25191 | 6.35e-03 | 0.01 | 0.00 | 3.1 |
1271 | | GO:0007188 | G\-protein signaling\, coupled to cAMP nucleotide second messenger | 11 | 1015 | 107 | 25147 | 6.52e-03 | 0.01 | 0.00 | 2.5 |
1272 | | GO:0007292 | female gamete generation | 7 | 1019 | 50 | 25204 | 6.54e-03 | 0.01 | 0.00 | 3.4 |
1273 | | GO:0009199 | ribonucleoside triphosphate metabolic process | 10 | 1016 | 92 | 25162 | 6.56e-03 | 0.01 | 0.00 | 2.7 |
1274 | | GO:0050768 | negative regulation of neurogenesis | 5 | 1021 | 26 | 25228 | 6.56e-03 | 0.00 | 0.00 | 4.7 |
1275 | | GO:0006268 | DNA unwinding during replication | 5 | 1021 | 26 | 25228 | 6.56e-03 | 0.00 | 0.00 | 4.7 |
1276 | | GO:0009408 | response to heat | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
1277 | | GO:0045727 | positive regulation of translation | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
1278 | | GO:0045069 | regulation of viral genome replication | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
1279 | | GO:0043193 | positive regulation of gene\-specific transcription | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
1280 | | GO:0045930 | negative regulation of mitotic cell cycle | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
1281 | | GO:0001759 | induction of an organ | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
1282 | | GO:0010092 | specification of organ identity | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
1283 | | GO:0006941 | striated muscle contraction | 8 | 1018 | 64 | 25190 | 6.91e-03 | 0.01 | 0.00 | 3.1 |
1284 | | GO:0019079 | viral genome replication | 6 | 1020 | 38 | 25216 | 6.94e-03 | 0.01 | 0.00 | 3.9 |
1285 | | GO:0016358 | dendrite development | 6 | 1020 | 38 | 25216 | 6.94e-03 | 0.01 | 0.00 | 3.9 |
1286 | | GO:0006805 | xenobiotic metabolic process | 6 | 1020 | 38 | 25216 | 6.94e-03 | 0.01 | 0.00 | 3.9 |
1287 | | GO:0006672 | ceramide metabolic process | 6 | 1020 | 38 | 25216 | 6.94e-03 | 0.01 | 0.00 | 3.9 |
1288 | | GO:0006071 | glycerol metabolic process | 6 | 1020 | 38 | 25216 | 6.94e-03 | 0.01 | 0.00 | 3.9 |
1289 | | GO:0006887 | exocytosis | 11 | 1015 | 108 | 25146 | 6.94e-03 | 0.01 | 0.00 | 2.5 |
1290 | | GO:0006650 | glycerophospholipid metabolic process | 10 | 1016 | 93 | 25161 | 7.01e-03 | 0.01 | 0.00 | 2.6 |
1291 | | GO:0030001 | metal ion transport | 42 | 984 | 662 | 24592 | 7.35e-03 | 0.04 | 0.03 | 1.6 |
1292 | | GO:0006576 | biogenic amine metabolic process | 9 | 1017 | 79 | 25175 | 7.38e-03 | 0.01 | 0.00 | 2.8 |
1293 | | GO:0001701 | in utero embryonic development | 10 | 1016 | 94 | 25160 | 7.50e-03 | 0.01 | 0.00 | 2.6 |
1294 | | GO:0006304 | DNA modification | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
1295 | | GO:0007405 | neuroblast proliferation | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
1296 | | GO:0043449 | alkene metabolic process | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
1297 | | GO:0006691 | leukotriene metabolic process | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
1298 | | GO:0043507 | positive regulation of JNK activity | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
1299 | | GO:0048278 | vesicle docking | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
1300 | | GO:0022406 | membrane docking | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
1301 | | GO:0006816 | calcium ion transport | 15 | 1011 | 173 | 25081 | 7.67e-03 | 0.01 | 0.01 | 2.1 |
1302 | | GO:0031331 | positive regulation of cellular catabolic process | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1303 | | GO:0048302 | regulation of isotype switching to IgG isotypes | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1304 | | GO:0048291 | isotype switching to IgG isotypes | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1305 | | GO:0021940 | positive regulation of granule cell precursor proliferation | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1306 | | GO:0021936 | regulation of granule cell precursor proliferation | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1307 | | GO:0021930 | granule cell precursor proliferation | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1308 | | GO:0021924 | cell proliferation in the external granule layer | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1309 | | GO:0021534 | cell proliferation in hindbrain | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1310 | | GO:0002698 | negative regulation of immune effector process | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1311 | | GO:0008582 | regulation of synaptic growth at neuromuscular junction | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1312 | | GO:0009071 | serine family amino acid catabolic process | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1313 | | GO:0045671 | negative regulation of osteoclast differentiation | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1314 | | GO:0019377 | glycolipid catabolic process | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1315 | | GO:0045577 | regulation of B cell differentiation | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1316 | | GO:0031341 | regulation of cell killing | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1317 | | GO:0001910 | regulation of leukocyte mediated cytotoxicity | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1318 | | GO:0006583 | melanin biosynthetic process from tyrosine | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1319 | | GO:0045416 | positive regulation of interleukin\-8 biosynthetic process | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1320 | | GO:0006526 | arginine biosynthetic process | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1321 | | GO:0006474 | N\-terminal protein amino acid acetylation | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1322 | | GO:0048567 | ectodermal gut morphogenesis | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1323 | | GO:0007439 | ectodermal gut development | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1324 | | GO:0007431 | salivary gland development | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
1325 | | GO:0030902 | hindbrain development | 6 | 1020 | 39 | 25215 | 7.74e-03 | 0.01 | 0.00 | 3.8 |
1326 | | GO:0000279 | M phase | 24 | 1002 | 329 | 24925 | 8.10e-03 | 0.02 | 0.01 | 1.8 |
1327 | | GO:0001906 | cell killing | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
1328 | | GO:0015671 | oxygen transport | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
1329 | | GO:0031128 | induction | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
1330 | | GO:0045168 | cell\-cell signaling during cell fate commitment | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
1331 | | GO:0045766 | positive regulation of angiogenesis | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
1332 | | GO:0048041 | focal adhesion formation | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
1333 | | GO:0009409 | response to cold | 17 | 1009 | 207 | 25047 | 8.42e-03 | 0.02 | 0.01 | 2.0 |
1334 | | GO:0032508 | DNA duplex unwinding | 5 | 1021 | 28 | 25226 | 8.59e-03 | 0.00 | 0.00 | 4.4 |
1335 | | GO:0032392 | DNA geometric change | 5 | 1021 | 28 | 25226 | 8.59e-03 | 0.00 | 0.00 | 4.4 |
1336 | | GO:0030203 | glycosaminoglycan metabolic process | 7 | 1019 | 53 | 25201 | 8.64e-03 | 0.01 | 0.00 | 3.3 |
1337 | | GO:0045541 | negative regulation of cholesterol biosynthetic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1338 | | GO:0032642 | regulation of chemokine production | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1339 | | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1340 | | GO:0019049 | evasion of host defenses by virus | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1341 | | GO:0044415 | evasion or tolerance of host defenses | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1342 | | GO:0044413 | avoidance of host defenses | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1343 | | GO:0051832 | avoidance of defenses of other organism during symbiotic interaction | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1344 | | GO:0051834 | evasion or tolerance of defenses of other organism during symbiotic interaction | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1345 | | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1346 | | GO:0051043 | regulation of membrane protein ectodomain proteolysis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1347 | | GO:0045721 | negative regulation of gluconeogenesis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1348 | | GO:0006788 | heme oxidation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1349 | | GO:0046013 | regulation of T cell homeostatic proliferation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1350 | | GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1351 | | GO:0001779 | natural killer cell differentiation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1352 | | GO:0046543 | development of secondary female sexual characteristics | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1353 | | GO:0046544 | development of secondary male sexual characteristics | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1354 | | GO:0021978 | telencephalon regionalization | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1355 | | GO:0001914 | regulation of T cell mediated cytotoxicity | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1356 | | GO:0010248 | establishment and/or maintenance of transmembrane electrochemical gradient | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1357 | | GO:0046855 | inositol phosphate dephosphorylation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1358 | | GO:0046856 | phosphoinositide dephosphorylation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1359 | | GO:0046621 | negative regulation of organ growth | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1360 | | GO:0006106 | fumarate metabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1361 | | GO:0048873 | homeostasis of number of cells within a tissue | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1362 | | GO:0050922 | negative regulation of chemotaxis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1363 | | GO:0007497 | posterior midgut development | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1364 | | GO:0007494 | midgut development | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1365 | | GO:0030819 | positive regulation of cAMP biosynthetic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1366 | | GO:0046950 | ketone body metabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1367 | | GO:0006982 | response to lipid hydroperoxide | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1368 | | GO:0033194 | response to hydroperoxide | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1369 | | GO:0033363 | secretory granule organization and biogenesis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1370 | | GO:0043653 | mitochondrial fragmentation during apoptosis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1371 | | GO:0019510 | S\-adenosylhomocysteine catabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1372 | | GO:0035229 | positive regulation of glutamate\-cysteine ligase activity | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1373 | | GO:0035227 | regulation of glutamate\-cysteine ligase activity | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1374 | | GO:0051409 | response to nitrosative stress | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1375 | | GO:0006701 | progesterone biosynthetic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1376 | | GO:0043587 | tongue morphogenesis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1377 | | GO:0043586 | tongue development | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
1378 | | GO:0032446 | protein modification by small protein conjugation | 11 | 1015 | 112 | 25142 | 8.82e-03 | 0.01 | 0.00 | 2.4 |
1379 | | GO:0033043 | regulation of organelle organization and biogenesis | 11 | 1015 | 113 | 25141 | 9.35e-03 | 0.01 | 0.00 | 2.4 |
1380 | | GO:0006302 | double\-strand break repair | 6 | 1020 | 41 | 25213 | 9.56e-03 | 0.01 | 0.00 | 3.6 |
1381 | | GO:0045621 | positive regulation of lymphocyte differentiation | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
1382 | | GO:0042402 | biogenic amine catabolic process | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
1383 | | GO:0030318 | melanocyte differentiation | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
1384 | | GO:0050931 | pigment cell differentiation | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
1385 | | GO:0000080 | G1 phase of mitotic cell cycle | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
1386 | | GO:0001935 | endothelial cell proliferation | 5 | 1021 | 29 | 25225 | 9.75e-03 | 0.00 | 0.00 | 4.2 |
1387 | | GO:0048002 | antigen processing and presentation of peptide antigen | 5 | 1021 | 29 | 25225 | 9.75e-03 | 0.00 | 0.00 | 4.2 |
1388 | | GO:0006986 | response to unfolded protein | 9 | 1017 | 83 | 25171 | 9.78e-03 | 0.01 | 0.00 | 2.7 |
1389 | | GO:0051789 | response to protein stimulus | 9 | 1017 | 83 | 25171 | 9.78e-03 | 0.01 | 0.00 | 2.7 |
1390 | | GO:0045833 | negative regulation of lipid metabolic process | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1391 | | GO:0046688 | response to copper ion | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1392 | | GO:0046325 | negative regulation of glucose import | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1393 | | GO:0007176 | regulation of epidermal growth factor receptor activity | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1394 | | GO:0051124 | synaptic growth at neuromuscular junction | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1395 | | GO:0006534 | cysteine metabolic process | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1396 | | GO:0001710 | mesodermal cell fate commitment | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1397 | | GO:0043471 | regulation of cellular carbohydrate catabolic process | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1398 | | GO:0043470 | regulation of carbohydrate catabolic process | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1399 | | GO:0040023 | establishment of nucleus localization | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1400 | | GO:0051647 | nucleus localization | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1401 | | GO:0045987 | positive regulation of smooth muscle contraction | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
1402 | | GO:0050808 | synapse organization and biogenesis | 8 | 1018 | 69 | 25185 | 1.03e-02 | 0.01 | 0.00 | 2.9 |
1403 | | GO:0001764 | neuron migration | 8 | 1018 | 69 | 25185 | 1.03e-02 | 0.01 | 0.00 | 2.9 |
1404 | | GO:0015986 | ATP synthesis coupled proton transport | 7 | 1019 | 55 | 25199 | 1.03e-02 | 0.01 | 0.00 | 3.1 |
1405 | | GO:0015985 | energy coupled proton transport\, down electrochemical gradient | 7 | 1019 | 55 | 25199 | 1.03e-02 | 0.01 | 0.00 | 3.1 |
1406 | | GO:0007067 | mitosis | 19 | 1007 | 247 | 25007 | 1.03e-02 | 0.02 | 0.01 | 1.9 |
1407 | | GO:0030521 | androgen receptor signaling pathway | 6 | 1020 | 42 | 25212 | 1.06e-02 | 0.01 | 0.00 | 3.5 |
1408 | | GO:0046519 | sphingoid metabolic process | 6 | 1020 | 42 | 25212 | 1.06e-02 | 0.01 | 0.00 | 3.5 |
1409 | | GO:0043506 | regulation of JNK activity | 5 | 1021 | 30 | 25224 | 1.10e-02 | 0.00 | 0.00 | 4.1 |
1410 | | GO:0018958 | phenol metabolic process | 8 | 1018 | 70 | 25184 | 1.10e-02 | 0.01 | 0.00 | 2.8 |
1411 | | GO:0045471 | response to ethanol | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1412 | | GO:0046839 | phospholipid dephosphorylation | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1413 | | GO:0051224 | negative regulation of protein transport | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1414 | | GO:0002819 | regulation of adaptive immune response | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1415 | | GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1416 | | GO:0002699 | positive regulation of immune effector process | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1417 | | GO:0007194 | negative regulation of adenylate cyclase activity | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1418 | | GO:0031280 | negative regulation of cyclase activity | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1419 | | GO:0051350 | negative regulation of lyase activity | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
1420 | | GO:0009141 | nucleoside triphosphate metabolic process | 10 | 1016 | 101 | 25153 | 1.16e-02 | 0.01 | 0.00 | 2.4 |
1421 | | GO:0046546 | development of primary male sexual characteristics | 6 | 1020 | 43 | 25211 | 1.17e-02 | 0.01 | 0.00 | 3.4 |
1422 | | GO:0009259 | ribonucleotide metabolic process | 12 | 1014 | 126 | 25128 | 1.20e-02 | 0.01 | 0.00 | 2.3 |
1423 | | GO:0001942 | hair follicle development | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
1424 | | GO:0022405 | hair cycle process | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
1425 | | GO:0042633 | hair cycle | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
1426 | | GO:0042303 | molting cycle | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
1427 | | GO:0022404 | molting cycle process | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
1428 | | GO:0050769 | positive regulation of neurogenesis | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
1429 | | GO:0015031 | protein transport | 52 | 974 | 887 | 24367 | 1.25e-02 | 0.05 | 0.04 | 1.4 |
1430 | | GO:0042312 | regulation of vasodilation | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1431 | | GO:0050810 | regulation of steroid biosynthetic process | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1432 | | GO:0009267 | cellular response to starvation | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1433 | | GO:0042346 | positive regulation of NF\-kappaB import into nucleus | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1434 | | GO:0010469 | regulation of receptor activity | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1435 | | GO:0050891 | multicellular organismal water homeostasis | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1436 | | GO:0042755 | eating behavior | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1437 | | GO:0042771 | DNA damage response\, signal transduction by p53 class mediator resulting in induction of apoptosis | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1438 | | GO:0007213 | acetylcholine receptor signaling\, muscarinic pathway | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1439 | | GO:0030049 | muscle filament sliding | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1440 | | GO:0033275 | actin\-myosin filament sliding | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1441 | | GO:0002709 | regulation of T cell mediated immunity | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1442 | | GO:0050854 | regulation of antigen receptor\-mediated signaling pathway | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1443 | | GO:0048547 | gut morphogenesis | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1444 | | GO:0006563 | L\-serine metabolic process | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
1445 | | GO:0016032 | viral reproduction | 8 | 1018 | 72 | 25182 | 1.28e-02 | 0.01 | 0.00 | 2.7 |
1446 | | GO:0030031 | cell projection biogenesis | 8 | 1018 | 72 | 25182 | 1.28e-02 | 0.01 | 0.00 | 2.7 |
1447 | | GO:0009152 | purine ribonucleotide biosynthetic process | 10 | 1016 | 103 | 25151 | 1.31e-02 | 0.01 | 0.00 | 2.4 |
1448 | | GO:0033077 | T cell differentiation in the thymus | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
1449 | | GO:0051924 | regulation of calcium ion transport | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
1450 | | GO:0046068 | cGMP metabolic process | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
1451 | | GO:0043393 | regulation of protein binding | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
1452 | | GO:0050821 | protein stabilization | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
1453 | | GO:0042094 | interleukin\-2 biosynthetic process | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
1454 | | GO:0002703 | regulation of leukocyte mediated immunity | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
1455 | | GO:0002706 | regulation of lymphocyte mediated immunity | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
1456 | | GO:0007530 | sex determination | 5 | 1021 | 32 | 25222 | 1.39e-02 | 0.00 | 0.00 | 3.8 |
1457 | | GO:0030100 | regulation of endocytosis | 6 | 1020 | 45 | 25209 | 1.41e-02 | 0.01 | 0.00 | 3.3 |
1458 | | GO:0051000 | positive regulation of nitric\-oxide synthase activity | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1459 | | GO:0032770 | positive regulation of monooxygenase activity | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1460 | | GO:0050665 | hydrogen peroxide biosynthetic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1461 | | GO:0043070 | regulation of non\-apoptotic programmed cell death | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1462 | | GO:0016244 | non\-apoptotic programmed cell death | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1463 | | GO:0030185 | nitric oxide transport | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1464 | | GO:0006924 | activated T cell apoptosis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1465 | | GO:0002003 | angiotensin maturation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1466 | | GO:0002002 | regulation of angiotensin levels in blood | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1467 | | GO:0060177 | regulation of angiotensin metabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1468 | | GO:0030264 | nuclear fragmentation during apoptosis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1469 | | GO:0046321 | positive regulation of fatty acid oxidation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1470 | | GO:0032655 | regulation of interleukin\-12 production | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1471 | | GO:0031670 | cellular response to nutrient | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1472 | | GO:0045722 | positive regulation of gluconeogenesis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1473 | | GO:0030240 | muscle thin filament assembly | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1474 | | GO:0042335 | cuticle development | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1475 | | GO:0030644 | cellular chloride ion homeostasis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1476 | | GO:0030320 | cellular monovalent inorganic anion homeostasis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1477 | | GO:0055083 | monovalent inorganic anion homeostasis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1478 | | GO:0055064 | chloride ion homeostasis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1479 | | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1480 | | GO:0006102 | isocitrate metabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1481 | | GO:0033700 | phospholipid efflux | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1482 | | GO:0060037 | pharyngeal system development | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1483 | | GO:0045672 | positive regulation of osteoclast differentiation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1484 | | GO:0006540 | glutamate decarboxylation to succinate | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1485 | | GO:0006105 | succinate metabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1486 | | GO:0001553 | luteinization | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1487 | | GO:0048521 | negative regulation of behavior | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1488 | | GO:0032846 | positive regulation of homeostatic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1489 | | GO:0006496 | protein amino acid terminal N\-glycosylation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1490 | | GO:0006494 | protein amino acid terminal glycosylation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1491 | | GO:0006287 | base\-excision repair\, gap\-filling | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1492 | | GO:0030816 | positive regulation of cAMP metabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1493 | | GO:0006975 | DNA damage induced protein phosphorylation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1494 | | GO:0000098 | sulfur amino acid catabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1495 | | GO:0044273 | sulfur compound catabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1496 | | GO:0007435 | salivary gland morphogenesis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1497 | | GO:0022612 | gland morphogenesis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1498 | | GO:0002268 | follicular dendritic cell differentiation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1499 | | GO:0002266 | follicular dendritic cell activation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1500 | | GO:0042396 | phosphagen biosynthetic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1501 | | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
1502 | | GO:0015672 | monovalent inorganic cation transport | 34 | 992 | 531 | 24723 | 1.50e-02 | 0.03 | 0.02 | 1.6 |
1503 | | GO:0042176 | regulation of protein catabolic process | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
1504 | | GO:0015669 | gas transport | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
1505 | | GO:0032387 | negative regulation of intracellular transport | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
1506 | | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
1507 | | GO:0030879 | mammary gland development | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
1508 | | GO:0006541 | glutamine metabolic process | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
1509 | | GO:0048562 | embryonic organ morphogenesis | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
1510 | | GO:0051318 | G1 phase | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
1511 | | GO:0007189 | G\-protein signaling\, adenylate cyclase activating pathway | 6 | 1020 | 46 | 25208 | 1.54e-02 | 0.01 | 0.00 | 3.2 |
1512 | | GO:0048167 | regulation of synaptic plasticity | 5 | 1021 | 33 | 25221 | 1.55e-02 | 0.00 | 0.00 | 3.7 |
1513 | | GO:0051145 | smooth muscle cell differentiation | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1514 | | GO:0032675 | regulation of interleukin\-6 production | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1515 | | GO:0015908 | fatty acid transport | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1516 | | GO:0006098 | pentose\-phosphate shunt | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1517 | | GO:0006740 | NADPH regeneration | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1518 | | GO:0046579 | positive regulation of Ras protein signal transduction | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1519 | | GO:0043299 | leukocyte degranulation | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1520 | | GO:0002444 | myeloid leukocyte mediated immunity | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1521 | | GO:0030901 | midbrain development | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1522 | | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1523 | | GO:0045861 | negative regulation of proteolysis | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1524 | | GO:0045086 | positive regulation of interleukin\-2 biosynthetic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1525 | | GO:0032868 | response to insulin stimulus | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1526 | | GO:0051289 | protein homotetramerization | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1527 | | GO:0042438 | melanin biosynthetic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1528 | | GO:0006582 | melanin metabolic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1529 | | GO:0006527 | arginine catabolic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1530 | | GO:0042403 | thyroid hormone metabolic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1531 | | GO:0006020 | inositol metabolic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1532 | | GO:0048738 | cardiac muscle development | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1533 | | GO:0031116 | positive regulation of microtubule polymerization | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1534 | | GO:0048546 | digestive tract morphogenesis | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1535 | | GO:0042135 | neurotransmitter catabolic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
1536 | | GO:0000087 | M phase of mitotic cell cycle | 19 | 1007 | 251 | 25003 | 1.61e-02 | 0.02 | 0.01 | 1.9 |
1537 | | GO:0016568 | chromatin modification | 17 | 1009 | 221 | 25033 | 1.68e-02 | 0.02 | 0.01 | 1.9 |
1538 | | GO:0009612 | response to mechanical stimulus | 5 | 1021 | 34 | 25220 | 1.72e-02 | 0.00 | 0.00 | 3.6 |
1539 | | GO:0050885 | neuromuscular process controlling balance | 5 | 1021 | 34 | 25220 | 1.72e-02 | 0.00 | 0.00 | 3.6 |
1540 | | GO:0016458 | gene silencing | 5 | 1021 | 34 | 25220 | 1.72e-02 | 0.00 | 0.00 | 3.6 |
1541 | | GO:0030111 | regulation of Wnt receptor signaling pathway | 5 | 1021 | 34 | 25220 | 1.72e-02 | 0.00 | 0.00 | 3.6 |
1542 | | GO:0050792 | regulation of viral reproduction | 4 | 1022 | 22 | 25232 | 1.74e-02 | 0.00 | 0.00 | 4.5 |
1543 | | GO:0006306 | DNA methylation | 4 | 1022 | 22 | 25232 | 1.74e-02 | 0.00 | 0.00 | 4.5 |
1544 | | GO:0006305 | DNA alkylation | 4 | 1022 | 22 | 25232 | 1.74e-02 | 0.00 | 0.00 | 4.5 |
1545 | | GO:0048477 | oogenesis | 4 | 1022 | 22 | 25232 | 1.74e-02 | 0.00 | 0.00 | 4.5 |
1546 | | GO:0008207 | C21\-steroid hormone metabolic process | 4 | 1022 | 22 | 25232 | 1.74e-02 | 0.00 | 0.00 | 4.5 |
1547 | | GO:0051248 | negative regulation of protein metabolic process | 11 | 1015 | 117 | 25137 | 1.77e-02 | 0.01 | 0.00 | 2.3 |
1548 | | GO:0046148 | pigment biosynthetic process | 6 | 1020 | 48 | 25206 | 1.83e-02 | 0.01 | 0.00 | 3.1 |
1549 | | GO:0050764 | regulation of phagocytosis | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1550 | | GO:0030104 | water homeostasis | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1551 | | GO:0044241 | lipid digestion | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1552 | | GO:0031645 | negative regulation of neurological system process | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1553 | | GO:0043550 | regulation of lipid kinase activity | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1554 | | GO:0006878 | cellular copper ion homeostasis | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1555 | | GO:0042994 | cytoplasmic sequestering of transcription factor | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1556 | | GO:0005980 | glycogen catabolic process | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1557 | | GO:0048599 | oocyte development | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1558 | | GO:0042733 | embryonic digit morphogenesis | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1559 | | GO:0018409 | peptide or protein amino\-terminal blocking | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1560 | | GO:0060038 | cardiac muscle cell proliferation | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1561 | | GO:0014855 | striated muscle cell proliferation | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1562 | | GO:0031113 | regulation of microtubule polymerization | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1563 | | GO:0045933 | positive regulation of muscle contraction | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
1564 | | GO:0008344 | adult locomotory behavior | 5 | 1021 | 35 | 25219 | 1.91e-02 | 0.00 | 0.00 | 3.5 |
1565 | | GO:0045087 | innate immune response | 11 | 1015 | 121 | 25133 | 1.96e-02 | 0.01 | 0.00 | 2.2 |
1566 | | GO:0045639 | positive regulation of myeloid cell differentiation | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
1567 | | GO:0017157 | regulation of exocytosis | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
1568 | | GO:0015914 | phospholipid transport | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
1569 | | GO:0007613 | memory | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
1570 | | GO:0048812 | neurite morphogenesis | 16 | 1010 | 204 | 25050 | 2.05e-02 | 0.02 | 0.01 | 1.9 |
1571 | | GO:0048667 | neuron morphogenesis during differentiation | 16 | 1010 | 204 | 25050 | 2.05e-02 | 0.02 | 0.01 | 1.9 |
1572 | | GO:0045939 | negative regulation of steroid metabolic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1573 | | GO:0060087 | relaxation of vascular smooth muscle | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1574 | | GO:0051646 | mitochondrion localization | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1575 | | GO:0030432 | peristalsis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1576 | | GO:0014821 | phasic smooth muscle contraction | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1577 | | GO:0050901 | leukocyte tethering or rolling | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1578 | | GO:0006927 | transformed cell apoptosis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1579 | | GO:0043267 | negative regulation of potassium ion transport | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1580 | | GO:0043266 | regulation of potassium ion transport | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1581 | | GO:0001781 | neutrophil apoptosis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1582 | | GO:0045741 | positive regulation of epidermal growth factor receptor activity | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1583 | | GO:0052173 | response to defenses of other organism during symbiotic interaction | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1584 | | GO:0052200 | response to host defenses | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1585 | | GO:0001660 | fever | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1586 | | GO:0046326 | positive regulation of glucose import | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1587 | | GO:0010039 | response to iron ion | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1588 | | GO:0031000 | response to caffeine | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1589 | | GO:0014074 | response to purine | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1590 | | GO:0014866 | skeletal myofibril assembly | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1591 | | GO:0015760 | glucose\-6\-phosphate transport | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1592 | | GO:0008628 | induction of apoptosis by hormones | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1593 | | GO:0035081 | induction of programmed cell death by hormones | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1594 | | GO:0032434 | regulation of proteasomal ubiquitin\-dependent protein catabolic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1595 | | GO:0001954 | positive regulation of cell\-matrix adhesion | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1596 | | GO:0006980 | redox signal response | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1597 | | GO:0051775 | response to redox state | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1598 | | GO:0007518 | myoblast cell fate determination | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1599 | | GO:0048625 | myoblast cell fate commitment | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1600 | | GO:0021871 | forebrain regionalization | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1601 | | GO:0050857 | positive regulation of antigen receptor\-mediated signaling pathway | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1602 | | GO:0006591 | ornithine metabolic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1603 | | GO:0018076 | N\-terminal peptidyl\-lysine acetylation | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1604 | | GO:0018394 | peptidyl\-lysine acetylation | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1605 | | GO:0001667 | ameboidal cell migration | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1606 | | GO:0051895 | negative regulation of focal adhesion formation | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1607 | | GO:0045409 | negative regulation of interleukin\-6 biosynthetic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1608 | | GO:0007183 | SMAD protein complex assembly | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1609 | | GO:0006533 | aspartate catabolic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1610 | | GO:0006531 | aspartate metabolic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1611 | | GO:0055091 | phospholipid homeostasis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1612 | | GO:0006599 | phosphagen metabolic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
1613 | | GO:0006826 | iron ion transport | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
1614 | | GO:0009239 | enterobactin biosynthetic process | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
1615 | | GO:0019540 | siderophore biosynthetic process from catechol | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
1616 | | GO:0009712 | catechol metabolic process | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
1617 | | GO:0009238 | enterobactin metabolic process | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
1618 | | GO:0019290 | siderophore biosynthetic process | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
1619 | | GO:0009237 | siderophore metabolic process | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
1620 | | GO:0007270 | nerve\-nerve synaptic transmission | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
1621 | | GO:0051640 | organelle localization | 6 | 1020 | 50 | 25204 | 2.16e-02 | 0.01 | 0.00 | 3.0 |
1622 | | GO:0043414 | biopolymer methylation | 6 | 1020 | 50 | 25204 | 2.16e-02 | 0.01 | 0.00 | 3.0 |
1623 | | GO:0009952 | anterior/posterior pattern formation | 9 | 1017 | 96 | 25158 | 2.17e-02 | 0.01 | 0.00 | 2.3 |
1624 | | GO:0001936 | regulation of endothelial cell proliferation | 4 | 1022 | 24 | 25230 | 2.24e-02 | 0.00 | 0.00 | 4.1 |
1625 | | GO:0042364 | water\-soluble vitamin biosynthetic process | 4 | 1022 | 24 | 25230 | 2.24e-02 | 0.00 | 0.00 | 4.1 |
1626 | | GO:0017156 | calcium ion\-dependent exocytosis | 4 | 1022 | 24 | 25230 | 2.24e-02 | 0.00 | 0.00 | 4.1 |
1627 | | GO:0001708 | cell fate specification | 4 | 1022 | 24 | 25230 | 2.24e-02 | 0.00 | 0.00 | 4.1 |
1628 | | GO:0043525 | positive regulation of neuron apoptosis | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1629 | | GO:0008210 | estrogen metabolic process | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1630 | | GO:0009896 | positive regulation of catabolic process | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1631 | | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1632 | | GO:0055070 | copper ion homeostasis | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1633 | | GO:0007567 | parturition | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1634 | | GO:0051220 | cytoplasmic sequestering of protein | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1635 | | GO:0048638 | regulation of developmental growth | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1636 | | GO:0009251 | glucan catabolic process | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1637 | | GO:0016079 | synaptic vesicle exocytosis | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1638 | | GO:0046852 | positive regulation of bone remodeling | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1639 | | GO:0034105 | positive regulation of tissue remodeling | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1640 | | GO:0045667 | regulation of osteoblast differentiation | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1641 | | GO:0009994 | oocyte differentiation | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1642 | | GO:0001909 | leukocyte mediated cytotoxicity | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1643 | | GO:0000050 | urea cycle | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1644 | | GO:0019627 | urea metabolic process | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1645 | | GO:0043603 | amide metabolic process | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1646 | | GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1647 | | GO:0035272 | exocrine system development | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
1648 | | GO:0048511 | rhythmic process | 9 | 1017 | 97 | 25157 | 2.30e-02 | 0.01 | 0.00 | 2.3 |
1649 | | GO:0051493 | regulation of cytoskeleton organization and biogenesis | 9 | 1017 | 97 | 25157 | 2.30e-02 | 0.01 | 0.00 | 2.3 |
1650 | | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 8 | 1018 | 81 | 25173 | 2.30e-02 | 0.01 | 0.00 | 2.4 |
1651 | | GO:0009145 | purine nucleoside triphosphate biosynthetic process | 8 | 1018 | 81 | 25173 | 2.30e-02 | 0.01 | 0.00 | 2.4 |
1652 | | GO:0007093 | mitotic cell cycle checkpoint | 5 | 1021 | 37 | 25217 | 2.31e-02 | 0.00 | 0.00 | 3.3 |
1653 | | GO:0031327 | negative regulation of cellular biosynthetic process | 5 | 1021 | 37 | 25217 | 2.31e-02 | 0.00 | 0.00 | 3.3 |
1654 | | GO:0006029 | proteoglycan metabolic process | 5 | 1021 | 37 | 25217 | 2.31e-02 | 0.00 | 0.00 | 3.3 |
1655 | | GO:0008064 | regulation of actin polymerization and/or depolymerization | 6 | 1020 | 51 | 25203 | 2.33e-02 | 0.01 | 0.00 | 2.9 |
1656 | | GO:0022600 | digestive system process | 4 | 1022 | 25 | 25229 | 2.52e-02 | 0.00 | 0.00 | 3.9 |
1657 | | GO:0006473 | protein amino acid acetylation | 4 | 1022 | 25 | 25229 | 2.52e-02 | 0.00 | 0.00 | 3.9 |
1658 | | GO:0007224 | smoothened signaling pathway | 4 | 1022 | 25 | 25229 | 2.52e-02 | 0.00 | 0.00 | 3.9 |
1659 | | GO:0000904 | cellular morphogenesis during differentiation | 16 | 1010 | 216 | 25038 | 2.55e-02 | 0.02 | 0.01 | 1.8 |
1660 | | GO:0009201 | ribonucleoside triphosphate biosynthetic process | 8 | 1018 | 83 | 25171 | 2.59e-02 | 0.01 | 0.00 | 2.4 |
1661 | | GO:0016567 | protein ubiquitination | 10 | 1016 | 108 | 25146 | 2.63e-02 | 0.01 | 0.00 | 2.3 |
1662 | | GO:0046854 | phosphoinositide phosphorylation | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1663 | | GO:0001837 | epithelial to mesenchymal transition | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1664 | | GO:0060232 | delamination | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1665 | | GO:0050832 | defense response to fungus | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1666 | | GO:0050702 | interleukin\-1 beta secretion | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1667 | | GO:0030032 | lamellipodium biogenesis | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1668 | | GO:0006342 | chromatin silencing | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1669 | | GO:0031507 | heterochromatin formation | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1670 | | GO:0002027 | regulation of heart rate | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1671 | | GO:0035051 | cardiac cell differentiation | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1672 | | GO:0046785 | microtubule polymerization | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1673 | | GO:0048593 | camera\-type eye morphogenesis | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1674 | | GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1675 | | GO:0002821 | positive regulation of adaptive immune response | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1676 | | GO:0048566 | embryonic gut development | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
1677 | | GO:0030832 | regulation of actin filament length | 6 | 1020 | 53 | 25201 | 2.71e-02 | 0.01 | 0.00 | 2.8 |
1678 | | GO:0008037 | cell recognition | 6 | 1020 | 53 | 25201 | 2.71e-02 | 0.01 | 0.00 | 2.8 |
1679 | | GO:0001895 | retina homeostasis | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1680 | | GO:0046627 | negative regulation of insulin receptor signaling pathway | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1681 | | GO:0019934 | cGMP\-mediated signaling | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1682 | | GO:0045071 | negative regulation of viral genome replication | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1683 | | GO:0042832 | defense response to protozoan | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1684 | | GO:0033028 | myeloid cell apoptosis | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1685 | | GO:0045806 | negative regulation of endocytosis | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1686 | | GO:0030889 | negative regulation of B cell proliferation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1687 | | GO:0030818 | negative regulation of cAMP biosynthetic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1688 | | GO:0030815 | negative regulation of cAMP metabolic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1689 | | GO:0019369 | arachidonic acid metabolic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1690 | | GO:0045600 | positive regulation of fat cell differentiation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1691 | | GO:0031641 | regulation of myelination | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1692 | | GO:0045912 | negative regulation of carbohydrate metabolic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1693 | | GO:0033003 | regulation of mast cell activation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1694 | | GO:0043304 | regulation of mast cell degranulation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1695 | | GO:0007253 | cytoplasmic sequestering of NF\-kappaB | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1696 | | GO:0031056 | regulation of histone modification | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1697 | | GO:0000002 | mitochondrial genome maintenance | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1698 | | GO:0006390 | transcription from mitochondrial promoter | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1699 | | GO:0019852 | L\-ascorbic acid metabolic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1700 | | GO:0006689 | ganglioside catabolic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1701 | | GO:0045647 | negative regulation of erythrocyte differentiation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1702 | | GO:0051893 | regulation of focal adhesion formation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1703 | | GO:0010552 | positive regulation of specific transcription from RNA polymerase II promoter | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1704 | | GO:0010551 | regulation of specific transcription from RNA polymerase II promoter | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1705 | | GO:0032569 | specific transcription from RNA polymerase II promoter | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1706 | | GO:0045162 | clustering of voltage\-gated sodium channels | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1707 | | GO:0001919 | regulation of receptor recycling | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1708 | | GO:0050805 | negative regulation of synaptic transmission | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1709 | | GO:0032691 | negative regulation of interleukin\-1 beta production | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1710 | | GO:0032692 | negative regulation of interleukin\-1 production | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1711 | | GO:0032651 | regulation of interleukin\-1 beta production | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1712 | | GO:0051966 | regulation of synaptic transmission\, glutamatergic | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1713 | | GO:0030502 | negative regulation of bone mineralization | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1714 | | GO:0051351 | positive regulation of ligase activity | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1715 | | GO:0021513 | spinal cord dorsal/ventral patterning | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1716 | | GO:0051001 | negative regulation of nitric\-oxide synthase activity | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1717 | | GO:0032769 | negative regulation of monooxygenase activity | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1718 | | GO:0002053 | positive regulation of mesenchymal cell proliferation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1719 | | GO:0010464 | regulation of mesenchymal cell proliferation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1720 | | GO:0010463 | mesenchymal cell proliferation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1721 | | GO:0060043 | regulation of cardiac muscle cell proliferation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1722 | | GO:0000154 | rRNA modification | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
1723 | | GO:0009110 | vitamin biosynthetic process | 4 | 1022 | 26 | 25228 | 2.82e-02 | 0.00 | 0.00 | 3.8 |
1724 | | GO:0007215 | glutamate signaling pathway | 4 | 1022 | 26 | 25228 | 2.82e-02 | 0.00 | 0.00 | 3.8 |
1725 | | GO:0032259 | methylation | 7 | 1019 | 69 | 25185 | 2.88e-02 | 0.01 | 0.00 | 2.5 |
1726 | | GO:0006665 | sphingolipid metabolic process | 7 | 1019 | 69 | 25185 | 2.88e-02 | 0.01 | 0.00 | 2.5 |
1727 | | GO:0050826 | response to freezing | 15 | 1011 | 196 | 25058 | 2.91e-02 | 0.01 | 0.01 | 1.9 |
1728 | | GO:0042309 | homoiothermy | 15 | 1011 | 197 | 25057 | 2.95e-02 | 0.01 | 0.01 | 1.9 |
1729 | | GO:0000910 | cytokinesis | 5 | 1021 | 40 | 25214 | 3.02e-02 | 0.00 | 0.00 | 3.1 |
1730 | | GO:0009142 | nucleoside triphosphate biosynthetic process | 8 | 1018 | 86 | 25168 | 3.06e-02 | 0.01 | 0.00 | 2.3 |
1731 | | GO:0001974 | blood vessel remodeling | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1732 | | GO:0051605 | protein maturation via proteolysis | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1733 | | GO:0042093 | T\-helper cell differentiation | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1734 | | GO:0002294 | CD4\-positive\, alpha\-beta T cell differentiation during immune response | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1735 | | GO:0002293 | alpha\-beta T cell differentiation during immune response | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1736 | | GO:0002292 | T cell differentiation during immune response | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1737 | | GO:0002286 | T cell activation during immune response | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1738 | | GO:0002285 | lymphocyte activation during immune response | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1739 | | GO:0046834 | lipid phosphorylation | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1740 | | GO:0032488 | Cdc42 protein signal transduction | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1741 | | GO:0006509 | membrane protein ectodomain proteolysis | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1742 | | GO:0033619 | membrane protein proteolysis | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1743 | | GO:0050892 | intestinal absorption | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1744 | | GO:0042992 | negative regulation of transcription factor import into nucleus | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1745 | | GO:0042308 | negative regulation of protein import into nucleus | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1746 | | GO:0051147 | regulation of muscle cell differentiation | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1747 | | GO:0031365 | N\-terminal protein amino acid modification | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1748 | | GO:0006637 | acyl\-CoA metabolic process | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1749 | | GO:0006555 | methionine metabolic process | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1750 | | GO:0000724 | double\-strand break repair via homologous recombination | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1751 | | GO:0000725 | recombinational repair | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
1752 | | GO:0045580 | regulation of T cell differentiation | 4 | 1022 | 27 | 25227 | 3.14e-02 | 0.00 | 0.00 | 3.6 |
1753 | | GO:0010212 | response to ionizing radiation | 4 | 1022 | 27 | 25227 | 3.14e-02 | 0.00 | 0.00 | 3.6 |
1754 | | GO:0030509 | BMP signaling pathway | 4 | 1022 | 27 | 25227 | 3.14e-02 | 0.00 | 0.00 | 3.6 |
1755 | | GO:0009260 | ribonucleotide biosynthetic process | 10 | 1016 | 115 | 25139 | 3.16e-02 | 0.01 | 0.00 | 2.1 |
1756 | | GO:0007528 | neuromuscular junction development | 4 | 1022 | 28 | 25226 | 3.49e-02 | 0.00 | 0.00 | 3.5 |
1757 | | GO:0009953 | dorsal/ventral pattern formation | 5 | 1021 | 42 | 25212 | 3.56e-02 | 0.00 | 0.00 | 2.9 |
1758 | | GO:0002437 | inflammatory response to antigenic stimulus | 6 | 1020 | 57 | 25197 | 3.60e-02 | 0.01 | 0.00 | 2.6 |
1759 | | GO:0019058 | viral infectious cycle | 6 | 1020 | 57 | 25197 | 3.60e-02 | 0.01 | 0.00 | 2.6 |
1760 | | GO:0046637 | regulation of alpha\-beta T cell differentiation | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1761 | | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1762 | | GO:0001937 | negative regulation of endothelial cell proliferation | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1763 | | GO:0050701 | interleukin\-1 secretion | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1764 | | GO:0000186 | activation of MAPKK activity | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1765 | | GO:0045055 | regulated secretory pathway | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1766 | | GO:0045767 | regulation of anti\-apoptosis | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1767 | | GO:0046823 | negative regulation of nucleocytoplasmic transport | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1768 | | GO:0016573 | histone acetylation | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1769 | | GO:0006700 | C21\-steroid hormone biosynthetic process | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1770 | | GO:0048806 | genitalia development | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1771 | | GO:0002708 | positive regulation of lymphocyte mediated immunity | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1772 | | GO:0002705 | positive regulation of leukocyte mediated immunity | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
1773 | | GO:0045909 | positive regulation of vasodilation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1774 | | GO:0051952 | regulation of amine transport | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1775 | | GO:0032715 | negative regulation of interleukin\-6 production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1776 | | GO:0048662 | negative regulation of smooth muscle cell proliferation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1777 | | GO:0045779 | negative regulation of bone resorption | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1778 | | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1779 | | GO:0030809 | negative regulation of nucleotide biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1780 | | GO:0030800 | negative regulation of cyclic nucleotide metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1781 | | GO:0014065 | phosphoinositide 3\-kinase cascade | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1782 | | GO:0002347 | response to tumor cell | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1783 | | GO:0006636 | unsaturated fatty acid biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1784 | | GO:0033559 | unsaturated fatty acid metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1785 | | GO:0040012 | regulation of locomotion | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1786 | | GO:0043300 | regulation of leukocyte degranulation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1787 | | GO:0008634 | negative regulation of survival gene product expression | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1788 | | GO:0030851 | granulocyte differentiation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1789 | | GO:0045773 | positive regulation of axon extension | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1790 | | GO:0016081 | synaptic vesicle docking during exocytosis | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1791 | | GO:0006002 | fructose 6\-phosphate metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1792 | | GO:0043249 | erythrocyte maturation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1793 | | GO:0042481 | regulation of odontogenesis | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1794 | | GO:0042487 | regulation of odontogenesis of dentine\-containing teeth | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1795 | | GO:0006108 | malate metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1796 | | GO:0006085 | acetyl\-CoA biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1797 | | GO:0001958 | endochondral ossification | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1798 | | GO:0031623 | receptor internalization | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1799 | | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1800 | | GO:0031343 | positive regulation of cell killing | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1801 | | GO:0032729 | positive regulation of interferon\-gamma production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1802 | | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1803 | | GO:0002717 | positive regulation of natural killer cell mediated immunity | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1804 | | GO:0042253 | granulocyte macrophage colony\-stimulating factor biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1805 | | GO:0032604 | granulocyte macrophage colony\-stimulating factor production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1806 | | GO:0002076 | osteoblast development | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1807 | | GO:0006907 | pinocytosis | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1808 | | GO:0045666 | positive regulation of neuron differentiation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1809 | | GO:0032869 | cellular response to insulin stimulus | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1810 | | GO:0032870 | cellular response to hormone stimulus | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1811 | | GO:0032652 | regulation of interleukin\-1 production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1812 | | GO:0032611 | interleukin\-1 beta production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1813 | | GO:0046174 | polyol catabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1814 | | GO:0045907 | positive regulation of vasoconstriction | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1815 | | GO:0045687 | positive regulation of glial cell differentiation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1816 | | GO:0014015 | positive regulation of gliogenesis | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1817 | | GO:0030850 | prostate gland development | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1818 | | GO:0051354 | negative regulation of oxidoreductase activity | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1819 | | GO:0048536 | spleen development | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
1820 | | GO:0043583 | ear development | 7 | 1019 | 73 | 25181 | 3.67e-02 | 0.01 | 0.00 | 2.4 |
1821 | | GO:0032535 | regulation of cellular component size | 6 | 1020 | 58 | 25196 | 3.84e-02 | 0.01 | 0.00 | 2.5 |
1822 | | GO:0014070 | response to organic cyclic substance | 4 | 1022 | 29 | 25225 | 3.85e-02 | 0.00 | 0.00 | 3.4 |
1823 | | GO:0046466 | membrane lipid catabolic process | 4 | 1022 | 29 | 25225 | 3.85e-02 | 0.00 | 0.00 | 3.4 |
1824 | | GO:0042775 | organelle ATP synthesis coupled electron transport | 5 | 1021 | 43 | 25211 | 3.85e-02 | 0.00 | 0.00 | 2.9 |
1825 | | GO:0000226 | microtubule cytoskeleton organization and biogenesis | 10 | 1016 | 122 | 25132 | 3.94e-02 | 0.01 | 0.00 | 2.0 |
1826 | | GO:0006820 | anion transport | 18 | 1008 | 261 | 24993 | 4.08e-02 | 0.02 | 0.01 | 1.7 |
1827 | | GO:0021782 | glial cell development | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
1828 | | GO:0031646 | positive regulation of neurological system process | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
1829 | | GO:0051604 | protein maturation | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
1830 | | GO:0006182 | cGMP biosynthetic process | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
1831 | | GO:0002366 | leukocyte activation during immune response | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
1832 | | GO:0002263 | cell activation during immune response | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
1833 | | GO:0045814 | negative regulation of gene expression\, epigenetic | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
1834 | | GO:0045076 | regulation of interleukin\-2 biosynthetic process | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
1835 | | GO:0015837 | amine transport | 9 | 1017 | 102 | 25152 | 4.18e-02 | 0.01 | 0.00 | 2.2 |
1836 | | GO:0001890 | placenta development | 4 | 1022 | 30 | 25224 | 4.23e-02 | 0.00 | 0.00 | 3.3 |
1837 | | GO:0007409 | axonogenesis | 14 | 1012 | 193 | 25061 | 4.46e-02 | 0.01 | 0.01 | 1.8 |
1838 | | GO:0007612 | learning | 5 | 1021 | 45 | 25209 | 4.48e-02 | 0.00 | 0.00 | 2.7 |
1839 | | GO:0048678 | response to axon injury | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1840 | | GO:0045986 | negative regulation of smooth muscle contraction | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1841 | | GO:0001562 | response to protozoan | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1842 | | GO:0045064 | T\-helper 2 cell differentiation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1843 | | GO:0048535 | lymph node development | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1844 | | GO:0008631 | induction of apoptosis by oxidative stress | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1845 | | GO:0051482 | elevation of cytosolic calcium ion concentration during G\-protein signaling\, coupled to IP3 second messenger (phospholipase C activating) | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1846 | | GO:0050873 | brown fat cell differentiation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1847 | | GO:0030823 | regulation of cGMP metabolic process | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1848 | | GO:0031571 | G1 DNA damage checkpoint | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1849 | | GO:0006972 | hyperosmotic response | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1850 | | GO:0042347 | negative regulation of NF\-kappaB import into nucleus | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1851 | | GO:0046835 | carbohydrate phosphorylation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1852 | | GO:0009650 | UV protection | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1853 | | GO:0048011 | nerve growth factor receptor signaling pathway | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1854 | | GO:0007044 | cell\-substrate junction assembly | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1855 | | GO:0045931 | positive regulation of mitotic cell cycle | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1856 | | GO:0045669 | positive regulation of osteoblast differentiation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1857 | | GO:0033238 | regulation of amine metabolic process | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1858 | | GO:0032613 | interleukin\-10 production | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1859 | | GO:0018106 | peptidyl\-histidine phosphorylation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1860 | | GO:0002711 | positive regulation of T cell mediated immunity | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1861 | | GO:0032649 | regulation of interferon\-gamma production | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1862 | | GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1863 | | GO:0002715 | regulation of natural killer cell mediated immunity | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1864 | | GO:0030431 | sleep | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1865 | | GO:0048558 | embryonic gut morphogenesis | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1866 | | GO:0051970 | negative regulation of transmission of nerve impulse | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1867 | | GO:0014047 | glutamate secretion | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1868 | | GO:0030252 | growth hormone secretion | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1869 | | GO:0032612 | interleukin\-1 production | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1870 | | GO:0021511 | spinal cord patterning | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1871 | | GO:0043409 | negative regulation of MAPKKK cascade | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1872 | | GO:0006590 | thyroid hormone generation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
1873 | | GO:0045762 | positive regulation of adenylate cyclase activity | 4 | 1022 | 31 | 25223 | 4.64e-02 | 0.00 | 0.00 | 3.2 |
1874 | | GO:0031281 | positive regulation of cyclase activity | 4 | 1022 | 31 | 25223 | 4.64e-02 | 0.00 | 0.00 | 3.2 |
1875 | | GO:0051349 | positive regulation of lyase activity | 4 | 1022 | 31 | 25223 | 4.64e-02 | 0.00 | 0.00 | 3.2 |
1876 | | GO:0032956 | regulation of actin cytoskeleton organization and biogenesis | 6 | 1020 | 61 | 25193 | 4.64e-02 | 0.01 | 0.00 | 2.4 |
1877 | | GO:0002026 | regulation of the force of heart contraction | 3 | 1023 | 18 | 25236 | 4.67e-02 | 0.00 | 0.00 | 4.1 |
1878 | | GO:0022408 | negative regulation of cell\-cell adhesion | 3 | 1023 | 18 | 25236 | 4.67e-02 | 0.00 | 0.00 | 4.1 |
1879 | | GO:0006000 | fructose metabolic process | 3 | 1023 | 18 | 25236 | 4.67e-02 | 0.00 | 0.00 | 4.1 |
1880 | | GO:0045058 | T cell selection | 3 | 1023 | 18 | 25236 | 4.67e-02 | 0.00 | 0.00 | 4.1 |
1881 | | GO:0051180 | vitamin transport | 3 | 1023 | 18 | 25236 | 4.67e-02 | 0.00 | 0.00 | 4.1 |
1882 | | GO:0048729 | tissue morphogenesis | 9 | 1017 | 107 | 25147 | 4.78e-02 | 0.01 | 0.00 | 2.1 |
1883 | | GO:0032970 | regulation of actin filament\-based process | 6 | 1020 | 62 | 25192 | 4.93e-02 | 0.01 | 0.00 | 2.4 |
1884 | | GO:0032269 | negative regulation of cellular protein metabolic process | 9 | 1017 | 109 | 25145 | 5.07e-02 | 0.01 | 0.00 | 2.0 |
1885 | | GO:0000041 | transition metal ion transport | 7 | 1019 | 79 | 25175 | 5.09e-02 | 0.01 | 0.00 | 2.2 |
1886 | | GO:0018105 | peptidyl\-serine phosphorylation | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
1887 | | GO:0046634 | regulation of alpha\-beta T cell activation | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
1888 | | GO:0043367 | CD4\-positive\, alpha beta T cell differentiation | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
1889 | | GO:0007618 | mating | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
1890 | | GO:0030149 | sphingolipid catabolic process | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
1891 | | GO:0006664 | glycolipid metabolic process | 4 | 1022 | 33 | 25221 | 5.51e-02 | 0.00 | 0.00 | 3.0 |
1892 | | GO:0042773 | ATP synthesis coupled electron transport | 5 | 1021 | 48 | 25206 | 5.52e-02 | 0.00 | 0.00 | 2.6 |
1893 | | GO:0030384 | phosphoinositide metabolic process | 6 | 1020 | 64 | 25190 | 5.54e-02 | 0.01 | 0.00 | 2.3 |
1894 | | GO:0022603 | regulation of anatomical structure morphogenesis | 9 | 1017 | 112 | 25142 | 5.56e-02 | 0.01 | 0.00 | 2.0 |
1895 | | GO:0048525 | negative regulation of viral reproduction | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1896 | | GO:0030146 | diuresis | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1897 | | GO:0003091 | renal water homeostasis | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1898 | | GO:0031649 | heat generation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1899 | | GO:0010224 | response to UV\-B | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1900 | | GO:0043303 | mast cell degranulation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1901 | | GO:0002448 | mast cell mediated immunity | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1902 | | GO:0006677 | glycosylceramide metabolic process | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1903 | | GO:0030002 | cellular anion homeostasis | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1904 | | GO:0055081 | anion homeostasis | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1905 | | GO:0030307 | positive regulation of cell growth | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1906 | | GO:0048821 | erythrocyte development | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1907 | | GO:0001556 | oocyte maturation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1908 | | GO:0050853 | B cell receptor signaling pathway | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1909 | | GO:0043094 | metabolic compound salvage | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1910 | | GO:0007603 | phototransduction\, visible light | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1911 | | GO:0060041 | retina development in camera\-type eye | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1912 | | GO:0050856 | regulation of T cell receptor signaling pathway | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1913 | | GO:0048557 | embryonic digestive tract morphogenesis | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1914 | | GO:0001881 | receptor recycling | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1915 | | GO:0033205 | cytokinesis during cell cycle | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1916 | | GO:0031295 | T cell costimulation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1917 | | GO:0031294 | lymphocyte costimulation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1918 | | GO:0030212 | hyaluronan metabolic process | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1919 | | GO:0015884 | folic acid transport | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1920 | | GO:0005984 | disaccharide metabolic process | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1921 | | GO:0046339 | diacylglycerol metabolic process | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
1922 | | GO:0015698 | inorganic anion transport | 15 | 1011 | 215 | 25039 | 5.64e-02 | 0.01 | 0.01 | 1.7 |
1923 | | GO:0030705 | cytoskeleton\-dependent intracellular transport | 11 | 1015 | 146 | 25108 | 5.83e-02 | 0.01 | 0.01 | 1.9 |
1924 | | GO:0007271 | synaptic transmission\, cholinergic | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
1925 | | GO:0007202 | activation of phospholipase C activity | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
1926 | | GO:0009166 | nucleotide catabolic process | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
1927 | | GO:0030199 | collagen fibril organization | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
1928 | | GO:0042417 | dopamine metabolic process | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
1929 | | GO:0045089 | positive regulation of innate immune response | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
1930 | | GO:0055067 | monovalent inorganic cation homeostasis | 5 | 1021 | 49 | 25205 | 5.90e-02 | 0.00 | 0.00 | 2.5 |
1931 | | GO:0051276 | chromosome organization and biogenesis | 31 | 995 | 529 | 24725 | 5.94e-02 | 0.03 | 0.02 | 1.4 |
1932 | | GO:0043161 | proteasomal ubiquitin\-dependent protein catabolic process | 4 | 1022 | 34 | 25220 | 5.97e-02 | 0.00 | 0.00 | 2.9 |
1933 | | GO:0010498 | proteasomal protein catabolic process | 4 | 1022 | 34 | 25220 | 5.97e-02 | 0.00 | 0.00 | 2.9 |
1934 | | GO:0008584 | male gonad development | 4 | 1022 | 34 | 25220 | 5.97e-02 | 0.00 | 0.00 | 2.9 |
1935 | | GO:0022904 | respiratory electron transport chain | 5 | 1021 | 50 | 25204 | 6.29e-02 | 0.00 | 0.00 | 2.5 |
1936 | | GO:0022900 | electron transport chain | 5 | 1021 | 50 | 25204 | 6.29e-02 | 0.00 | 0.00 | 2.5 |
1937 | | GO:0055114 | oxidation reduction | 5 | 1021 | 50 | 25204 | 6.29e-02 | 0.00 | 0.00 | 2.5 |
1938 | | GO:0043543 | protein amino acid acylation | 4 | 1022 | 35 | 25219 | 6.46e-02 | 0.00 | 0.00 | 2.8 |
1939 | | GO:0042398 | amino acid derivative biosynthetic process | 4 | 1022 | 35 | 25219 | 6.46e-02 | 0.00 | 0.00 | 2.8 |
1940 | | GO:0048168 | regulation of neuronal synaptic plasticity | 3 | 1023 | 21 | 25233 | 6.53e-02 | 0.00 | 0.00 | 3.5 |
1941 | | GO:0043279 | response to alkaloid | 3 | 1023 | 21 | 25233 | 6.53e-02 | 0.00 | 0.00 | 3.5 |
1942 | | GO:0030004 | cellular monovalent inorganic cation homeostasis | 3 | 1023 | 21 | 25233 | 6.53e-02 | 0.00 | 0.00 | 3.5 |
1943 | | GO:0030330 | DNA damage response\, signal transduction by p53 class mediator | 3 | 1023 | 21 | 25233 | 6.53e-02 | 0.00 | 0.00 | 3.5 |
1944 | | GO:0044247 | cellular polysaccharide catabolic process | 3 | 1023 | 21 | 25233 | 6.53e-02 | 0.00 | 0.00 | 3.5 |
1945 | | GO:0000272 | polysaccharide catabolic process | 3 | 1023 | 21 | 25233 | 6.53e-02 | 0.00 | 0.00 | 3.5 |
1946 | | GO:0044403 | symbiosis\, encompassing mutualism through parasitism | 6 | 1020 | 67 | 25187 | 6.54e-02 | 0.01 | 0.00 | 2.2 |
1947 | | GO:0044419 | interspecies interaction between organisms | 6 | 1020 | 67 | 25187 | 6.54e-02 | 0.01 | 0.00 | 2.2 |
1948 | | GO:0000075 | cell cycle checkpoint | 6 | 1020 | 67 | 25187 | 6.54e-02 | 0.01 | 0.00 | 2.2 |
1949 | | GO:0042177 | negative regulation of protein catabolic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1950 | | GO:0045932 | negative regulation of muscle contraction | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1951 | | GO:0048708 | astrocyte differentiation | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1952 | | GO:0043271 | negative regulation of ion transport | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1953 | | GO:0045980 | negative regulation of nucleotide metabolic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1954 | | GO:0045862 | positive regulation of proteolysis | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1955 | | GO:0045598 | regulation of fat cell differentiation | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1956 | | GO:0051453 | regulation of intracellular pH | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1957 | | GO:0010332 | response to gamma radiation | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1958 | | GO:0006744 | ubiquinone biosynthetic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1959 | | GO:0045426 | quinone cofactor biosynthetic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1960 | | GO:0006743 | ubiquinone metabolic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1961 | | GO:0045576 | mast cell activation | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1962 | | GO:0046513 | ceramide biosynthetic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1963 | | GO:0045793 | positive regulation of cell size | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1964 | | GO:0001573 | ganglioside metabolic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1965 | | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1966 | | GO:0001975 | response to amphetamine | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1967 | | GO:0014075 | response to amine stimulus | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1968 | | GO:0045745 | positive regulation of G\-protein coupled receptor protein signaling pathway | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1969 | | GO:0045661 | regulation of myoblast differentiation | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1970 | | GO:0051457 | maintenance of protein localization in nucleus | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1971 | | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1972 | | GO:0019794 | nonprotein amino acid metabolic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1973 | | GO:0018205 | peptidyl\-lysine modification | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1974 | | GO:0018202 | peptidyl\-histidine modification | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1975 | | GO:0045161 | neuronal ion channel clustering | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1976 | | GO:0032409 | regulation of transporter activity | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1977 | | GO:0032412 | regulation of ion transmembrane transporter activity | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1978 | | GO:0022898 | regulation of transmembrane transporter activity | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1979 | | GO:0021675 | nerve development | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1980 | | GO:0045685 | regulation of glial cell differentiation | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1981 | | GO:0014013 | regulation of gliogenesis | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1982 | | GO:0051340 | regulation of ligase activity | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1983 | | GO:0006312 | mitotic recombination | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1984 | | GO:0006568 | tryptophan metabolic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
1985 | | GO:0006325 | establishment and/or maintenance of chromatin architecture | 26 | 1000 | 438 | 24816 | 6.81e-02 | 0.03 | 0.02 | 1.5 |
1986 | | GO:0048839 | inner ear development | 6 | 1020 | 68 | 25186 | 6.89e-02 | 0.01 | 0.00 | 2.2 |
1987 | | GO:0006836 | neurotransmitter transport | 6 | 1020 | 68 | 25186 | 6.89e-02 | 0.01 | 0.00 | 2.2 |
1988 | | GO:0006471 | protein amino acid ADP\-ribosylation | 4 | 1022 | 36 | 25218 | 6.96e-02 | 0.00 | 0.00 | 2.7 |
1989 | | GO:0006265 | DNA topological change | 4 | 1022 | 36 | 25218 | 6.96e-02 | 0.00 | 0.00 | 2.7 |
1990 | | GO:0007566 | embryo implantation | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
1991 | | GO:0018209 | peptidyl\-serine modification | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
1992 | | GO:0022407 | regulation of cell\-cell adhesion | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
1993 | | GO:0051607 | defense response to virus | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
1994 | | GO:0006687 | glycosphingolipid metabolic process | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
1995 | | GO:0007628 | adult walking behavior | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
1996 | | GO:0009084 | glutamine family amino acid biosynthetic process | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
1997 | | GO:0032609 | interferon\-gamma production | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
1998 | | GO:0016068 | type I hypersensitivity | 5 | 1021 | 53 | 25201 | 7.55e-02 | 0.00 | 0.00 | 2.3 |
1999 | | GO:0032287 | myelin maintenance in the peripheral nervous system | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2000 | | GO:0043217 | myelin maintenance | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2001 | | GO:0033081 | regulation of T cell differentiation in the thymus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2002 | | GO:0051659 | maintenance of mitochondrion localization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2003 | | GO:0043012 | regulation of fusion of sperm to egg plasma membrane | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2004 | | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2005 | | GO:0001999 | renal response to blood flow during renin\-angiotensin regulation of systemic arterial blood pressure | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2006 | | GO:0002018 | renin\-angiotensin regulation of aldosterone production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2007 | | GO:0002019 | regulation of renal output by angiotensin | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2008 | | GO:0046622 | positive regulation of organ growth | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2009 | | GO:0048143 | astrocyte activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2010 | | GO:0045994 | positive regulation of translational initiation by iron | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2011 | | GO:0002439 | chronic inflammatory response to antigenic stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2012 | | GO:0032722 | positive regulation of chemokine production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2013 | | GO:0045083 | negative regulation of interleukin\-12 biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2014 | | GO:0001315 | age\-dependent response to reactive oxygen species | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2015 | | GO:0043117 | positive regulation of vascular permeability | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2016 | | GO:0009817 | defense response to fungus\, incompatible interaction | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2017 | | GO:0009814 | defense response\, incompatible interaction | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2018 | | GO:0050765 | negative regulation of phagocytosis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2019 | | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2020 | | GO:0051771 | negative regulation of nitric\-oxide synthase biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2021 | | GO:0051769 | regulation of nitric\-oxide synthase biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2022 | | GO:0051767 | nitric\-oxide synthase biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2023 | | GO:0042313 | protein kinase C deactivation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2024 | | GO:0007258 | JUN phosphorylation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2025 | | GO:0006746 | FADH2 metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2026 | | GO:0010544 | negative regulation of platelet activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2027 | | GO:0010543 | regulation of platelet activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2028 | | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2029 | | GO:0009441 | glycolate metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2030 | | GO:0032000 | positive regulation of fatty acid beta\-oxidation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2031 | | GO:0019371 | cyclooxygenase pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2032 | | GO:0051097 | negative regulation of helicase activity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2033 | | GO:0051095 | regulation of helicase activity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2034 | | GO:0018144 | RNA\-protein covalent cross\-linking | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2035 | | GO:0018143 | nucleic acid\-protein covalent cross\-linking | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2036 | | GO:0006010 | glucose 6\-phosphate utilization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2037 | | GO:0015682 | ferric iron transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2038 | | GO:0031643 | positive regulation of myelination | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2039 | | GO:0006060 | sorbitol metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2040 | | GO:0043305 | negative regulation of mast cell degranulation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2041 | | GO:0033004 | negative regulation of mast cell activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2042 | | GO:0043301 | negative regulation of leukocyte degranulation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2043 | | GO:0045920 | negative regulation of exocytosis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2044 | | GO:0043071 | positive regulation of non\-apoptotic programmed cell death | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2045 | | GO:0018894 | dibenzo\-p\-dioxin metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2046 | | GO:0018904 | organic ether metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2047 | | GO:0030886 | negative regulation of myeloid dendritic cell activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2048 | | GO:0032695 | negative regulation of interleukin\-12 production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2049 | | GO:0045355 | negative regulation of interferon\-alpha biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2050 | | GO:0051594 | detection of glucose | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2051 | | GO:0009732 | detection of hexose stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2052 | | GO:0034287 | detection of monosaccharide stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2053 | | GO:0009730 | detection of carbohydrate stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2054 | | GO:0010269 | response to selenium ion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2055 | | GO:0046318 | negative regulation of glucosylceramide biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2056 | | GO:0046317 | regulation of glucosylceramide biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2057 | | GO:0015866 | ADP transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2058 | | GO:0051024 | positive regulation of immunoglobulin secretion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2059 | | GO:0006642 | triacylglycerol mobilization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2060 | | GO:0002523 | leukocyte migration during inflammatory response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2061 | | GO:0050713 | negative regulation of interleukin\-1 beta secretion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2062 | | GO:0045056 | transcytosis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2063 | | GO:0046628 | positive regulation of insulin receptor signaling pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2064 | | GO:0051385 | response to mineralocorticoid stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2065 | | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2066 | | GO:0000747 | conjugation with cellular fusion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2067 | | GO:0000746 | conjugation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2068 | | GO:0006507 | GPI anchor release | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2069 | | GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2070 | | GO:0045916 | negative regulation of complement activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2071 | | GO:0002921 | negative regulation of humoral immune response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2072 | | GO:0030449 | regulation of complement activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2073 | | GO:0002920 | regulation of humoral immune response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2074 | | GO:0021506 | anterior neuropore closure | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2075 | | GO:0021995 | neuropore closure | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2076 | | GO:0001941 | postsynaptic membrane organization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2077 | | GO:0051584 | regulation of dopamine uptake | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2078 | | GO:0051940 | regulation of catecholamine uptake during transmission of nerve impulse | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2079 | | GO:0051580 | regulation of neurotransmitter uptake | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2080 | | GO:0051588 | regulation of neurotransmitter transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2081 | | GO:0018352 | protein\-pyridoxal\-5\-phosphate linkage | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2082 | | GO:0042840 | D\-glucuronate catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2083 | | GO:0006064 | glucuronate catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2084 | | GO:0042839 | D\-glucuronate metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2085 | | GO:0046185 | aldehyde catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2086 | | GO:0030578 | PML body organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2087 | | GO:0030575 | nuclear body organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2088 | | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2089 | | GO:0010149 | senescence | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2090 | | GO:0001915 | negative regulation of T cell mediated cytotoxicity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2091 | | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2092 | | GO:0031342 | negative regulation of cell killing | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2093 | | GO:0010106 | cellular response to iron ion starvation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2094 | | GO:0010046 | response to mycotoxin | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2095 | | GO:0006178 | guanine salvage | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2096 | | GO:0046098 | guanine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2097 | | GO:0045964 | positive regulation of dopamine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2098 | | GO:0045915 | positive regulation of catecholamine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2099 | | GO:0033240 | positive regulation of amine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2100 | | GO:0046100 | hypoxanthine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2101 | | GO:0045189 | connective tissue growth factor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2102 | | GO:0032601 | connective tissue growth factor production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2103 | | GO:0006741 | NADP biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2104 | | GO:0006571 | tyrosine biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2105 | | GO:0009095 | aromatic amino acid family biosynthetic process\, prephenate pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2106 | | GO:0018126 | protein amino acid hydroxylation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2107 | | GO:0000115 | S\-phase\-specific transcription in mitotic cell cycle | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2108 | | GO:0006657 | CDP\-choline pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2109 | | GO:0006894 | Golgi to secretory vesicle transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2110 | | GO:0006543 | glutamine catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2111 | | GO:0046549 | retinal cone cell development | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2112 | | GO:0042670 | retinal cone cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2113 | | GO:0060219 | camera\-type eye photoreceptor cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2114 | | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2115 | | GO:0032836 | glomerular basement membrane development | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2116 | | GO:0006264 | mitochondrial DNA replication | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2117 | | GO:0032042 | mitochondrial DNA metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2118 | | GO:0051066 | dihydrobiopterin metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2119 | | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2120 | | GO:0042519 | regulation of tyrosine phosphorylation of Stat4 protein | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2121 | | GO:0042504 | tyrosine phosphorylation of Stat4 protein | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2122 | | GO:0001916 | positive regulation of T cell mediated cytotoxicity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2123 | | GO:0032223 | negative regulation of synaptic transmission\, cholinergic | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2124 | | GO:0045212 | neurotransmitter receptor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2125 | | GO:0043697 | cell dedifferentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2126 | | GO:0043696 | dedifferentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2127 | | GO:0048484 | enteric nervous system development | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2128 | | GO:0046327 | glycerol biosynthetic process from pyruvate | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2129 | | GO:0006114 | glycerol biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2130 | | GO:0006113 | fermentation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2131 | | GO:0043366 | beta selection | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2132 | | GO:0045588 | positive regulation of gamma\-delta T cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2133 | | GO:0046645 | positive regulation of gamma\-delta T cell activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2134 | | GO:0045586 | regulation of gamma\-delta T cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2135 | | GO:0046643 | regulation of gamma\-delta T cell activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2136 | | GO:0006585 | dopamine biosynthetic process from tyrosine | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2137 | | GO:0043400 | cortisol secretion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2138 | | GO:0019310 | inositol catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2139 | | GO:0014067 | negative regulation of phosphoinositide 3\-kinase cascade | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2140 | | GO:0033364 | mast cell secretory granule organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2141 | | GO:0033371 | T cell secretory granule organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2142 | | GO:0033373 | maintenance of protease localization in mast cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2143 | | GO:0033370 | maintenance of protein localization in mast cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2144 | | GO:0033367 | protein localization in mast cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2145 | | GO:0033368 | protease localization in mast cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2146 | | GO:0033366 | protein localization in secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2147 | | GO:0033382 | maintenance of granzyme B localization in T cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2148 | | GO:0033379 | maintenance of protease localization in T cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2149 | | GO:0033377 | maintenance of protein localization in T cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2150 | | GO:0033374 | protein localization in T cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2151 | | GO:0033380 | granzyme B localization in T cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2152 | | GO:0033375 | protease localization in T cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2153 | | GO:0042489 | negative regulation of odontogenesis of dentine\-containing teeth | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2154 | | GO:0042483 | negative regulation of odontogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2155 | | GO:0030913 | paranodal junction assembly | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2156 | | GO:0032288 | myelin formation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2157 | | GO:0043568 | positive regulation of insulin\-like growth factor receptor signaling pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2158 | | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2159 | | GO:0060155 | platelet dense granule organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2160 | | GO:0045906 | negative regulation of vasoconstriction | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2161 | | GO:0002227 | innate immune response in mucosa | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2162 | | GO:0002385 | mucosal immune response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2163 | | GO:0002251 | organ or tissue specific immune response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2164 | | GO:0042160 | lipoprotein modification | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2165 | | GO:0065005 | protein\-lipid complex assembly | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2166 | | GO:0050666 | regulation of homocysteine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2167 | | GO:0031335 | regulation of sulfur amino acid metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2168 | | GO:0006521 | regulation of amino acid metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2169 | | GO:0042762 | regulation of sulfur metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2170 | | GO:0009854 | oxidative photosynthetic carbon pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2171 | | GO:0009853 | photorespiration | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2172 | | GO:0045794 | negative regulation of cell volume | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2173 | | GO:0060082 | eye blink reflex | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2174 | | GO:0008627 | induction of apoptosis by ionic changes | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2175 | | GO:0007228 | positive regulation of hh target transcription factor activity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2176 | | GO:0007227 | signal transduction downstream of smoothened | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2177 | | GO:0032435 | negative regulation of proteasomal ubiquitin\-dependent protein catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2178 | | GO:0060020 | Bergmann glial cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2179 | | GO:0060019 | radial glial cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2180 | | GO:0019682 | glyceraldehyde\-3\-phosphate metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2181 | | GO:0043308 | eosinophil degranulation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2182 | | GO:0043307 | eosinophil activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2183 | | GO:0002447 | eosinophil mediated immunity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2184 | | GO:0006554 | lysine catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2185 | | GO:0006553 | lysine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2186 | | GO:0002358 | B cell homeostatic proliferation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2187 | | GO:0032976 | release of matrix enzymes from mitochondria | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2188 | | GO:0046674 | induction of retinal programmed cell death | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2189 | | GO:0046670 | positive regulation of retinal cell programmed cell death | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2190 | | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2191 | | GO:0046314 | phosphocreatine biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2192 | | GO:0006603 | phosphocreatine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2193 | | GO:0005997 | xylulose metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2194 | | GO:0030422 | RNA interference\, production of siRNA | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2195 | | GO:0030423 | RNA interference\, targeting of mRNA for destruction | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2196 | | GO:0002539 | prostaglandin production during acute inflammatory response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2197 | | GO:0002538 | production of arachidonic acid metabolites during acute inflammatory response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2198 | | GO:0002532 | production of molecular mediator of acute inflammatory response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2199 | | GO:0043651 | linoleic acid metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2200 | | GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2201 | | GO:0032075 | positive regulation of nuclease activity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2202 | | GO:0032069 | regulation of nuclease activity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2203 | | GO:0000023 | maltose metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2204 | | GO:0005985 | sucrose metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2205 | | GO:0043181 | vacuolar sequestering | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2206 | | GO:0042262 | DNA protection | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2207 | | GO:0001661 | conditioned taste aversion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2208 | | GO:0042026 | protein refolding | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2209 | | GO:0042685 | cardioblast cell fate specification | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2210 | | GO:0042684 | cardioblast cell fate commitment | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2211 | | GO:0046340 | diacylglycerol catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2212 | | GO:0051569 | regulation of histone H3\-K4 methylation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2213 | | GO:0031060 | regulation of histone methylation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2214 | | GO:0051568 | histone H3\-K4 methylation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2215 | | GO:0051106 | positive regulation of DNA ligation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2216 | | GO:0051105 | regulation of DNA ligation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2217 | | GO:0006994 | positive regulation of sterol regulatory element binding protein target gene transcription involved in sterol depletion response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2218 | | GO:0045716 | positive regulation of low\-density lipoprotein receptor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2219 | | GO:0045714 | regulation of low\-density lipoprotein receptor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2220 | | GO:0045713 | low\-density lipoprotein receptor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2221 | | GO:0006843 | mitochondrial citrate transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2222 | | GO:0006089 | lactate metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2223 | | GO:0032682 | negative regulation of chemokine production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2224 | | GO:0035166 | post\-embryonic hemopoiesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2225 | | GO:0007403 | glial cell fate determination | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2226 | | GO:0021781 | glial cell fate commitment | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
2227 | | GO:0007342 | fusion of sperm to egg plasma membrane | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2228 | | GO:0045822 | negative regulation of heart contraction | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2229 | | GO:0042640 | anagen | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2230 | | GO:0046638 | positive regulation of alpha\-beta T cell differentiation | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2231 | | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2232 | | GO:0019048 | virus\-host interaction | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2233 | | GO:0040011 | locomotion | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2234 | | GO:0042375 | quinone cofactor metabolic process | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2235 | | GO:0002718 | regulation of cytokine production during immune response | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2236 | | GO:0045768 | positive regulation of anti\-apoptosis | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2237 | | GO:0043154 | negative regulation of caspase activity | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2238 | | GO:0010466 | negative regulation of peptidase activity | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2239 | | GO:0046520 | sphingoid biosynthetic process | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2240 | | GO:0051205 | protein insertion into membrane | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2241 | | GO:0048340 | paraxial mesoderm morphogenesis | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2242 | | GO:0007028 | cytoplasm organization and biogenesis | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2243 | | GO:0001963 | synaptic transmission\, dopaminergic | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2244 | | GO:0006266 | DNA ligation | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2245 | | GO:0051148 | negative regulation of muscle cell differentiation | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2246 | | GO:0042116 | macrophage activation | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2247 | | GO:0046128 | purine ribonucleoside metabolic process | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2248 | | GO:0042278 | purine nucleoside metabolic process | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2249 | | GO:0009268 | response to pH | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
2250 | | GO:0030516 | regulation of axon extension | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
2251 | | GO:0016050 | vesicle organization and biogenesis | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
2252 | | GO:0045088 | regulation of innate immune response | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
2253 | | GO:0007131 | meiotic recombination | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
2254 | | GO:0030178 | negative regulation of Wnt receptor signaling pathway | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
2255 | | GO:0005978 | glycogen biosynthetic process | 4 | 1022 | 38 | 25216 | 8.03e-02 | 0.00 | 0.00 | 2.6 |
2256 | | GO:0009250 | glucan biosynthetic process | 4 | 1022 | 38 | 25216 | 8.03e-02 | 0.00 | 0.00 | 2.6 |
2257 | | GO:0051656 | establishment of organelle localization | 4 | 1022 | 39 | 25215 | 8.60e-02 | 0.00 | 0.00 | 2.5 |
2258 | | GO:0009112 | nucleobase metabolic process | 3 | 1023 | 24 | 25230 | 8.67e-02 | 0.00 | 0.00 | 3.1 |
2259 | | GO:0045807 | positive regulation of endocytosis | 3 | 1023 | 24 | 25230 | 8.67e-02 | 0.00 | 0.00 | 3.1 |
2260 | | GO:0033692 | cellular polysaccharide biosynthetic process | 5 | 1021 | 56 | 25198 | 8.93e-02 | 0.00 | 0.00 | 2.2 |
2261 | | GO:0000271 | polysaccharide biosynthetic process | 5 | 1021 | 56 | 25198 | 8.93e-02 | 0.00 | 0.00 | 2.2 |
2262 | | GO:0002524 | hypersensitivity | 5 | 1021 | 56 | 25198 | 8.93e-02 | 0.00 | 0.00 | 2.2 |
2263 | | GO:0002438 | acute inflammatory response to antigenic stimulus | 5 | 1021 | 56 | 25198 | 8.93e-02 | 0.00 | 0.00 | 2.2 |
2264 | | GO:0050869 | negative regulation of B cell activation | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2265 | | GO:0051291 | protein heterooligomerization | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2266 | | GO:0030299 | cholesterol absorption | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2267 | | GO:0031069 | hair follicle morphogenesis | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2268 | | GO:0002700 | regulation of production of molecular mediator of immune response | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2269 | | GO:0003085 | negative regulation of systemic arterial blood pressure | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2270 | | GO:0032594 | protein transport within lipid bilayer | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2271 | | GO:0006656 | phosphatidylcholine biosynthetic process | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2272 | | GO:0030520 | estrogen receptor signaling pathway | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2273 | | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2274 | | GO:0045778 | positive regulation of ossification | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2275 | | GO:0008045 | motor axon guidance | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2276 | | GO:0009086 | methionine biosynthetic process | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2277 | | GO:0006857 | oligopeptide transport | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2278 | | GO:0050766 | positive regulation of phagocytosis | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2279 | | GO:0006586 | indolalkylamine metabolic process | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2280 | | GO:0042434 | indole derivative metabolic process | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2281 | | GO:0042430 | indole and derivative metabolic process | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
2282 | | GO:0006865 | amino acid transport | 7 | 1019 | 83 | 25171 | 8.98e-02 | 0.01 | 0.00 | 2.1 |
2283 | | GO:0051701 | interaction with host | 3 | 1023 | 25 | 25229 | 9.44e-02 | 0.00 | 0.00 | 3.0 |
2284 | | GO:0008206 | bile acid metabolic process | 3 | 1023 | 25 | 25229 | 9.44e-02 | 0.00 | 0.00 | 3.0 |
2285 | | GO:0051320 | S phase | 3 | 1023 | 25 | 25229 | 9.44e-02 | 0.00 | 0.00 | 3.0 |
2286 | | GO:0006023 | aminoglycan biosynthetic process | 3 | 1023 | 25 | 25229 | 9.44e-02 | 0.00 | 0.00 | 3.0 |
2287 | | GO:0016055 | Wnt receptor signaling pathway | 10 | 1016 | 144 | 25110 | 9.56e-02 | 0.01 | 0.01 | 1.7 |
2288 | | GO:0006417 | regulation of translation | 9 | 1017 | 119 | 25135 | 1.01e-01 | 0.01 | 0.00 | 1.9 |
2289 | | GO:0048820 | hair follicle maturation | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2290 | | GO:0046635 | positive regulation of alpha\-beta T cell activation | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2291 | | GO:0006707 | cholesterol catabolic process | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2292 | | GO:0016127 | sterol catabolic process | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2293 | | GO:0050706 | regulation of interleukin\-1 beta secretion | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2294 | | GO:0007617 | mating behavior | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2295 | | GO:0060191 | regulation of lipase activity | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2296 | | GO:0048339 | paraxial mesoderm development | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2297 | | GO:0009070 | serine family amino acid biosynthetic process | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2298 | | GO:0030539 | male genitalia development | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2299 | | GO:0006378 | mRNA polyadenylation | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2300 | | GO:0043113 | receptor clustering | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2301 | | GO:0042267 | natural killer cell mediated cytotoxicity | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2302 | | GO:0002228 | natural killer cell mediated immunity | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2303 | | GO:0035249 | synaptic transmission\, glutamatergic | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2304 | | GO:0035116 | embryonic hindlimb morphogenesis | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2305 | | GO:0009954 | proximal/distal pattern formation | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
2306 | | GO:0030166 | proteoglycan biosynthetic process | 3 | 1023 | 26 | 25228 | 1.02e-01 | 0.00 | 0.00 | 2.8 |
2307 | | GO:0006752 | group transfer coenzyme metabolic process | 3 | 1023 | 26 | 25228 | 1.02e-01 | 0.00 | 0.00 | 2.8 |
2308 | | GO:0000723 | telomere maintenance | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
2309 | | GO:0032200 | telomere organization and biogenesis | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
2310 | | GO:0051017 | actin filament bundle formation | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
2311 | | GO:0007190 | activation of adenylate cyclase activity | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
2312 | | GO:0022011 | myelination in the peripheral nervous system | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2313 | | GO:0032292 | ensheathment of axons in the peripheral nervous system | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2314 | | GO:0043072 | negative regulation of non\-apoptotic programmed cell death | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2315 | | GO:0051657 | maintenance of organelle localization | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2316 | | GO:0010155 | regulation of proton transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2317 | | GO:0001543 | ovarian follicle rupture | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2318 | | GO:0042756 | drinking behavior | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2319 | | GO:0006447 | regulation of translational initiation by iron | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2320 | | GO:0002544 | chronic inflammatory response | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2321 | | GO:0019858 | cytosine metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2322 | | GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2323 | | GO:0048296 | regulation of isotype switching to IgA isotypes | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2324 | | GO:0048290 | isotype switching to IgA isotypes | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2325 | | GO:0035307 | positive regulation of protein amino acid dephosphorylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2326 | | GO:0035306 | positive regulation of dephosphorylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2327 | | GO:0035304 | regulation of protein amino acid dephosphorylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2328 | | GO:0051290 | protein heterotetramerization | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2329 | | GO:0035026 | leading edge cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2330 | | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2331 | | GO:0033143 | regulation of steroid hormone receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2332 | | GO:0050872 | white fat cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2333 | | GO:0006925 | inflammatory cell apoptosis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2334 | | GO:0032735 | positive regulation of interleukin\-12 production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2335 | | GO:0032848 | negative regulation of cellular pH reduction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2336 | | GO:0032847 | regulation of cellular pH reduction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2337 | | GO:0035025 | positive regulation of Rho protein signal transduction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2338 | | GO:0048261 | negative regulation of receptor\-mediated endocytosis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2339 | | GO:0006059 | hexitol metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2340 | | GO:0019400 | alditol metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2341 | | GO:0032764 | negative regulation of mast cell cytokine production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2342 | | GO:0019372 | lipoxygenase pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2343 | | GO:0045192 | low\-density lipoprotein catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2344 | | GO:0030885 | regulation of myeloid dendritic cell activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2345 | | GO:0045347 | negative regulation of MHC class II biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2346 | | GO:0035066 | positive regulation of histone acetylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2347 | | GO:0009726 | detection of endogenous stimulus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2348 | | GO:0033599 | regulation of mammary gland epithelial cell proliferation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2349 | | GO:0033598 | mammary gland epithelial cell proliferation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2350 | | GO:0045542 | positive regulation of cholesterol biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2351 | | GO:0006679 | glucosylceramide biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2352 | | GO:0051503 | adenine nucleotide transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2353 | | GO:0015865 | purine nucleotide transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2354 | | GO:0015867 | ATP transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2355 | | GO:0046415 | urate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2356 | | GO:0043006 | calcium\-dependent phospholipase A2 activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2357 | | GO:0006107 | oxaloacetate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2358 | | GO:0032792 | inhibition of CREB transcription factor | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2359 | | GO:0055009 | atrial cardiac muscle morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2360 | | GO:0051583 | dopamine uptake | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2361 | | GO:0051934 | catecholamine uptake during transmission of nerve impulse | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2362 | | GO:0051937 | catecholamine transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2363 | | GO:0000183 | chromatin silencing at rDNA | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2364 | | GO:0006348 | chromatin silencing at telomere | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2365 | | GO:0031509 | telomeric heterochromatin formation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2366 | | GO:0019853 | L\-ascorbic acid biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2367 | | GO:0021904 | dorsoventral neural tube patterning | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2368 | | GO:0032331 | negative regulation of chondrocyte differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2369 | | GO:0001544 | initiation of primordial ovarian follicle growth | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2370 | | GO:0033088 | negative regulation of immature T cell proliferation in the thymus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2371 | | GO:0033087 | negative regulation of immature T cell proliferation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2372 | | GO:0001960 | negative regulation of cytokine and chemokine mediated signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2373 | | GO:0002378 | immunoglobulin biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2374 | | GO:0006168 | adenine salvage | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2375 | | GO:0046083 | adenine metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2376 | | GO:0043096 | purine base salvage | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2377 | | GO:0016046 | detection of fungus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2378 | | GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2379 | | GO:0042450 | arginine biosynthetic process via ornithine | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2380 | | GO:0000053 | argininosuccinate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2381 | | GO:0009073 | aromatic amino acid family biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2382 | | GO:0046417 | chorismate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2383 | | GO:0015961 | diadenosine polyphosphate catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2384 | | GO:0015958 | bis(5'\-nucleosidyl) oligophosphate catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2385 | | GO:0046130 | purine ribonucleoside catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2386 | | GO:0006152 | purine nucleoside catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2387 | | GO:0015956 | bis(5'\-nucleosidyl) oligophosphate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2388 | | GO:0015959 | diadenosine polyphosphate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2389 | | GO:0006663 | platelet activating factor biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2390 | | GO:0046469 | platelet activating factor metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2391 | | GO:0048102 | autophagic cell death | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2392 | | GO:0045821 | positive regulation of glycolysis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2393 | | GO:0060042 | retina morphogenesis in camera\-type eye | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2394 | | GO:0034097 | response to cytokine stimulus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2395 | | GO:0006097 | glyoxylate cycle | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2396 | | GO:0006880 | intracellular sequestering of iron ion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2397 | | GO:0007616 | long\-term memory | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2398 | | GO:0032835 | glomerulus development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2399 | | GO:0046827 | positive regulation of protein export from nucleus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2400 | | GO:0032816 | positive regulation of natural killer cell activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2401 | | GO:0032814 | regulation of natural killer cell activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2402 | | GO:0030538 | embryonic genitalia morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2403 | | GO:0035112 | genitalia morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2404 | | GO:0048619 | embryonic hindgut morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2405 | | GO:0001507 | acetylcholine catabolic process in synaptic cleft | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2406 | | GO:0006581 | acetylcholine catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2407 | | GO:0032222 | regulation of synaptic transmission\, cholinergic | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2408 | | GO:0032417 | positive regulation of sodium\:hydrogen antiporter activity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2409 | | GO:0032414 | positive regulation of ion transmembrane transporter activity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2410 | | GO:0032411 | positive regulation of transporter activity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2411 | | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2412 | | GO:0006475 | internal protein amino acid acetylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2413 | | GO:0045634 | regulation of melanocyte differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2414 | | GO:0050932 | regulation of pigment cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2415 | | GO:0042492 | gamma\-delta T cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2416 | | GO:0046629 | gamma\-delta T cell activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2417 | | GO:0051549 | positive regulation of keratinocyte migration | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2418 | | GO:0051547 | regulation of keratinocyte migration | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2419 | | GO:0040013 | negative regulation of locomotion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2420 | | GO:0051965 | positive regulation of synaptogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2421 | | GO:0051962 | positive regulation of nervous system development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2422 | | GO:0051960 | regulation of nervous system development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2423 | | GO:0050779 | RNA destabilization | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2424 | | GO:0022617 | extracellular matrix disassembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2425 | | GO:0031581 | hemidesmosome assembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2426 | | GO:0001867 | complement activation\, lectin pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2427 | | GO:0019102 | male somatic sex determination | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2428 | | GO:0050667 | homocysteine metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2429 | | GO:0055090 | acylglycerol homeostasis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2430 | | GO:0006931 | substrate\-bound cell migration\, cell attachment to substrate | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2431 | | GO:0032023 | trypsinogen activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2432 | | GO:0021631 | optic nerve morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2433 | | GO:0021602 | cranial nerve morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2434 | | GO:0021554 | optic nerve development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2435 | | GO:0002755 | MyD88\-dependent toll\-like receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2436 | | GO:0001878 | response to yeast | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2437 | | GO:0016539 | intein\-mediated protein splicing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2438 | | GO:0030908 | protein splicing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2439 | | GO:0045780 | positive regulation of bone resorption | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2440 | | GO:0043312 | neutrophil degranulation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2441 | | GO:0002446 | neutrophil mediated immunity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2442 | | GO:0009448 | gamma\-aminobutyric acid metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2443 | | GO:0009450 | gamma\-aminobutyric acid catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2444 | | GO:0046359 | butyrate catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2445 | | GO:0019626 | short\-chain fatty acid catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2446 | | GO:0006649 | phospholipid transfer to membrane | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2447 | | GO:0032914 | positive regulation of transforming growth factor\-beta1 production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2448 | | GO:0032908 | regulation of transforming growth factor\-beta1 production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2449 | | GO:0032905 | transforming growth factor\-beta1 production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2450 | | GO:0001844 | protein insertion into mitochondrial membrane during induction of apoptosis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2451 | | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2452 | | GO:0050758 | regulation of thymidylate synthase biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2453 | | GO:0050757 | thymidylate synthase biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2454 | | GO:0048711 | positive regulation of astrocyte differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2455 | | GO:0060046 | regulation of acrosome reaction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2456 | | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2457 | | GO:0060055 | angiogenesis involved in wound healing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2458 | | GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2459 | | GO:0060057 | apoptosis involved in mammary gland involution | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2460 | | GO:0002315 | marginal zone B cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2461 | | GO:0002313 | mature B cell differentiation during immune response | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2462 | | GO:0002312 | B cell activation during immune response | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2463 | | GO:0002335 | mature B cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2464 | | GO:0031333 | negative regulation of protein complex assembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2465 | | GO:0042732 | D\-xylose metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2466 | | GO:0001957 | intramembranous ossification | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2467 | | GO:0006463 | steroid hormone receptor complex assembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2468 | | GO:0046655 | folic acid metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2469 | | GO:0002086 | diaphragm contraction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2470 | | GO:0003011 | involuntary skeletal muscle contraction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2471 | | GO:0006601 | creatine biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2472 | | GO:0045019 | negative regulation of nitric oxide biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2473 | | GO:0010226 | response to lithium ion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2474 | | GO:0033159 | negative regulation of protein import into nucleus\, translocation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2475 | | GO:0033158 | regulation of protein import into nucleus\, translocation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2476 | | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2477 | | GO:0050862 | positive regulation of T cell receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2478 | | GO:0035104 | positive regulation of sterol regulatory element binding protein target gene transcription | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2479 | | GO:0030967 | ER\-nuclear sterol response pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2480 | | GO:0015888 | thiamin transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2481 | | GO:0006167 | AMP biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2482 | | GO:0007144 | female meiosis I | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2483 | | GO:0002636 | positive regulation of germinal center formation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2484 | | GO:0031296 | B cell costimulation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2485 | | GO:0006587 | serotonin biosynthetic process from tryptophan | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2486 | | GO:0042427 | serotonin biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2487 | | GO:0000729 | DNA double\-strand break processing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2488 | | GO:0045003 | double\-strand break repair via synthesis\-dependent strand annealing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2489 | | GO:0045002 | double\-strand break repair via single\-strand annealing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2490 | | GO:0043297 | apical junction assembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
2491 | | GO:0006206 | pyrimidine base metabolic process | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2492 | | GO:0006929 | substrate\-bound cell migration | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2493 | | GO:0010165 | response to X\-ray | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2494 | | GO:0045351 | type I interferon biosynthetic process | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2495 | | GO:0032606 | type I interferon production | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2496 | | GO:0007512 | adult heart development | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2497 | | GO:0009119 | ribonucleoside metabolic process | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2498 | | GO:0019363 | pyridine nucleotide biosynthetic process | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2499 | | GO:0043631 | RNA polyadenylation | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2500 | | GO:0043547 | positive regulation of GTPase activity | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2501 | | GO:0008589 | regulation of smoothened signaling pathway | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2502 | | GO:0007052 | mitotic spindle organization and biogenesis | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
2503 | | GO:0006885 | regulation of pH | 4 | 1022 | 44 | 25210 | 1.17e-01 | 0.00 | 0.00 | 2.2 |
2504 | | GO:0003007 | heart morphogenesis | 3 | 1023 | 28 | 25226 | 1.19e-01 | 0.00 | 0.00 | 2.6 |
2505 | | GO:0006479 | protein amino acid methylation | 3 | 1023 | 28 | 25226 | 1.19e-01 | 0.00 | 0.00 | 2.6 |
2506 | | GO:0008213 | protein amino acid alkylation | 3 | 1023 | 28 | 25226 | 1.19e-01 | 0.00 | 0.00 | 2.6 |
2507 | | GO:0007017 | microtubule\-based process | 16 | 1010 | 265 | 24989 | 1.21e-01 | 0.02 | 0.01 | 1.5 |
2508 | | GO:0007096 | regulation of exit from mitosis | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
2509 | | GO:0050704 | regulation of interleukin\-1 secretion | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
2510 | | GO:0008209 | androgen metabolic process | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
2511 | | GO:0021510 | spinal cord development | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
2512 | | GO:0042490 | mechanoreceptor differentiation | 3 | 1023 | 29 | 25225 | 1.28e-01 | 0.00 | 0.00 | 2.5 |
2513 | | GO:0048489 | synaptic vesicle transport | 3 | 1023 | 29 | 25225 | 1.28e-01 | 0.00 | 0.00 | 2.5 |
2514 | | GO:0006298 | mismatch repair | 3 | 1023 | 29 | 25225 | 1.28e-01 | 0.00 | 0.00 | 2.5 |
2515 | | GO:0006334 | nucleosome assembly | 3 | 1023 | 188 | 25066 | 1.29e-01 | 0.00 | 0.01 | 0.4 |
2516 | | GO:0051606 | detection of stimulus | 7 | 1019 | 98 | 25156 | 1.32e-01 | 0.01 | 0.00 | 1.8 |
2517 | | GO:0006720 | isoprenoid metabolic process | 3 | 1023 | 30 | 25224 | 1.37e-01 | 0.00 | 0.00 | 2.5 |
2518 | | GO:0045005 | maintenance of fidelity during DNA\-dependent DNA replication | 3 | 1023 | 30 | 25224 | 1.37e-01 | 0.00 | 0.00 | 2.5 |
2519 | | GO:0050770 | regulation of axonogenesis | 4 | 1022 | 47 | 25207 | 1.37e-01 | 0.00 | 0.00 | 2.1 |
2520 | | GO:0009895 | negative regulation of catabolic process | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2521 | | GO:0050806 | positive regulation of synaptic transmission | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2522 | | GO:0045582 | positive regulation of T cell differentiation | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2523 | | GO:0010458 | exit from mitosis | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2524 | | GO:0031016 | pancreas development | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2525 | | GO:0033044 | regulation of chromosome organization and biogenesis | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2526 | | GO:0015807 | L\-amino acid transport | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2527 | | GO:0051668 | localization within membrane | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2528 | | GO:0006721 | terpenoid metabolic process | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2529 | | GO:0009067 | aspartate family amino acid biosynthetic process | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2530 | | GO:0007212 | dopamine receptor signaling pathway | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2531 | | GO:0035137 | hindlimb morphogenesis | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2532 | | GO:0007492 | endoderm development | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2533 | | GO:0000209 | protein polyubiquitination | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
2534 | | GO:0042157 | lipoprotein metabolic process | 6 | 1020 | 78 | 25176 | 1.45e-01 | 0.01 | 0.00 | 1.9 |
2535 | | GO:0048675 | axon extension | 3 | 1023 | 31 | 25223 | 1.46e-01 | 0.00 | 0.00 | 2.4 |
2536 | | GO:0031110 | regulation of microtubule polymerization or depolymerization | 3 | 1023 | 31 | 25223 | 1.46e-01 | 0.00 | 0.00 | 2.4 |
2537 | | GO:0045908 | negative regulation of vasodilation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2538 | | GO:0007199 | G\-protein signaling\, coupled to cGMP nucleotide second messenger | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2539 | | GO:0008065 | establishment of blood\-nerve barrier | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2540 | | GO:0045630 | positive regulation of T\-helper 2 cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2541 | | GO:0045066 | regulatory T cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2542 | | GO:0046007 | negative regulation of activated T cell proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2543 | | GO:0031583 | G\-protein signaling\, phospholipase D activating pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2544 | | GO:0043179 | rhythmic excitation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2545 | | GO:0050996 | positive regulation of lipid catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2546 | | GO:0030300 | regulation of cholesterol absorption | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2547 | | GO:0032099 | negative regulation of appetite | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2548 | | GO:0032096 | negative regulation of response to food | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2549 | | GO:0032108 | negative regulation of response to nutrient levels | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2550 | | GO:0032105 | negative regulation of response to extracellular stimulus | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2551 | | GO:0051902 | negative regulation of mitochondrial depolarization | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2552 | | GO:0042149 | cellular response to glucose starvation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2553 | | GO:0045817 | positive regulation of transcription from RNA polymerase II promoter\, global | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2554 | | GO:0002719 | negative regulation of cytokine production during immune response | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2555 | | GO:0002701 | negative regulation of production of molecular mediator of immune response | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2556 | | GO:0031058 | positive regulation of histone modification | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2557 | | GO:0035065 | regulation of histone acetylation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2558 | | GO:0045725 | positive regulation of glycogen biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2559 | | GO:0046476 | glycosylceramide biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2560 | | GO:0006862 | nucleotide transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2561 | | GO:0051935 | glutamate uptake during transmission of nerve impulse | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2562 | | GO:0051933 | amino acid uptake during transmission of nerve impulse | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2563 | | GO:0051938 | L\-glutamate import | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2564 | | GO:0043090 | amino acid import | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2565 | | GO:0043092 | L\-amino acid import | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2566 | | GO:0009629 | response to gravity | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2567 | | GO:0032431 | activation of phospholipase A2 | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2568 | | GO:0032430 | positive regulation of phospholipase A2 activity | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2569 | | GO:0010518 | positive regulation of phospholipase activity | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2570 | | GO:0032436 | positive regulation of proteasomal ubiquitin\-dependent protein catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2571 | | GO:0050711 | negative regulation of interleukin\-1 secretion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2572 | | GO:0001101 | response to acid | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2573 | | GO:0006200 | ATP catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2574 | | GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2575 | | GO:0009203 | ribonucleoside triphosphate catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2576 | | GO:0017055 | negative regulation of transcriptional preinitiation complex assembly | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2577 | | GO:0042488 | positive regulation of odontogenesis of dentine\-containing teeth | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2578 | | GO:0042482 | positive regulation of odontogenesis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2579 | | GO:0019585 | glucuronate metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2580 | | GO:0006063 | uronic acid metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2581 | | GO:0033083 | regulation of immature T cell proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2582 | | GO:0033084 | regulation of immature T cell proliferation in the thymus | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2583 | | GO:0033080 | immature T cell proliferation in the thymus | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2584 | | GO:0033079 | immature T cell proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2585 | | GO:0001959 | regulation of cytokine and chemokine mediated signaling pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2586 | | GO:0021756 | striatum development | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2587 | | GO:0009228 | thiamin biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2588 | | GO:0042454 | ribonucleoside catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2589 | | GO:0042404 | thyroid hormone catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2590 | | GO:0045065 | cytotoxic T cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2591 | | GO:0009651 | response to salt stress | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2592 | | GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2593 | | GO:0002420 | natural killer cell mediated cytotoxicity directed against tumor cell target | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2594 | | GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2595 | | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2596 | | GO:0002839 | positive regulation of immune response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2597 | | GO:0002836 | positive regulation of response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2598 | | GO:0002833 | positive regulation of response to biotic stimulus | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2599 | | GO:0002855 | regulation of natural killer cell mediated immune response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2600 | | GO:0002837 | regulation of immune response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2601 | | GO:0002834 | regulation of response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2602 | | GO:0002423 | natural killer cell mediated immune response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2603 | | GO:0002418 | immune response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2604 | | GO:0042231 | interleukin\-13 biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2605 | | GO:0032616 | interleukin\-13 production | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2606 | | GO:0008291 | acetylcholine metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2607 | | GO:0032415 | regulation of sodium\:hydrogen antiporter activity | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2608 | | GO:0048549 | positive regulation of pinocytosis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2609 | | GO:0048548 | regulation of pinocytosis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2610 | | GO:0006335 | DNA replication\-dependent nucleosome assembly | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2611 | | GO:0006244 | pyrimidine nucleotide catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2612 | | GO:0006481 | C\-terminal protein amino acid methylation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2613 | | GO:0018410 | peptide or protein carboxyl\-terminal blocking | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2614 | | GO:0007412 | axon target recognition | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2615 | | GO:0046173 | polyol biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2616 | | GO:0046641 | positive regulation of alpha\-beta T cell proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2617 | | GO:0045401 | positive regulation of interleukin\-3 biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2618 | | GO:0045399 | regulation of interleukin\-3 biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2619 | | GO:0042223 | interleukin\-3 biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2620 | | GO:0032632 | interleukin\-3 production | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2621 | | GO:0001820 | serotonin secretion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2622 | | GO:0046676 | negative regulation of insulin secretion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2623 | | GO:0002792 | negative regulation of peptide secretion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2624 | | GO:0060079 | regulation of excitatory postsynaptic membrane potential | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2625 | | GO:0014066 | regulation of phosphoinositide 3\-kinase cascade | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2626 | | GO:0051967 | negative regulation of synaptic transmission\, glutamatergic | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2627 | | GO:0007208 | serotonin receptor\, phospholipase C activating pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2628 | | GO:0016925 | protein sumoylation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2629 | | GO:0045879 | negative regulation of smoothened signaling pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2630 | | GO:0006426 | glycyl\-tRNA aminoacylation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2631 | | GO:0033365 | protein localization in organelle | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2632 | | GO:0002507 | tolerance induction | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2633 | | GO:0043558 | regulation of translational initiation in response to stress | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2634 | | GO:0043555 | regulation of translation in response to stress | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2635 | | GO:0000022 | mitotic spindle elongation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2636 | | GO:0051231 | spindle elongation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2637 | | GO:0018993 | somatic sex determination | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2638 | | GO:0044240 | multicellular organismal lipid catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2639 | | GO:0042159 | lipoprotein catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2640 | | GO:0032344 | regulation of aldosterone metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2641 | | GO:0032341 | aldosterone metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2642 | | GO:0008212 | mineralocorticoid metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2643 | | GO:0045475 | locomotor rhythm | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2644 | | GO:0060083 | smooth muscle contraction involved in micturition | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2645 | | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2646 | | GO:0021910 | smoothened signaling pathway in ventral spinal cord patterning | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2647 | | GO:0021521 | ventral spinal cord interneuron specification | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2648 | | GO:0021514 | ventral spinal cord interneuron differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2649 | | GO:0021776 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2650 | | GO:0021520 | spinal cord motor neuron cell fate specification | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2651 | | GO:0002238 | response to molecule of fungal origin | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2652 | | GO:0000915 | cytokinesis\, contractile ring formation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2653 | | GO:0000912 | formation of actomyosin apparatus involved in cytokinesis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2654 | | GO:0007108 | cytokinesis\, initiation of separation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2655 | | GO:0019605 | butyrate metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2656 | | GO:0051204 | protein insertion into mitochondrial membrane | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2657 | | GO:0006922 | cleavage of lamin | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2658 | | GO:0006923 | cleavage of cytoskeletal proteins during apoptosis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2659 | | GO:0048710 | regulation of astrocyte differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2660 | | GO:0032582 | negative regulation of gene\-specific transcription | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2661 | | GO:0060056 | mammary gland involution | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2662 | | GO:0016246 | RNA interference | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2663 | | GO:0031050 | dsRNA fragmentation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2664 | | GO:0035196 | gene silencing by miRNA\, production of miRNAs | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2665 | | GO:0035195 | gene silencing by miRNA | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2666 | | GO:0015014 | heparan sulfate proteoglycan biosynthetic process\, polysaccharide chain biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2667 | | GO:0007529 | establishment of synaptic specificity at neuromuscular junction | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2668 | | GO:0051928 | positive regulation of calcium ion transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2669 | | GO:0043270 | positive regulation of ion transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2670 | | GO:0006123 | mitochondrial electron transport\, cytochrome c to oxygen | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2671 | | GO:0006784 | heme a biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2672 | | GO:0046160 | heme a metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2673 | | GO:0006600 | creatine metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2674 | | GO:0051172 | negative regulation of nitrogen compound metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2675 | | GO:0046477 | glycosylceramide catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2676 | | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2677 | | GO:0045663 | positive regulation of myoblast differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2678 | | GO:0007309 | oocyte axis determination | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2679 | | GO:0007308 | oocyte construction | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2680 | | GO:0000066 | mitochondrial ornithine transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2681 | | GO:0015822 | ornithine transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2682 | | GO:0045746 | negative regulation of Notch signaling pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2683 | | GO:0032933 | SREBP\-mediated signaling pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2684 | | GO:0046033 | AMP metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2685 | | GO:0015755 | fructose transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2686 | | GO:0002318 | myeloid progenitor cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2687 | | GO:0006346 | methylation\-dependent chromatin silencing | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2688 | | GO:0002634 | regulation of germinal center formation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2689 | | GO:0040016 | embryonic cleavage | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2690 | | GO:0042428 | serotonin metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2691 | | GO:0006122 | mitochondrial electron transport\, ubiquinol to cytochrome c | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
2692 | | GO:0051971 | positive regulation of transmission of nerve impulse | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
2693 | | GO:0030641 | regulation of cellular pH | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
2694 | | GO:0006825 | copper ion transport | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
2695 | | GO:0019098 | reproductive behavior | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
2696 | | GO:0048706 | embryonic skeletal development | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
2697 | | GO:0033261 | regulation of S phase | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
2698 | | GO:0008088 | axon cargo transport | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
2699 | | GO:0046847 | filopodium formation | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
2700 | | GO:0000077 | DNA damage checkpoint | 3 | 1023 | 32 | 25222 | 1.55e-01 | 0.00 | 0.00 | 2.3 |
2701 | | GO:0006493 | protein amino acid O\-linked glycosylation | 3 | 1023 | 32 | 25222 | 1.55e-01 | 0.00 | 0.00 | 2.3 |
2702 | | GO:0016339 | calcium\-dependent cell\-cell adhesion | 3 | 1023 | 32 | 25222 | 1.55e-01 | 0.00 | 0.00 | 2.3 |
2703 | | GO:0016197 | endosome transport | 4 | 1022 | 50 | 25204 | 1.59e-01 | 0.00 | 0.00 | 2.0 |
2704 | | GO:0006584 | catecholamine metabolic process | 3 | 1023 | 33 | 25221 | 1.65e-01 | 0.00 | 0.00 | 2.2 |
2705 | | GO:0006487 | protein amino acid N\-linked glycosylation | 4 | 1022 | 51 | 25203 | 1.67e-01 | 0.00 | 0.00 | 1.9 |
2706 | | GO:0045446 | endothelial cell differentiation | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
2707 | | GO:0006278 | RNA\-dependent DNA replication | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
2708 | | GO:0030035 | microspike biogenesis | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
2709 | | GO:0031124 | mRNA 3'\-end processing | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
2710 | | GO:0006783 | heme biosynthetic process | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
2711 | | GO:0032886 | regulation of microtubule\-based process | 3 | 1023 | 34 | 25220 | 1.74e-01 | 0.00 | 0.00 | 2.2 |
2712 | | GO:0031109 | microtubule polymerization or depolymerization | 3 | 1023 | 34 | 25220 | 1.74e-01 | 0.00 | 0.00 | 2.2 |
2713 | | GO:0046942 | carboxylic acid transport | 11 | 1015 | 173 | 25081 | 1.75e-01 | 0.01 | 0.01 | 1.6 |
2714 | | GO:0015849 | organic acid transport | 11 | 1015 | 174 | 25080 | 1.76e-01 | 0.01 | 0.01 | 1.6 |
2715 | | GO:0014044 | Schwann cell development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2716 | | GO:0019836 | hemolysis by symbiont of host red blood cells | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2717 | | GO:0001897 | cytolysis by symbiont of host cells | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2718 | | GO:0051801 | cytolysis of cells in other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2719 | | GO:0051715 | cytolysis of cells of another organism | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2720 | | GO:0031640 | killing of cells of another organism | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2721 | | GO:0052331 | hemolysis by organism of red blood cells in other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2722 | | GO:0051883 | killing of cells in other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2723 | | GO:0001907 | killing by symbiont of host cells | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2724 | | GO:0044004 | disruption by symbiont of host cells | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2725 | | GO:0044003 | modification by symbiont of host morphology or physiology | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2726 | | GO:0052025 | modification by symbiont of host cell membrane | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2727 | | GO:0052043 | modification by symbiont of host cellular component | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2728 | | GO:0052111 | modification by symbiont of host structure | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2729 | | GO:0051818 | disruption of cells of other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2730 | | GO:0051817 | modification of morphology or physiology of other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2731 | | GO:0052185 | modification of structure of other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2732 | | GO:0052332 | modification by organism of cell membrane in other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2733 | | GO:0052188 | modification of cellular component in other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2734 | | GO:0043114 | regulation of vascular permeability | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2735 | | GO:0042474 | middle ear morphogenesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2736 | | GO:0060024 | rhythmic synaptic transmission | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2737 | | GO:0040009 | regulation of growth rate | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2738 | | GO:0032755 | positive regulation of interleukin\-6 production | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2739 | | GO:0030828 | positive regulation of cGMP biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2740 | | GO:0030825 | positive regulation of cGMP metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2741 | | GO:0032801 | receptor catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2742 | | GO:0031642 | negative regulation of myelination | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2743 | | GO:0045091 | regulation of retroviral genome replication | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2744 | | GO:0007207 | muscarinic acetylcholine receptor\, phospholipase C activating pathway | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2745 | | GO:0006358 | regulation of transcription from RNA polymerase II promoter\, global | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2746 | | GO:0032763 | regulation of mast cell cytokine production | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2747 | | GO:0032762 | mast cell cytokine production | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2748 | | GO:0042537 | benzene and derivative metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2749 | | GO:0005979 | regulation of glycogen biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2750 | | GO:0032885 | regulation of polysaccharide biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2751 | | GO:0055003 | cardiac myofibril assembly | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2752 | | GO:0055013 | cardiac muscle cell development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2753 | | GO:0045940 | positive regulation of steroid metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2754 | | GO:0006678 | glucosylceramide metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2755 | | GO:0032364 | oxygen homeostasis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2756 | | GO:0033483 | gas homeostasis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2757 | | GO:0010517 | regulation of phospholipase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2758 | | GO:0032429 | regulation of phospholipase A2 activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2759 | | GO:0009146 | purine nucleoside triphosphate catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2760 | | GO:0015872 | dopamine transport | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2761 | | GO:0006288 | base\-excision repair\, DNA ligation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2762 | | GO:0021532 | neural tube patterning | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2763 | | GO:0032330 | regulation of chondrocyte differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2764 | | GO:0001547 | antral ovarian follicle growth | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2765 | | GO:0043030 | regulation of macrophage activation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2766 | | GO:0048103 | somatic stem cell division | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2767 | | GO:0000320 | re\-entry into mitotic cell cycle | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2768 | | GO:0045737 | positive regulation of cyclin\-dependent protein kinase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2769 | | GO:0002710 | negative regulation of T cell mediated immunity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2770 | | GO:0002707 | negative regulation of lymphocyte mediated immunity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2771 | | GO:0002704 | negative regulation of leukocyte mediated immunity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2772 | | GO:0006166 | purine ribonucleoside salvage | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2773 | | GO:0043174 | nucleoside salvage | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2774 | | GO:0043101 | purine salvage | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2775 | | GO:0021544 | subpallium development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2776 | | GO:0006726 | eye pigment biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2777 | | GO:0042441 | eye pigment metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2778 | | GO:0042724 | thiamin and derivative biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2779 | | GO:0048293 | regulation of isotype switching to IgE isotypes | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2780 | | GO:0048289 | isotype switching to IgE isotypes | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2781 | | GO:0007252 | I\-kappaB phosphorylation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2782 | | GO:0055012 | ventricular cardiac muscle cell differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2783 | | GO:0051005 | negative regulation of lipoprotein lipase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2784 | | GO:0060192 | negative regulation of lipase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2785 | | GO:0000105 | histidine biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2786 | | GO:0009076 | histidine family amino acid biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2787 | | GO:0002088 | lens development in camera\-type eye | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2788 | | GO:0046487 | glyoxylate metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2789 | | GO:0008218 | bioluminescence | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2790 | | GO:0046825 | regulation of protein export from nucleus | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2791 | | GO:0006432 | phenylalanyl\-tRNA aminoacylation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2792 | | GO:0018401 | peptidyl\-proline hydroxylation to 4\-hydroxy\-L\-proline | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2793 | | GO:0019471 | 4\-hydroxyproline metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2794 | | GO:0019511 | peptidyl\-proline hydroxylation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2795 | | GO:0018208 | peptidyl\-proline modification | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2796 | | GO:0048613 | embryonic ectodermal gut morphogenesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2797 | | GO:0048611 | embryonic ectodermal gut development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2798 | | GO:0009264 | deoxyribonucleotide catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2799 | | GO:0043206 | fibril organization and biogenesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2800 | | GO:0016322 | neuron remodeling | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2801 | | GO:0048070 | regulation of pigmentation during development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2802 | | GO:0045063 | T\-helper 1 cell differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2803 | | GO:0046640 | regulation of alpha\-beta T cell proliferation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2804 | | GO:0045425 | positive regulation of granulocyte macrophage colony\-stimulating factor biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2805 | | GO:0043306 | positive regulation of mast cell degranulation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2806 | | GO:0033005 | positive regulation of mast cell activation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2807 | | GO:0043302 | positive regulation of leukocyte degranulation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2808 | | GO:0000281 | cytokinesis after mitosis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2809 | | GO:0046580 | negative regulation of Ras protein signal transduction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2810 | | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2811 | | GO:0001778 | plasma membrane repair | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2812 | | GO:0043567 | regulation of insulin\-like growth factor receptor signaling pathway | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2813 | | GO:0032374 | regulation of cholesterol transport | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2814 | | GO:0032371 | regulation of sterol transport | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2815 | | GO:0032368 | regulation of lipid transport | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2816 | | GO:0021545 | cranial nerve development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2817 | | GO:0008228 | opsonization | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2818 | | GO:0000920 | cell separation during cytokinesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2819 | | GO:0002052 | positive regulation of neuroblast proliferation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2820 | | GO:0007418 | ventral midline development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2821 | | GO:0046639 | negative regulation of alpha\-beta T cell differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2822 | | GO:0045581 | negative regulation of T cell differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2823 | | GO:0032743 | positive regulation of interleukin\-2 production | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2824 | | GO:0048148 | behavioral response to cocaine | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2825 | | GO:0015909 | long\-chain fatty acid transport | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2826 | | GO:0046329 | negative regulation of JNK cascade | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2827 | | GO:0001783 | B cell apoptosis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2828 | | GO:0060011 | Sertoli cell proliferation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2829 | | GO:0010225 | response to UV\-C | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2830 | | GO:0019730 | antimicrobial humoral response | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2831 | | GO:0007097 | nuclear migration | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2832 | | GO:0002063 | chondrocyte development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2833 | | GO:0003016 | respiratory system process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2834 | | GO:0051149 | positive regulation of muscle cell differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2835 | | GO:0045880 | positive regulation of smoothened signaling pathway | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2836 | | GO:0010002 | cardioblast differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2837 | | GO:0019433 | triacylglycerol catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2838 | | GO:0046464 | acylglycerol catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2839 | | GO:0046503 | glycerolipid catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2840 | | GO:0044269 | glycerol ether catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2841 | | GO:0035162 | embryonic hemopoiesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2842 | | GO:0030091 | protein repair | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2843 | | GO:0006564 | L\-serine biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2844 | | GO:0032781 | positive regulation of ATPase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2845 | | GO:0006991 | response to sterol depletion | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2846 | | GO:0032799 | low\-density lipoprotein receptor metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2847 | | GO:0048569 | post\-embryonic organ development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2848 | | GO:0045730 | respiratory burst | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2849 | | GO:0001835 | blastocyst hatching | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2850 | | GO:0035188 | hatching | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2851 | | GO:0046219 | indolalkylamine biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2852 | | GO:0042435 | indole derivative biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2853 | | GO:0000738 | DNA catabolic process\, exonucleolytic | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
2854 | | GO:0008380 | RNA splicing | 5 | 1021 | 240 | 25014 | 1.81e-01 | 0.00 | 0.01 | 0.5 |
2855 | | GO:0045777 | positive regulation of blood pressure | 2 | 1024 | 18 | 25236 | 1.83e-01 | 0.00 | 0.00 | 2.7 |
2856 | | GO:0006760 | folic acid and derivative metabolic process | 2 | 1024 | 18 | 25236 | 1.83e-01 | 0.00 | 0.00 | 2.7 |
2857 | | GO:0018298 | protein\-chromophore linkage | 2 | 1024 | 18 | 25236 | 1.83e-01 | 0.00 | 0.00 | 2.7 |
2858 | | GO:0045664 | regulation of neuron differentiation | 3 | 1023 | 35 | 25219 | 1.84e-01 | 0.00 | 0.00 | 2.1 |
2859 | | GO:0007602 | phototransduction | 3 | 1023 | 35 | 25219 | 1.84e-01 | 0.00 | 0.00 | 2.1 |
2860 | | GO:0006289 | nucleotide\-excision repair | 3 | 1023 | 36 | 25218 | 1.94e-01 | 0.00 | 0.00 | 2.1 |
2861 | | GO:0031570 | DNA integrity checkpoint | 3 | 1023 | 36 | 25218 | 1.94e-01 | 0.00 | 0.00 | 2.1 |
2862 | | GO:0006120 | mitochondrial electron transport\, NADH to ubiquinone | 3 | 1023 | 36 | 25218 | 1.94e-01 | 0.00 | 0.00 | 2.1 |
2863 | | GO:0032318 | regulation of Ras GTPase activity | 1 | 1025 | 104 | 25150 | 1.97e-01 | 0.00 | 0.00 | 0.2 |
2864 | | GO:0045103 | intermediate filament\-based process | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2865 | | GO:0001889 | liver development | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2866 | | GO:0050772 | positive regulation of axonogenesis | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2867 | | GO:0008299 | isoprenoid biosynthetic process | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2868 | | GO:0031123 | RNA 3'\-end processing | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2869 | | GO:0000097 | sulfur amino acid biosynthetic process | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2870 | | GO:0006611 | protein export from nucleus | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2871 | | GO:0008542 | visual learning | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2872 | | GO:0048663 | neuron fate commitment | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
2873 | | GO:0007411 | axon guidance | 7 | 1019 | 100 | 25154 | 2.00e-01 | 0.01 | 0.00 | 1.7 |
2874 | | GO:0065004 | protein\-DNA complex assembly | 6 | 1020 | 259 | 24995 | 2.01e-01 | 0.01 | 0.01 | 0.6 |
2875 | | GO:0006813 | potassium ion transport | 18 | 1008 | 325 | 24929 | 2.04e-01 | 0.02 | 0.01 | 1.4 |
2876 | | GO:0007127 | meiosis I | 3 | 1023 | 37 | 25217 | 2.04e-01 | 0.00 | 0.00 | 2.0 |
2877 | | GO:0000084 | S phase of mitotic cell cycle | 2 | 1024 | 20 | 25234 | 2.11e-01 | 0.00 | 0.00 | 2.5 |
2878 | | GO:0014002 | astrocyte development | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2879 | | GO:0002037 | negative regulation of L\-glutamate transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2880 | | GO:0051956 | negative regulation of amino acid transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2881 | | GO:0051953 | negative regulation of amine transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2882 | | GO:0032891 | negative regulation of organic acid transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2883 | | GO:0051955 | regulation of amino acid transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2884 | | GO:0002036 | regulation of L\-glutamate transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2885 | | GO:0032890 | regulation of organic acid transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2886 | | GO:0033209 | tumor necrosis factor\-mediated signaling pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2887 | | GO:0045624 | positive regulation of T\-helper cell differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2888 | | GO:0045628 | regulation of T\-helper 2 cell differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2889 | | GO:0033138 | positive regulation of peptidyl\-serine phosphorylation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2890 | | GO:0033135 | regulation of peptidyl\-serine phosphorylation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2891 | | GO:0007184 | SMAD protein nuclear translocation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2892 | | GO:0031536 | positive regulation of exit from mitosis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2893 | | GO:0035303 | regulation of dephosphorylation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2894 | | GO:0031953 | negative regulation of protein amino acid autophosphorylation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2895 | | GO:0031952 | regulation of protein amino acid autophosphorylation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2896 | | GO:0030826 | regulation of cGMP biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2897 | | GO:0046686 | response to cadmium ion | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2898 | | GO:0042062 | long\-term strengthening of neuromuscular junction | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2899 | | GO:0007320 | insemination | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2900 | | GO:0009154 | purine ribonucleotide catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2901 | | GO:0006545 | glycine biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2902 | | GO:0009299 | mRNA transcription | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2903 | | GO:0048251 | elastic fiber assembly | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2904 | | GO:0048701 | embryonic cranial skeleton morphogenesis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2905 | | GO:0045662 | negative regulation of myoblast differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2906 | | GO:0032088 | inhibition of NF\-kappaB transcription factor | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2907 | | GO:0007625 | grooming behavior | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2908 | | GO:0048069 | eye pigmentation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2909 | | GO:0016117 | carotenoid biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2910 | | GO:0016109 | tetraterpenoid biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2911 | | GO:0016114 | terpenoid biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2912 | | GO:0009164 | nucleoside catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2913 | | GO:0006883 | cellular sodium ion homeostasis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2914 | | GO:0055078 | sodium ion homeostasis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2915 | | GO:0018343 | protein farnesylation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2916 | | GO:0050860 | negative regulation of T cell receptor signaling pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2917 | | GO:0050858 | negative regulation of antigen receptor\-mediated signaling pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2918 | | GO:0030150 | protein import into mitochondrial matrix | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2919 | | GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2920 | | GO:0051151 | negative regulation of smooth muscle cell differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2921 | | GO:0051150 | regulation of smooth muscle cell differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2922 | | GO:0048483 | autonomic nervous system development | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2923 | | GO:0060158 | dopamine receptor\, phospholipase C activating pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2924 | | GO:0019432 | triacylglycerol biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2925 | | GO:0045423 | regulation of granulocyte macrophage colony\-stimulating factor biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2926 | | GO:0051546 | keratinocyte migration | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2927 | | GO:0014059 | regulation of dopamine secretion | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2928 | | GO:0014046 | dopamine secretion | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2929 | | GO:0007210 | serotonin receptor signaling pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2930 | | GO:0002011 | morphogenesis of an epithelial sheet | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2931 | | GO:0035022 | positive regulation of Rac protein signal transduction | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2932 | | GO:0042420 | dopamine catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2933 | | GO:0042424 | catecholamine catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2934 | | GO:0001561 | fatty acid alpha\-oxidation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2935 | | GO:0048512 | circadian behavior | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2936 | | GO:0046541 | saliva secretion | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2937 | | GO:0060073 | micturition | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2938 | | GO:0032506 | cytokinetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2939 | | GO:0006569 | tryptophan catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2940 | | GO:0046218 | indolalkylamine catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2941 | | GO:0042436 | indole derivative catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2942 | | GO:0021938 | smoothened signaling pathway in regulation of granule cell precursor cell proliferation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2943 | | GO:0021937 | Purkinje cell\-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2944 | | GO:0031330 | negative regulation of cellular catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2945 | | GO:0046636 | negative regulation of alpha\-beta T cell activation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2946 | | GO:0002726 | positive regulation of T cell cytokine production | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2947 | | GO:0046459 | short\-chain fatty acid metabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2948 | | GO:0031579 | membrane raft organization and biogenesis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2949 | | GO:0005989 | lactose biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2950 | | GO:0046351 | disaccharide biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2951 | | GO:0005988 | lactose metabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2952 | | GO:0045082 | positive regulation of interleukin\-10 biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2953 | | GO:0045074 | regulation of interleukin\-10 biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2954 | | GO:0042091 | interleukin\-10 biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2955 | | GO:0035194 | posttranscriptional gene silencing by RNA | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2956 | | GO:0016441 | posttranscriptional gene silencing | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2957 | | GO:0031503 | protein complex localization | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2958 | | GO:0046168 | glycerol\-3\-phosphate catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2959 | | GO:0019563 | glycerol catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2960 | | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2961 | | GO:0048505 | regulation of timing of cell differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2962 | | GO:0040034 | regulation of development\, heterochronic | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2963 | | GO:0046461 | neutral lipid catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2964 | | GO:0032981 | mitochondrial respiratory chain complex I assembly | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2965 | | GO:0033108 | mitochondrial respiratory chain complex assembly | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2966 | | GO:0010257 | NADH dehydrogenase complex assembly | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2967 | | GO:0002244 | hemopoietic progenitor cell differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2968 | | GO:0007143 | female meiosis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
2969 | | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 3 | 1023 | 38 | 25216 | 2.15e-01 | 0.00 | 0.00 | 1.9 |
2970 | | GO:0006397 | mRNA processing | 7 | 1019 | 282 | 24972 | 2.23e-01 | 0.01 | 0.01 | 0.6 |
2971 | | GO:0009116 | nucleoside metabolic process | 3 | 1023 | 39 | 25215 | 2.25e-01 | 0.00 | 0.00 | 1.9 |
2972 | | GO:0050908 | detection of light stimulus involved in visual perception | 3 | 1023 | 39 | 25215 | 2.25e-01 | 0.00 | 0.00 | 1.9 |
2973 | | GO:0050962 | detection of light stimulus involved in sensory perception | 3 | 1023 | 39 | 25215 | 2.25e-01 | 0.00 | 0.00 | 1.9 |
2974 | | GO:0042491 | auditory receptor cell differentiation | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2975 | | GO:0015813 | L\-glutamate transport | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2976 | | GO:0015800 | acidic amino acid transport | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2977 | | GO:0006706 | steroid catabolic process | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2978 | | GO:0006004 | fucose metabolic process | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2979 | | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2980 | | GO:0009127 | purine nucleoside monophosphate biosynthetic process | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2981 | | GO:0009126 | purine nucleoside monophosphate metabolic process | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2982 | | GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2983 | | GO:0051181 | cofactor transport | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
2984 | | GO:0006275 | regulation of DNA replication | 3 | 1023 | 40 | 25214 | 2.35e-01 | 0.00 | 0.00 | 1.8 |
2985 | | GO:0009584 | detection of visible light | 3 | 1023 | 40 | 25214 | 2.35e-01 | 0.00 | 0.00 | 1.8 |
2986 | | GO:0007156 | homophilic cell adhesion | 10 | 1016 | 166 | 25088 | 2.36e-01 | 0.01 | 0.01 | 1.5 |
2987 | | GO:0045026 | plasma membrane fusion | 2 | 1024 | 22 | 25232 | 2.41e-01 | 0.00 | 0.00 | 2.2 |
2988 | | GO:0007632 | visual behavior | 2 | 1024 | 22 | 25232 | 2.41e-01 | 0.00 | 0.00 | 2.2 |
2989 | | GO:0009311 | oligosaccharide metabolic process | 2 | 1024 | 22 | 25232 | 2.41e-01 | 0.00 | 0.00 | 2.2 |
2990 | | GO:0060088 | auditory receptor cell stereocilium organization and biogenesis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2991 | | GO:0002093 | auditory receptor cell morphogenesis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2992 | | GO:0060117 | auditory receptor cell development | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2993 | | GO:0048384 | retinoic acid receptor signaling pathway | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2994 | | GO:0050829 | defense response to Gram\-negative bacterium | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2995 | | GO:0001885 | endothelial cell development | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2996 | | GO:0045948 | positive regulation of translational initiation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2997 | | GO:0051926 | negative regulation of calcium ion transport | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2998 | | GO:0045090 | retroviral genome replication | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
2999 | | GO:0031529 | ruffle organization and biogenesis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3000 | | GO:0045354 | regulation of interferon\-alpha biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3001 | | GO:0045349 | interferon\-alpha biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3002 | | GO:0032607 | interferon\-alpha production | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3003 | | GO:0032881 | regulation of polysaccharide metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3004 | | GO:0001967 | suckling behavior | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3005 | | GO:0060193 | positive regulation of lipase activity | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3006 | | GO:0006356 | regulation of transcription from RNA polymerase I promoter | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3007 | | GO:0043353 | enucleate erythrocyte differentiation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3008 | | GO:0031397 | negative regulation of protein ubiquitination | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3009 | | GO:0045732 | positive regulation of protein catabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3010 | | GO:0046685 | response to arsenic | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3011 | | GO:0007620 | copulation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3012 | | GO:0006195 | purine nucleotide catabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3013 | | GO:0045995 | regulation of embryonic development | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3014 | | GO:0051103 | DNA ligation during DNA repair | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3015 | | GO:0018065 | protein\-cofactor linkage | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3016 | | GO:0006977 | DNA damage response\, signal transduction by p53 class mediator resulting in cell cycle arrest | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3017 | | GO:0017145 | stem cell division | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3018 | | GO:0042069 | regulation of catecholamine metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3019 | | GO:0042053 | regulation of dopamine metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3020 | | GO:0042723 | thiamin and derivative metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3021 | | GO:0006772 | thiamin metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3022 | | GO:0016116 | carotenoid metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3023 | | GO:0016108 | tetraterpenoid metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3024 | | GO:0006703 | estrogen biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3025 | | GO:0007089 | traversing start control point of mitotic cell cycle | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3026 | | GO:0000089 | mitotic metaphase | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3027 | | GO:0008340 | determination of adult life span | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3028 | | GO:0045910 | negative regulation of DNA recombination | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3029 | | GO:0045604 | regulation of epidermal cell differentiation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3030 | | GO:0060070 | Wnt receptor signaling pathway through beta\-catenin | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3031 | | GO:0042439 | ethanolamine and derivative metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3032 | | GO:0045668 | negative regulation of osteoblast differentiation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3033 | | GO:0046500 | S\-adenosylmethionine metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3034 | | GO:0010043 | response to zinc ion | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3035 | | GO:0045921 | positive regulation of exocytosis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3036 | | GO:0035313 | wound healing\, spreading of epidermal cells | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3037 | | GO:0045060 | negative thymic T cell selection | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3038 | | GO:0043383 | negative T cell selection | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3039 | | GO:0001825 | blastocyst formation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3040 | | GO:0032228 | regulation of synaptic transmission\, GABAergic | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3041 | | GO:0032367 | intracellular cholesterol transport | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3042 | | GO:0032366 | intracellular sterol transport | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3043 | | GO:0032365 | intracellular lipid transport | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3044 | | GO:0031638 | zymogen activation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3045 | | GO:0043043 | peptide biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3046 | | GO:0048665 | neuron fate specification | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3047 | | GO:0002224 | toll\-like receptor signaling pathway | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3048 | | GO:0008063 | Toll signaling pathway | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3049 | | GO:0032760 | positive regulation of tumor necrosis factor production | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3050 | | GO:0002724 | regulation of T cell cytokine production | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3051 | | GO:0002369 | T cell cytokine production | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3052 | | GO:0032663 | regulation of interleukin\-2 production | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3053 | | GO:0042220 | response to cocaine | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3054 | | GO:0014073 | response to tropane | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3055 | | GO:0051925 | regulation of calcium ion transport via voltage\-gated calcium channel | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3056 | | GO:0007341 | penetration of zona pellucida | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3057 | | GO:0017158 | regulation of calcium ion\-dependent exocytosis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3058 | | GO:0031274 | positive regulation of pseudopodium formation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3059 | | GO:0031272 | regulation of pseudopodium formation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3060 | | GO:0031269 | pseudopodium formation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3061 | | GO:0031268 | pseudopodium organization and biogenesis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3062 | | GO:0006926 | virus\-infected cell apoptosis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3063 | | GO:0051930 | regulation of sensory perception of pain | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3064 | | GO:0051931 | regulation of sensory perception | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3065 | | GO:0046514 | ceramide catabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3066 | | GO:0006467 | protein thiol\-disulfide exchange | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3067 | | GO:0001662 | behavioral fear response | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3068 | | GO:0002209 | behavioral defense response | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3069 | | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3070 | | GO:0050732 | negative regulation of peptidyl\-tyrosine phosphorylation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3071 | | GO:0006882 | cellular zinc ion homeostasis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3072 | | GO:0055069 | zinc ion homeostasis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3073 | | GO:0042572 | retinol metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3074 | | GO:0015746 | citrate transport | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3075 | | GO:0006842 | tricarboxylic acid transport | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3076 | | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3077 | | GO:0007130 | synaptonemal complex assembly | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
3078 | | GO:0009583 | detection of light stimulus | 3 | 1023 | 41 | 25213 | 2.46e-01 | 0.00 | 0.00 | 1.8 |
3079 | | GO:0006518 | peptide metabolic process | 2 | 1024 | 23 | 25231 | 2.55e-01 | 0.00 | 0.00 | 2.1 |
3080 | | GO:0006024 | glycosaminoglycan biosynthetic process | 2 | 1024 | 23 | 25231 | 2.55e-01 | 0.00 | 0.00 | 2.1 |
3081 | | GO:0030216 | keratinocyte differentiation | 3 | 1023 | 42 | 25212 | 2.56e-01 | 0.00 | 0.00 | 1.8 |
3082 | | GO:0006956 | complement activation | 3 | 1023 | 42 | 25212 | 2.56e-01 | 0.00 | 0.00 | 1.8 |
3083 | | GO:0002541 | activation of plasma proteins during acute inflammatory response | 3 | 1023 | 42 | 25212 | 2.56e-01 | 0.00 | 0.00 | 1.8 |
3084 | | GO:0009100 | glycoprotein metabolic process | 11 | 1015 | 187 | 25067 | 2.64e-01 | 0.01 | 0.01 | 1.4 |
3085 | | GO:0035023 | regulation of Rho protein signal transduction | 1 | 1025 | 84 | 25170 | 2.65e-01 | 0.00 | 0.00 | 0.3 |
3086 | | GO:0030148 | sphingolipid biosynthetic process | 2 | 1024 | 24 | 25230 | 2.70e-01 | 0.00 | 0.00 | 2.1 |
3087 | | GO:0051705 | behavioral interaction between organisms | 2 | 1024 | 24 | 25230 | 2.70e-01 | 0.00 | 0.00 | 2.1 |
3088 | | GO:0046928 | regulation of neurotransmitter secretion | 2 | 1024 | 24 | 25230 | 2.70e-01 | 0.00 | 0.00 | 2.1 |
3089 | | GO:0050658 | RNA transport | 1 | 1025 | 91 | 25163 | 2.72e-01 | 0.00 | 0.00 | 0.3 |
3090 | | GO:0051236 | establishment of RNA localization | 1 | 1025 | 91 | 25163 | 2.72e-01 | 0.00 | 0.00 | 0.3 |
3091 | | GO:0050657 | nucleic acid transport | 1 | 1025 | 91 | 25163 | 2.72e-01 | 0.00 | 0.00 | 0.3 |
3092 | | GO:0060052 | neurofilament cytoskeleton organization and biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3093 | | GO:0060119 | inner ear receptor cell development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3094 | | GO:0060122 | inner ear receptor stereocilium organization and biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3095 | | GO:0048286 | alveolus development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3096 | | GO:0007168 | receptor guanylyl cyclase signaling pathway | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3097 | | GO:0043372 | positive regulation of CD4\-positive\, alpha beta T cell differentiation | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3098 | | GO:0030147 | natriuresis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3099 | | GO:0009143 | nucleoside triphosphate catabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3100 | | GO:0009261 | ribonucleotide catabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3101 | | GO:0030501 | positive regulation of bone mineralization | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3102 | | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3103 | | GO:0002820 | negative regulation of adaptive immune response | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3104 | | GO:0021895 | cerebral cortex neuron differentiation | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3105 | | GO:0006704 | glucocorticoid biosynthetic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3106 | | GO:0042447 | hormone catabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3107 | | GO:0051323 | metaphase | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3108 | | GO:0010259 | multicellular organismal aging | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3109 | | GO:0016446 | somatic hypermutation of immunoglobulin genes | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3110 | | GO:0002566 | somatic diversification of immune receptors via somatic mutation | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3111 | | GO:0042462 | eye photoreceptor cell development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3112 | | GO:0007029 | endoplasmic reticulum organization and biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3113 | | GO:0046633 | alpha\-beta T cell proliferation | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3114 | | GO:0042416 | dopamine biosynthetic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3115 | | GO:0051932 | synaptic transmission\, GABAergic | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3116 | | GO:0035020 | regulation of Rac protein signal transduction | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3117 | | GO:0033151 | V(D)J recombination | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3118 | | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3119 | | GO:0007622 | rhythmic behavior | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3120 | | GO:0060004 | reflex | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3121 | | GO:0021517 | ventral spinal cord development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3122 | | GO:0021522 | spinal cord motor neuron differentiation | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3123 | | GO:0002221 | pattern recognition receptor signaling pathway | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3124 | | GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3125 | | GO:0045620 | negative regulation of lymphocyte differentiation | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3126 | | GO:0002720 | positive regulation of cytokine production during immune response | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3127 | | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3128 | | GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3129 | | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3130 | | GO:0045749 | negative regulation of S phase of mitotic cell cycle | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3131 | | GO:0002064 | epithelial cell development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3132 | | GO:0019827 | stem cell maintenance | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3133 | | GO:0048864 | stem cell development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3134 | | GO:0017144 | drug metabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3135 | | GO:0003009 | skeletal muscle contraction | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3136 | | GO:0046426 | negative regulation of JAK\-STAT cascade | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3137 | | GO:0006349 | genetic imprinting | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3138 | | GO:0006621 | protein retention in ER | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3139 | | GO:0043462 | regulation of ATPase activity | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3140 | | GO:0043124 | negative regulation of I\-kappaB kinase/NF\-kappaB cascade | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
3141 | | GO:0006403 | RNA localization | 1 | 1025 | 93 | 25161 | 2.75e-01 | 0.00 | 0.00 | 0.3 |
3142 | | GO:0007265 | Ras protein signal transduction | 15 | 1011 | 280 | 24974 | 2.88e-01 | 0.01 | 0.01 | 1.3 |
3143 | | GO:0051129 | negative regulation of cellular component organization and biogenesis | 6 | 1020 | 95 | 25159 | 2.93e-01 | 0.01 | 0.00 | 1.6 |
3144 | | GO:0042471 | ear morphogenesis | 4 | 1022 | 55 | 25199 | 2.93e-01 | 0.00 | 0.00 | 1.8 |
3145 | | GO:0001541 | ovarian follicle development | 2 | 1024 | 26 | 25228 | 2.99e-01 | 0.00 | 0.00 | 1.9 |
3146 | | GO:0006779 | porphyrin biosynthetic process | 2 | 1024 | 26 | 25228 | 2.99e-01 | 0.00 | 0.00 | 1.9 |
3147 | | GO:0033014 | tetrapyrrole biosynthetic process | 2 | 1024 | 26 | 25228 | 2.99e-01 | 0.00 | 0.00 | 1.9 |
3148 | | GO:0006486 | protein amino acid glycosylation | 9 | 1017 | 152 | 25102 | 3.01e-01 | 0.01 | 0.01 | 1.5 |
3149 | | GO:0014037 | Schwann cell differentiation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3150 | | GO:0006269 | DNA replication\, synthesis of RNA primer | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3151 | | GO:0051452 | intracellular pH reduction | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3152 | | GO:0045851 | pH reduction | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3153 | | GO:0043467 | regulation of generation of precursor metabolites and energy | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3154 | | GO:0043149 | stress fiber formation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3155 | | GO:0007217 | tachykinin signaling pathway | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3156 | | GO:0015936 | coenzyme A metabolic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3157 | | GO:0015991 | ATP hydrolysis coupled proton transport | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3158 | | GO:0045898 | regulation of transcriptional preinitiation complex assembly | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3159 | | GO:0051123 | transcriptional preinitiation complex assembly | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3160 | | GO:0045648 | positive regulation of erythrocyte differentiation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3161 | | GO:0042074 | cell migration involved in gastrulation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3162 | | GO:0007516 | hemocyte development | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3163 | | GO:0055007 | cardiac muscle cell differentiation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3164 | | GO:0051004 | regulation of lipoprotein lipase activity | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3165 | | GO:0007191 | dopamine receptor\, adenylate cyclase activating pathway | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3166 | | GO:0001754 | eye photoreceptor cell differentiation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3167 | | GO:0031572 | G2/M transition DNA damage checkpoint | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3168 | | GO:0031576 | G2/M transition checkpoint | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3169 | | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3170 | | GO:0046463 | acylglycerol biosynthetic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3171 | | GO:0046460 | neutral lipid biosynthetic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3172 | | GO:0060078 | regulation of postsynaptic membrane potential | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3173 | | GO:0042255 | ribosome assembly | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3174 | | GO:0002758 | innate immune response\-activating signal transduction | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3175 | | GO:0002218 | activation of innate immune response | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3176 | | GO:0019856 | pyrimidine base biosynthetic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3177 | | GO:0009435 | NAD biosynthetic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3178 | | GO:0002702 | positive regulation of production of molecular mediator of immune response | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3179 | | GO:0006906 | vesicle fusion | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3180 | | GO:0043254 | regulation of protein complex assembly | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3181 | | GO:0031346 | positive regulation of cell projection organization and biogenesis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3182 | | GO:0031344 | regulation of cell projection organization and biogenesis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3183 | | GO:0048863 | stem cell differentiation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3184 | | GO:0008535 | respiratory chain complex IV assembly | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3185 | | GO:0046521 | sphingoid catabolic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3186 | | GO:0006572 | tyrosine catabolic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3187 | | GO:0008593 | regulation of Notch signaling pathway | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3188 | | GO:0015979 | photosynthesis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3189 | | GO:0007129 | synapsis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
3190 | | GO:0043413 | biopolymer glycosylation | 9 | 1017 | 154 | 25100 | 3.04e-01 | 0.01 | 0.01 | 1.4 |
3191 | | GO:0009582 | detection of abiotic stimulus | 4 | 1022 | 59 | 25195 | 3.12e-01 | 0.00 | 0.00 | 1.7 |
3192 | | GO:0007600 | sensory perception | 44 | 982 | 934 | 24320 | 3.13e-01 | 0.04 | 0.04 | 1.2 |
3193 | | GO:0060113 | inner ear receptor cell differentiation | 2 | 1024 | 27 | 25227 | 3.14e-01 | 0.00 | 0.00 | 1.8 |
3194 | | GO:0001824 | blastocyst development | 2 | 1024 | 27 | 25227 | 3.14e-01 | 0.00 | 0.00 | 1.8 |
3195 | | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2 | 1024 | 27 | 25227 | 3.14e-01 | 0.00 | 0.00 | 1.8 |
3196 | | GO:0009101 | glycoprotein biosynthetic process | 9 | 1017 | 160 | 25094 | 3.16e-01 | 0.01 | 0.01 | 1.4 |
3197 | | GO:0043407 | negative regulation of MAP kinase activity | 2 | 1024 | 28 | 25226 | 3.28e-01 | 0.00 | 0.00 | 1.8 |
3198 | | GO:0051053 | negative regulation of DNA metabolic process | 2 | 1024 | 28 | 25226 | 3.28e-01 | 0.00 | 0.00 | 1.8 |
3199 | | GO:0007051 | spindle organization and biogenesis | 2 | 1024 | 28 | 25226 | 3.28e-01 | 0.00 | 0.00 | 1.8 |
3200 | | GO:0046689 | response to mercury ion | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3201 | | GO:0002028 | regulation of sodium ion transport | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3202 | | GO:0001938 | positive regulation of endothelial cell proliferation | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3203 | | GO:0048259 | regulation of receptor\-mediated endocytosis | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3204 | | GO:0015844 | monoamine transport | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3205 | | GO:0042386 | hemocyte differentiation | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3206 | | GO:0031018 | endocrine pancreas development | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3207 | | GO:0006548 | histidine catabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3208 | | GO:0009077 | histidine family amino acid catabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3209 | | GO:0042461 | photoreceptor cell development | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3210 | | GO:0050830 | defense response to Gram\-positive bacterium | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3211 | | GO:0050433 | regulation of catecholamine secretion | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3212 | | GO:0032350 | regulation of hormone metabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3213 | | GO:0006884 | cell volume homeostasis | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3214 | | GO:0021515 | cell differentiation in spinal cord | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3215 | | GO:0019674 | NAD metabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3216 | | GO:0006012 | galactose metabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3217 | | GO:0050881 | musculoskeletal movement | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3218 | | GO:0050879 | multicellular organismal movement | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3219 | | GO:0042596 | fear response | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3220 | | GO:0050828 | regulation of liquid surface tension | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3221 | | GO:0009791 | post\-embryonic development | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
3222 | | GO:0006364 | rRNA processing | 4 | 1022 | 66 | 25188 | 3.53e-01 | 0.00 | 0.00 | 1.5 |
3223 | | GO:0045622 | regulation of T\-helper cell differentiation | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3224 | | GO:0015988 | energy coupled proton transport\, against electrochemical gradient | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3225 | | GO:0018342 | protein prenylation | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3226 | | GO:0031532 | actin cytoskeleton reorganization | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3227 | | GO:0030321 | transepithelial chloride transport | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3228 | | GO:0046504 | glycerol ether biosynthetic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3229 | | GO:0045017 | glycerolipid biosynthetic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3230 | | GO:0050432 | catecholamine secretion | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3231 | | GO:0048169 | regulation of long\-term neuronal synaptic plasticity | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3232 | | GO:0006699 | bile acid biosynthetic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3233 | | GO:0007016 | cytoskeletal anchoring | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3234 | | GO:0014003 | oligodendrocyte development | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3235 | | GO:0019884 | antigen processing and presentation of exogenous antigen | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3236 | | GO:0008333 | endosome to lysosome transport | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3237 | | GO:0006911 | phagocytosis\, engulfment | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3238 | | GO:0021575 | hindbrain morphogenesis | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3239 | | GO:0006684 | sphingomyelin metabolic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3240 | | GO:0006282 | regulation of DNA repair | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
3241 | | GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2 | 1024 | 30 | 25224 | 3.57e-01 | 0.00 | 0.00 | 1.6 |
3242 | | GO:0009161 | ribonucleoside monophosphate metabolic process | 2 | 1024 | 30 | 25224 | 3.57e-01 | 0.00 | 0.00 | 1.6 |
3243 | | GO:0042401 | biogenic amine biosynthetic process | 2 | 1024 | 30 | 25224 | 3.57e-01 | 0.00 | 0.00 | 1.6 |
3244 | | GO:0007283 | spermatogenesis | 14 | 1012 | 274 | 24980 | 3.59e-01 | 0.01 | 0.01 | 1.3 |
3245 | | GO:0048232 | male gamete generation | 14 | 1012 | 274 | 24980 | 3.59e-01 | 0.01 | 0.01 | 1.3 |
3246 | | GO:0007338 | single fertilization | 4 | 1022 | 67 | 25187 | 3.60e-01 | 0.00 | 0.00 | 1.5 |
3247 | | GO:0009581 | detection of external stimulus | 4 | 1022 | 67 | 25187 | 3.60e-01 | 0.00 | 0.00 | 1.5 |
3248 | | GO:0046578 | regulation of Ras protein signal transduction | 5 | 1021 | 198 | 25056 | 3.64e-01 | 0.00 | 0.01 | 0.6 |
3249 | | GO:0007266 | Rho protein signal transduction | 7 | 1019 | 125 | 25129 | 3.65e-01 | 0.01 | 0.00 | 1.4 |
3250 | | GO:0009124 | nucleoside monophosphate biosynthetic process | 2 | 1024 | 31 | 25223 | 3.71e-01 | 0.00 | 0.00 | 1.6 |
3251 | | GO:0009123 | nucleoside monophosphate metabolic process | 2 | 1024 | 31 | 25223 | 3.71e-01 | 0.00 | 0.00 | 1.6 |
3252 | | GO:0000398 | nuclear mRNA splicing\, via spliceosome | 1 | 1025 | 78 | 25176 | 3.76e-01 | 0.00 | 0.00 | 0.3 |
3253 | | GO:0000377 | RNA splicing\, via transesterification reactions with bulged adenosine as nucleophile | 1 | 1025 | 78 | 25176 | 3.76e-01 | 0.00 | 0.00 | 0.3 |
3254 | | GO:0000375 | RNA splicing\, via transesterification reactions | 1 | 1025 | 78 | 25176 | 3.76e-01 | 0.00 | 0.00 | 0.3 |
3255 | | GO:0051028 | mRNA transport | 1 | 1025 | 80 | 25174 | 3.80e-01 | 0.00 | 0.00 | 0.3 |
3256 | | GO:0050718 | positive regulation of interleukin\-1 beta secretion | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3257 | | GO:0030878 | thyroid gland development | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3258 | | GO:0048704 | embryonic skeletal morphogenesis | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3259 | | GO:0006144 | purine base metabolic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3260 | | GO:0008211 | glucocorticoid metabolic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3261 | | GO:0009396 | folic acid and derivative biosynthetic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3262 | | GO:0046530 | photoreceptor cell differentiation | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3263 | | GO:0018279 | protein amino acid N\-linked glycosylation via asparagine | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3264 | | GO:0018196 | peptidyl\-asparagine modification | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3265 | | GO:0002831 | regulation of response to biotic stimulus | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3266 | | GO:0032680 | regulation of tumor necrosis factor production | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3267 | | GO:0007090 | regulation of S phase of mitotic cell cycle | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3268 | | GO:0009312 | oligosaccharide biosynthetic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3269 | | GO:0019321 | pentose metabolic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3270 | | GO:0007164 | establishment of tissue polarity | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3271 | | GO:0001523 | retinoid metabolic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3272 | | GO:0016101 | diterpenoid metabolic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3273 | | GO:0001832 | blastocyst growth | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
3274 | | GO:0048538 | thymus development | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3275 | | GO:0043370 | regulation of CD4\-positive\, alpha beta T cell differentiation | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3276 | | GO:0015074 | DNA integration | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3277 | | GO:0048813 | dendrite morphogenesis | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3278 | | GO:0045682 | regulation of epidermis development | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3279 | | GO:0007004 | telomere maintenance via telomerase | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3280 | | GO:0045197 | establishment and/or maintenance of epithelial cell polarity | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3281 | | GO:0000045 | autophagic vacuole formation | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3282 | | GO:0007157 | heterophilic cell adhesion | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3283 | | GO:0007340 | acrosome reaction | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3284 | | GO:0043588 | skin development | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3285 | | GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3286 | | GO:0006379 | mRNA cleavage | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3287 | | GO:0007140 | male meiosis | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3288 | | GO:0000726 | non\-recombinational repair | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
3289 | | GO:0007126 | meiosis | 5 | 1021 | 89 | 25165 | 4.19e-01 | 0.00 | 0.00 | 1.4 |
3290 | | GO:0051327 | M phase of meiotic cell cycle | 5 | 1021 | 89 | 25165 | 4.19e-01 | 0.00 | 0.00 | 1.4 |
3291 | | GO:0006814 | sodium ion transport | 4 | 1022 | 162 | 25092 | 4.21e-01 | 0.00 | 0.01 | 0.6 |
3292 | | GO:0006457 | protein folding | 13 | 1013 | 255 | 24999 | 4.25e-01 | 0.01 | 0.01 | 1.3 |
3293 | | GO:0009405 | pathogenesis | 3 | 1023 | 43 | 25211 | 4.27e-01 | 0.00 | 0.00 | 1.7 |
3294 | | GO:0050716 | positive regulation of interleukin\-1 secretion | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3295 | | GO:0035094 | response to nicotine | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3296 | | GO:0007274 | neuromuscular synaptic transmission | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3297 | | GO:0006360 | transcription from RNA polymerase I promoter | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3298 | | GO:0042355 | L\-fucose catabolic process | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3299 | | GO:0019317 | fucose catabolic process | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3300 | | GO:0021954 | central nervous system neuron development | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3301 | | GO:0050771 | negative regulation of axonogenesis | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3302 | | GO:0009262 | deoxyribonucleotide metabolic process | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3303 | | GO:0042423 | catecholamine biosynthetic process | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3304 | | GO:0045061 | thymic T cell selection | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3305 | | GO:0009083 | branched chain family amino acid catabolic process | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3306 | | GO:0016236 | macroautophagy | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3307 | | GO:0042384 | cilium biogenesis | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3308 | | GO:0030514 | negative regulation of BMP signaling pathway | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3309 | | GO:0008306 | associative learning | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3310 | | GO:0016571 | histone methylation | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
3311 | | GO:0051321 | meiotic cell cycle | 5 | 1021 | 91 | 25163 | 4.28e-01 | 0.00 | 0.00 | 1.4 |
3312 | | GO:0007163 | establishment and/or maintenance of cell polarity | 3 | 1023 | 44 | 25210 | 4.31e-01 | 0.00 | 0.00 | 1.7 |
3313 | | GO:0001539 | ciliary or flagellar motility | 3 | 1023 | 47 | 25207 | 4.46e-01 | 0.00 | 0.00 | 1.6 |
3314 | | GO:0015931 | nucleobase\, nucleoside\, nucleotide and nucleic acid transport | 2 | 1024 | 106 | 25148 | 4.48e-01 | 0.00 | 0.00 | 0.5 |
3315 | | GO:0003084 | positive regulation of systemic arterial blood pressure | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3316 | | GO:0031396 | regulation of protein ubiquitination | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3317 | | GO:0006942 | regulation of striated muscle contraction | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3318 | | GO:0009075 | histidine family amino acid metabolic process | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3319 | | GO:0006547 | histidine metabolic process | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3320 | | GO:0009395 | phospholipid catabolic process | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3321 | | GO:0042982 | amyloid precursor protein metabolic process | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3322 | | GO:0046112 | nucleobase biosynthetic process | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3323 | | GO:0048709 | oligodendrocyte differentiation | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3324 | | GO:0006903 | vesicle targeting | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
3325 | | GO:0006446 | regulation of translational initiation | 3 | 1023 | 49 | 25205 | 4.57e-01 | 0.00 | 0.00 | 1.5 |
3326 | | GO:0008277 | regulation of G\-protein coupled receptor protein signaling pathway | 3 | 1023 | 49 | 25205 | 4.57e-01 | 0.00 | 0.00 | 1.5 |
3327 | | GO:0035270 | endocrine system development | 3 | 1023 | 49 | 25205 | 4.57e-01 | 0.00 | 0.00 | 1.5 |
3328 | | GO:0042472 | inner ear morphogenesis | 3 | 1023 | 50 | 25204 | 4.63e-01 | 0.00 | 0.00 | 1.5 |
3329 | | GO:0042354 | L\-fucose metabolic process | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
3330 | | GO:0043681 | protein import into mitochondrion | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
3331 | | GO:0035088 | establishment and/or maintenance of apical/basal cell polarity | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
3332 | | GO:0016601 | Rac protein signal transduction | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
3333 | | GO:0030201 | heparan sulfate proteoglycan metabolic process | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
3334 | | GO:0030510 | regulation of BMP signaling pathway | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
3335 | | GO:0022604 | regulation of cell morphogenesis | 3 | 1023 | 54 | 25200 | 4.88e-01 | 0.00 | 0.00 | 1.4 |
3336 | | GO:0030433 | ER\-associated protein catabolic process | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
3337 | | GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
3338 | | GO:0009595 | detection of biotic stimulus | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
3339 | | GO:0009303 | rRNA transcription | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
3340 | | GO:0007098 | centrosome cycle | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
3341 | | GO:0007339 | binding of sperm to zona pellucida | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
3342 | | GO:0031047 | gene silencing by RNA | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
3343 | | GO:0006396 | RNA processing | 17 | 1009 | 506 | 24748 | 4.95e-01 | 0.02 | 0.02 | 0.8 |
3344 | | GO:0007219 | Notch signaling pathway | 3 | 1023 | 56 | 25198 | 5.02e-01 | 0.00 | 0.00 | 1.3 |
3345 | | GO:0042158 | lipoprotein biosynthetic process | 3 | 1023 | 57 | 25197 | 5.08e-01 | 0.00 | 0.00 | 1.3 |
3346 | | GO:0051168 | nuclear export | 3 | 1023 | 57 | 25197 | 5.08e-01 | 0.00 | 0.00 | 1.3 |
3347 | | GO:0021537 | telencephalon development | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3348 | | GO:0021953 | central nervous system neuron differentiation | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3349 | | GO:0015711 | organic anion transport | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3350 | | GO:0042095 | interferon\-gamma biosynthetic process | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3351 | | GO:0009081 | branched chain family amino acid metabolic process | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3352 | | GO:0008272 | sulfate transport | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3353 | | GO:0035036 | sperm\-egg recognition | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3354 | | GO:0033555 | multicellular organismal response to stress | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3355 | | GO:0006776 | vitamin A metabolic process | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
3356 | | GO:0006338 | chromatin remodeling | 3 | 1023 | 58 | 25196 | 5.15e-01 | 0.00 | 0.00 | 1.3 |
3357 | | GO:0050906 | detection of stimulus involved in sensory perception | 3 | 1023 | 58 | 25196 | 5.15e-01 | 0.00 | 0.00 | 1.3 |
3358 | | GO:0009913 | epidermal cell differentiation | 1 | 1025 | 65 | 25189 | 5.22e-01 | 0.00 | 0.00 | 0.4 |
3359 | | GO:0045104 | intermediate filament cytoskeleton organization and biogenesis | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
3360 | | GO:0009247 | glycolipid biosynthetic process | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
3361 | | GO:0048705 | skeletal morphogenesis | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
3362 | | GO:0008038 | neuron recognition | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
3363 | | GO:0015804 | neutral amino acid transport | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
3364 | | GO:0007041 | lysosomal transport | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
3365 | | GO:0007601 | visual perception | 13 | 1013 | 266 | 24988 | 5.31e-01 | 0.01 | 0.01 | 1.2 |
3366 | | GO:0050953 | sensory perception of light stimulus | 13 | 1013 | 266 | 24988 | 5.31e-01 | 0.01 | 0.01 | 1.2 |
3367 | | GO:0016072 | rRNA metabolic process | 4 | 1022 | 69 | 25185 | 5.35e-01 | 0.00 | 0.00 | 1.4 |
3368 | | GO:0009566 | fertilization | 4 | 1022 | 70 | 25184 | 5.37e-01 | 0.00 | 0.00 | 1.4 |
3369 | | GO:0065002 | intracellular protein transport across a membrane | 4 | 1022 | 72 | 25182 | 5.43e-01 | 0.00 | 0.00 | 1.4 |
3370 | | GO:0008156 | negative regulation of DNA replication | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
3371 | | GO:0021983 | pituitary gland development | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
3372 | | GO:0007026 | negative regulation of microtubule depolymerization | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
3373 | | GO:0031114 | regulation of microtubule depolymerization | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
3374 | | GO:0006516 | glycoprotein catabolic process | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
3375 | | GO:0051650 | establishment of vesicle localization | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
3376 | | GO:0006418 | tRNA aminoacylation for protein translation | 4 | 1022 | 76 | 25178 | 5.56e-01 | 0.00 | 0.00 | 1.3 |
3377 | | GO:0043039 | tRNA aminoacylation | 4 | 1022 | 76 | 25178 | 5.56e-01 | 0.00 | 0.00 | 1.3 |
3378 | | GO:0043038 | amino acid activation | 4 | 1022 | 76 | 25178 | 5.56e-01 | 0.00 | 0.00 | 1.3 |
3379 | | GO:0000188 | inactivation of MAPK activity | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
3380 | | GO:0021536 | diencephalon development | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
3381 | | GO:0042246 | tissue regeneration | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
3382 | | GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
3383 | | GO:0007019 | microtubule depolymerization | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
3384 | | GO:0045494 | photoreceptor cell maintenance | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
3385 | | GO:0009988 | cell\-cell recognition | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
3386 | | GO:0006888 | ER to Golgi vesicle\-mediated transport | 4 | 1022 | 81 | 25173 | 5.76e-01 | 0.00 | 0.00 | 1.2 |
3387 | | GO:0016071 | mRNA metabolic process | 11 | 1015 | 335 | 24919 | 5.77e-01 | 0.01 | 0.01 | 0.8 |
3388 | | GO:0009593 | detection of chemical stimulus | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
3389 | | GO:0015718 | monocarboxylic acid transport | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
3390 | | GO:0051297 | centrosome organization and biogenesis | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
3391 | | GO:0031023 | microtubule organizing center organization and biogenesis | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
3392 | | GO:0051648 | vesicle localization | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
3393 | | GO:0006775 | fat\-soluble vitamin metabolic process | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
3394 | | GO:0031497 | chromatin assembly | 6 | 1020 | 201 | 25053 | 5.88e-01 | 0.01 | 0.01 | 0.7 |
3395 | | GO:0019835 | cytolysis | 1 | 1025 | 22 | 25232 | 6.00e-01 | 0.00 | 0.00 | 1.1 |
3396 | | GO:0007223 | Wnt receptor signaling pathway\, calcium modulating pathway | 1 | 1025 | 22 | 25232 | 6.00e-01 | 0.00 | 0.00 | 1.1 |
3397 | | GO:0042254 | ribosome biogenesis and assembly | 5 | 1021 | 98 | 25156 | 6.04e-01 | 0.00 | 0.00 | 1.3 |
3398 | | GO:0006323 | DNA packaging | 7 | 1019 | 233 | 25021 | 6.13e-01 | 0.01 | 0.01 | 0.7 |
3399 | | GO:0007193 | G\-protein signaling\, adenylate cyclase inhibiting pathway | 1 | 1025 | 23 | 25231 | 6.16e-01 | 0.00 | 0.00 | 1.1 |
3400 | | GO:0051056 | regulation of small GTPase mediated signal transduction | 8 | 1018 | 250 | 25004 | 6.28e-01 | 0.01 | 0.01 | 0.8 |
3401 | | GO:0007018 | microtubule\-based movement | 6 | 1020 | 124 | 25130 | 6.46e-01 | 0.01 | 0.00 | 1.2 |
3402 | | GO:0006958 | complement activation\, classical pathway | 2 | 1024 | 34 | 25220 | 6.51e-01 | 0.00 | 0.00 | 1.4 |
3403 | | GO:0006512 | ubiquitin cycle | 23 | 1003 | 522 | 24732 | 6.55e-01 | 0.02 | 0.02 | 1.1 |
3404 | | GO:0007623 | circadian rhythm | 2 | 1024 | 37 | 25217 | 6.65e-01 | 0.00 | 0.00 | 1.3 |
3405 | | GO:0006399 | tRNA metabolic process | 7 | 1019 | 147 | 25107 | 6.73e-01 | 0.01 | 0.01 | 1.2 |
3406 | | GO:0009451 | RNA modification | 2 | 1024 | 39 | 25215 | 6.74e-01 | 0.00 | 0.00 | 1.3 |
3407 | | GO:0006367 | transcription initiation from RNA polymerase II promoter | 2 | 1024 | 40 | 25214 | 6.79e-01 | 0.00 | 0.00 | 1.2 |
3408 | | GO:0006497 | protein amino acid lipidation | 1 | 1025 | 52 | 25202 | 7.24e-01 | 0.00 | 0.00 | 0.5 |
3409 | | GO:0051494 | negative regulation of cytoskeleton organization and biogenesis | 1 | 1025 | 53 | 25201 | 7.25e-01 | 0.00 | 0.00 | 0.5 |
3410 | | GO:0007264 | small GTPase mediated signal transduction | 24 | 1002 | 560 | 24694 | 7.46e-01 | 0.02 | 0.02 | 1.1 |
3411 | | GO:0007059 | chromosome segregation | 2 | 1024 | 75 | 25179 | 7.71e-01 | 0.00 | 0.00 | 0.7 |
3412 | | GO:0006835 | dicarboxylic acid transport | 2 | 1024 | 77 | 25177 | 7.71e-01 | 0.00 | 0.00 | 0.6 |
3413 | | GO:0046467 | membrane lipid biosynthetic process | 5 | 1021 | 111 | 25143 | 8.07e-01 | 0.00 | 0.00 | 1.1 |
3414 | | GO:0043087 | regulation of GTPase activity | 4 | 1022 | 127 | 25127 | 8.21e-01 | 0.00 | 0.01 | 0.8 |
3415 | | GO:0006412 | translation | 23 | 1003 | 539 | 24715 | 8.25e-01 | 0.02 | 0.02 | 1.1 |
3416 | | GO:0019941 | modification\-dependent protein catabolic process | 7 | 1019 | 199 | 25055 | 8.57e-01 | 0.01 | 0.01 | 0.9 |
3417 | | GO:0043632 | modification\-dependent macromolecule catabolic process | 7 | 1019 | 199 | 25055 | 8.57e-01 | 0.01 | 0.01 | 0.9 |
3418 | | GO:0006333 | chromatin assembly or disassembly | 11 | 1015 | 257 | 24997 | 8.73e-01 | 0.01 | 0.01 | 1.1 |
3419 | | GO:0006413 | translational initiation | 3 | 1023 | 81 | 25173 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
3420 | | GO:0022618 | protein\-RNA complex assembly | 5 | 1021 | 131 | 25123 | 1.00e+00 | 0.00 | 0.01 | 0.9 |
3421 | | GO:0022613 | ribonucleoprotein complex biogenesis and assembly | 9 | 1017 | 224 | 25030 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
3422 | | GO:0048730 | epidermis morphogenesis | 3 | 1023 | 76 | 25178 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
3423 | | GO:0000819 | sister chromatid segregation | 1 | 1025 | 39 | 25215 | 1.00e+00 | 0.00 | 0.00 | 0.6 |
3424 | | GO:0051603 | proteolysis involved in cellular protein catabolic process | 8 | 1018 | 202 | 25052 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
3425 | | GO:0044257 | cellular protein catabolic process | 8 | 1018 | 207 | 25047 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
3426 | | GO:0006511 | ubiquitin\-dependent protein catabolic process | 7 | 1019 | 196 | 25058 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
3427 | | GO:0006352 | transcription initiation | 2 | 1024 | 67 | 25187 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
3428 | | GO:0006821 | chloride transport | 3 | 1023 | 89 | 25165 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3429 | | GO:0008033 | tRNA processing | 3 | 1023 | 75 | 25179 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
3430 | | GO:0008360 | regulation of cell shape | 2 | 1024 | 51 | 25203 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
3431 | | GO:0046474 | glycerophospholipid biosynthetic process | 2 | 1024 | 53 | 25201 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
3432 | | GO:0008654 | phospholipid biosynthetic process | 3 | 1023 | 86 | 25168 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
3433 | | GO:0007218 | neuropeptide signaling pathway | 4 | 1022 | 108 | 25146 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
3434 | | GO:0006406 | mRNA export from nucleus | 1 | 1025 | 29 | 25225 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3435 | | GO:0006405 | RNA export from nucleus | 1 | 1025 | 38 | 25216 | 1.00e+00 | 0.00 | 0.00 | 0.6 |
3436 | | GO:0006505 | GPI anchor metabolic process | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3437 | | GO:0031099 | regeneration | 1 | 1025 | 24 | 25230 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
3438 | | GO:0048193 | Golgi vesicle transport | 5 | 1021 | 135 | 25119 | 1.00e+00 | 0.00 | 0.01 | 0.9 |
3439 | | GO:0016338 | calcium\-independent cell\-cell adhesion | 1 | 1025 | 36 | 25218 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
3440 | | GO:0001756 | somitogenesis | 1 | 1025 | 31 | 25223 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3441 | | GO:0035282 | segmentation | 1 | 1025 | 45 | 25209 | 1.00e+00 | 0.00 | 0.00 | 0.5 |
3442 | | GO:0015904 | tetracycline transport | 1 | 1025 | 28 | 25226 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
3443 | | GO:0015893 | drug transport | 1 | 1025 | 33 | 25221 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
3444 | | GO:0046677 | response to antibiotic | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3445 | | GO:0051261 | protein depolymerization | 1 | 1025 | 44 | 25210 | 1.00e+00 | 0.00 | 0.00 | 0.6 |
3446 | | GO:0006383 | transcription from RNA polymerase III promoter | 1 | 1025 | 33 | 25221 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
3447 | | GO:0006220 | pyrimidine nucleotide metabolic process | 1 | 1025 | 42 | 25212 | 1.00e+00 | 0.00 | 0.00 | 0.6 |
3448 | | GO:0006612 | protein targeting to membrane | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3449 | | GO:0030317 | sperm motility | 1 | 1025 | 31 | 25223 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3450 | | GO:0032312 | regulation of ARF GTPase activity | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3451 | | GO:0032012 | regulation of ARF protein signal transduction | 1 | 1025 | 47 | 25207 | 1.00e+00 | 0.00 | 0.00 | 0.5 |
3452 | | GO:0032011 | ARF protein signal transduction | 1 | 1025 | 48 | 25206 | 1.00e+00 | 0.00 | 0.00 | 0.5 |
3453 | | GO:0006914 | autophagy | 1 | 1025 | 29 | 25225 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3454 | | GO:0007368 | determination of left/right symmetry | 1 | 1025 | 29 | 25225 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3455 | | GO:0009855 | determination of bilateral symmetry | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3456 | | GO:0009799 | determination of symmetry | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3457 | | GO:0006892 | post\-Golgi vesicle\-mediated transport | 1 | 1025 | 32 | 25222 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
3458 | | GO:0007034 | vacuolar transport | 1 | 1025 | 25 | 25229 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
3459 | | GO:0006414 | translational elongation | 1 | 1025 | 27 | 25227 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
3460 | | GO:0009798 | axis specification | 1 | 1025 | 24 | 25230 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
3461 | | GO:0006270 | DNA replication initiation | 1 | 1025 | 42 | 25212 | 1.00e+00 | 0.00 | 0.00 | 0.6 |